Sentence,class,file
Science  2010; 327:291-5; PMID:20075244; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/84/onci-1-940.PMC3489752.pdf
Nature 2011; 477:592-5; PMID:21874021;  http://dx.doi.org/10.1038/nature10394.investigated whether NLR signaling was  required for anti-tumor immunity gener - ated in response to flagellin-expressing tumor cells.,OADS,/arxiv_data1/oa_pdf/60/84/onci-1-940.PMC3489752.pdf
Proc Natl Acad Sci USA  2011; 108:9601-6; PMID:21593405; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/84/onci-1-940.PMC3489752.pdf
Nat Med 2009; 15:1170- 8; PMID:19767732; http://dx.doi.org/10.1038/ nm.2028.,OADS,/arxiv_data1/oa_pdf/60/84/onci-1-940.PMC3489752.pdf
"huber1,2,* 1Departments of t ranslational r adiation Oncology; German Cancer r esearch Center (DKFZ); h eidelberg, Germany; 2Department of r adiation Oncology; u niversity h ospital  Center; h eidelberg, Germany; 3Department of Oncology; t ongji h ospital, t ongji Medical College; h uazhong u niversity of Science and t echnology; w uhan, China; 4Oncology  early Clinical Investigation; Lilly r esearch Laboratories; Indianapolis, Indiana Keywords:  radiotherapy, TGF b, glioblastoma, combination therapy, stem cells *Correspondence to: Peter E. Huber; Email: p.huber@dkfz.de Submitted: 02/20/12; Accepted: 02/21/12http://dx.doi.org/10.4161/onci.19789median survival of 14.6 mo.",Non-OADS,/arxiv_data1/oa_pdf/2e/2a/onci-1-943.PMC3489753.pdf
Cancer Res 2011; 71:7155-67; PMID:22006998; http://dx.doi.org/10.1158/0008-5472.CAN-11-1212.,Non-OADS,/arxiv_data1/oa_pdf/2e/2a/onci-1-943.PMC3489753.pdf
Nature  2010; 468:829-33; PMID:21102433; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/2a/onci-1-943.PMC3489753.pdf
Clin Cancer Res  2010; 16:461-73; PMID:20068105; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/2a/onci-1-943.PMC3489753.pdf
Cancer Cell 2007; 11:147-60; PMID:17292826;  http://dx.doi.org/10.1016/j.ccr.2006.11.023.,Non-OADS,/arxiv_data1/oa_pdf/2e/2a/onci-1-943.PMC3489753.pdf
Cancer Cell 2009; 15:315- 27; PMID:19345330; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/2e/2a/onci-1-943.PMC3489753.pdf
"To this end, Tumor suppressor ARF The new player of innate immunity Paqui G. t ravés,1 Alfonso Luque2 and Sonsoles h ortelano3,* 1Molecular Neurobiology Laboratory; t he Salk Institute; La Jolla, CA u SA; 2Centro de Investigación en Sanidad Animal (CISA-INIA); Valdeolmos, Spain; 3unidad de Inflamación y  Cáncer, Área de Biología Celular y Desarrollo; Centro Nacional de Microbiología; Instituto de Salud Carlos III; Madrid, Spain Keywords:  inflammation, cáncer, tumor suppressor, macrophages, p19ARF *Correspondence to: Sonsoles Hortelano; Email: shortelano@isciii.es Submitted: 03/06/12; Accepted: 03/08/12http://dx.doi.org/10.4161/onci.19948we administered LPS to ARF-/- mice,  showing that ARF deficiency conferred  resistance to LPS-endotoxic shock.",Non-OADS,/arxiv_data1/oa_pdf/11/7c/onci-1-946.PMC3489754.pdf
Nat Immunol  2001; 2:947-50; PMID:11547333; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/7c/onci-1-946.PMC3489754.pdf
Curr Opin Genet Dev 1999;  9:22-30; PMID:10072356; http://dx.doi.org/10.1016/ S0959-437X(99)80004-5.,OADS,/arxiv_data1/oa_pdf/11/7c/onci-1-946.PMC3489754.pdf
EMBO J 2006; 25:4284- 92; PMID:16957780; http://dx.doi.org/10.1038/ sj.emboj.7601302.,OADS,/arxiv_data1/oa_pdf/11/7c/onci-1-946.PMC3489754.pdf
J Immunol 2011; 187:6527-38; PMID:22095712; http://dx.doi.org/10.4049/jimmu- nol.1004070.,Non-OADS,/arxiv_data1/oa_pdf/11/7c/onci-1-946.PMC3489754.pdf
Carcinogenesis  2007; 28:1140-4; PMID:17347139; http://dx.doi.org/10.1093/carcin/bgm048.,Non-OADS,/arxiv_data1/oa_pdf/11/7c/onci-1-946.PMC3489754.pdf
Mol Cell Biol 2008; 28:6557-67; PMID:18779317;  http://dx.doi.org/10.1128/MCB.01202-08.,Non-OADS,/arxiv_data1/oa_pdf/11/7c/onci-1-946.PMC3489754.pdf
Oncogene 2001; 20:1033- 41; PMID:11314038; http://dx.doi.org/10.1038/ sj.onc.1204220.,OADS,/arxiv_data1/oa_pdf/11/7c/onci-1-946.PMC3489754.pdf
"3 Taken together, there is strong  evidence that targeting Tregs can improve the efficacy of immunotherapy.Class I histone deacetylase inhibition   is a novel mechanism to target regulatory T cells   in immunotherapy Li Shen and r oberto Pili roswell Park Cancer Institute; Buffalo, NY u SA Keywords:  HDAC inhibitors, regulatory T cells, Foxp3, immunotherapy, STAT3 Abbreviations:  Tregs, regulatory T cells; HDAC, histone deacetylase; HDACi, histone deacetylase inhibitor; Teffs, effector T cells;  TSA, trichostatin A; HAT, histone acetyltransferase *Correspondence to: Li Shen and Roberto Pili; Email: li.shen@roswellpark.org and roberto.pili@roswellpark.org Submitted: 04/03/12; Accepted: 04/09/12http://dx.doi.org/10.4161/onci.20306Most current strategies to target Tregs  aim at depletion of Tregs with monoclonal  antibodies or ligand-directed toxins that bind to the cell-surface receptor, CD25, or with metronomic cyclophosphamide treatment.",Non-OADS,/arxiv_data1/oa_pdf/d1/35/onci-1-948.PMC3489755.pdf
Clin Cancer Res 2008; 14:1032-40; PMID:18281535;  http://dx.doi.org/10.1158/1078-0432.CCR-07-2056.,Non-OADS,/arxiv_data1/oa_pdf/d1/35/onci-1-948.PMC3489755.pdf
J Immunother 2002; 25:202-6; PMID:12000861;  http://dx.doi.org/10.1097/00002371-200205000- 00002.,Non-OADS,/arxiv_data1/oa_pdf/d1/35/onci-1-948.PMC3489755.pdf
Blood 2006; 107:2409-14; PMID:16304057; http://dx.doi.org/10.1182/blood- 2005-06-2399.,Non-OADS,/arxiv_data1/oa_pdf/d1/35/onci-1-948.PMC3489755.pdf
Nat Rev Cancer 2007; 7:880-7;  PMID:17957190; http://dx.doi.org/10.1038/nrc2250.5.,Non-OADS,/arxiv_data1/oa_pdf/d1/35/onci-1-948.PMC3489755.pdf
PLoS ONE 2012; 7:30815; PMID:22303460;  http://dx.doi.org/10.1371/journal.pone.0030815.,OADS,/arxiv_data1/oa_pdf/d1/35/onci-1-948.PMC3489755.pdf
Nat Med  2007; 13:1299-307; PMID:17922010; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d1/35/onci-1-948.PMC3489755.pdf
Blood 2010; 115:965-74; PMID:19996091; http://dx.doi.org/10.1182/blood- 2009-02-207118.8.,Non-OADS,/arxiv_data1/oa_pdf/d1/35/onci-1-948.PMC3489755.pdf
Science 2005; 307:269-73;  PMID:15653507; http://dx.doi.org/10.1126/sci- ence.1105166.,OADS,/arxiv_data1/oa_pdf/d1/35/onci-1-948.PMC3489755.pdf
Cancer Lett 2009; 280:233-41; PMID:19344997;  http://dx.doi.org/10.1016/j.canlet.2009.02.019.,Non-OADS,/arxiv_data1/oa_pdf/d1/35/onci-1-948.PMC3489755.pdf
"4 How two sites of inflammation promote  carcinogenesis The role of macrophages in inflammation associated  carcinogenesis Susanne Sebens1,* and h einer Schäfer2 1Department of Inflammatory Carcinogenesis; Institute for e xperimental Medicine; Kiel, Germany; 2Laboratory of Molecular Gastroenterology & h epatology; Department of  Internal Medicine I; u K-Sh Campus Kiel; Kiel, Germany Keywords:  epithelial-mesenchymal transition, macrophages, colitis associated cancer, colorectal cancer, L1CAM, CD171, Nrf2 *Correspondence to: Susanne Sebens; Email: mueerkoe@1med.uni-kiel.de Submitted: 03/07/12; Accepted: 03/08/12http://dx.doi.org/10.4161/onci.19949Moreover, this mechanism is also involved  in early carcinogenesis,5 including CRC,6  and therapy resistance,7 so that one could  expect L1CAM contributing to tumori - genic alterations in the inflamed colon during IBD.",Non-OADS,/arxiv_data1/oa_pdf/39/57/onci-1-951.PMC3489756.pdf
Gastroenterology 2011; 140:1807-16;  PMID:21530747; http://dx.doi.org/10.1053/j.gas- tro.2011.01.057.,Non-OADS,/arxiv_data1/oa_pdf/39/57/onci-1-951.PMC3489756.pdf
J Biol Chem  2011; 286:40911-21; PMID:21990354; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/39/57/onci-1-951.PMC3489756.pdf
Int Immunopharmacol 2009; 9:761- 6; PMID:19285572; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/39/57/onci-1-951.PMC3489756.pdf
Carcinogenesis 2012; 33:84-93;  PMID:22095073; http://dx.doi.org/10.1093/carcin/ bgr262.The appearance of such tumor associ - ated macrophages might have occurred  already in chronic inflammation and early carcinogenesis as indicated by our recent study in reference 4.,Non-OADS,/arxiv_data1/oa_pdf/39/57/onci-1-951.PMC3489756.pdf
Cancer Microenviron 2011; 4:141-54;  PMID:21909876; http://dx.doi.org/10.1007/s12307- 010-0052-5.8.,Non-OADS,/arxiv_data1/oa_pdf/39/57/onci-1-951.PMC3489756.pdf
Mod Pathol 2007; 20:1183-90; PMID:17873897;  http://dx.doi.org/10.1038/modpathol.3800955.,Non-OADS,/arxiv_data1/oa_pdf/39/57/onci-1-951.PMC3489756.pdf
Cancer Lett 2012; 319:66-82; PMID:22210381;  http://dx.doi.org/10.1016/j.canlet.2011.12.0356.,OADS,/arxiv_data1/oa_pdf/39/57/onci-1-951.PMC3489756.pdf
J Cell Biol  2005; 168:633-42; PMID:15716380; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/39/57/onci-1-951.PMC3489756.pdf
Oncogene  2007; 26:2759-68; PMID:17086212; http://dx.doi.org/10.1038/sj.onc.1210076.,Non-OADS,/arxiv_data1/oa_pdf/39/57/onci-1-951.PMC3489756.pdf
"Anderson Cancer Center; h ouston, t X uSA; 3university of t exas Graduate School of Biomedical Sciences; h ouston, t X uSA; 4university of t exas Medical School at  houston; h ouston, t X uSA Keywords: melanoma, tumor-infiltrating lymphocytes, CTL, CD8+ effector-memory, CD57 Abbreviations:  CTL, cytotoxic T lymphocytes; TCR, T cell receptor; TIL, tumor-infiltrating lymphocytes; ACT, adoptive T-cell  therapy; PBMC, peripheral blood mononuclear cells; Perf, perforin; GB, granzyme B; HNK-1, human natural killer-1; TN, naïve T  cells; TEM, effector-memory T cells; TTDE, terminally-differentiated effector cells *Correspondence to: Laszlo G. Radvanyi; Email: lradvanyi@mdanderson.org Submitted: 04/05/12; Accepted: 04/09/12http://dx.doi.org/10.4161/onci.20307of humans and non-human primates, but  not of mice.3 CD57 is a marker on highly  differentiated CD8+CD27-CD28- T cells  needed to control CMV and other endemic viruses in humans.",Non-OADS,/arxiv_data1/oa_pdf/56/45/onci-1-954.PMC3489757.pdf
Clin  Cancer Res 2012; 18(9):2465-2477; PMID:22307139;  http://dx.doi.org/10.1158/1078-0432.CCR-11-2034.,Non-OADS,/arxiv_data1/oa_pdf/56/45/onci-1-954.PMC3489757.pdf
Immunology 2011; 134:17-32; PMID:21711350; http://dx.doi.org/10.1111/j.1365- 2567.2011.03470.x.,Non-OADS,/arxiv_data1/oa_pdf/56/45/onci-1-954.PMC3489757.pdf
Clin Vaccine Immunol  2007; 14:74-80; PMID:17079436; http://dx.doi.org/10.1128/CVI.00250-06.ultimately differentiate into CD27-CD57-  (also CD28-) cells subset with high perfo - rin and killing activity.,Non-OADS,/arxiv_data1/oa_pdf/56/45/onci-1-954.PMC3489757.pdf
Blood  2003; 101:2711-20; PMID:12433688; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/45/onci-1-954.PMC3489757.pdf
Clin Cancer Res 2008; 14:5270-83; PMID:18698047; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/45/onci-1-954.PMC3489757.pdf
"Cancer Res 2010; 70:8378-87;  PMID:20861189; http://dx.doi.org/10.1158/0008- 5472.CAN-10-2028.In conclusion, we characterized a novel  subset of TILs in metastatic melanoma  and breast cancer that seems to be locked in a transitional state between early T EM  and fully-differentiated CTL.",Non-OADS,/arxiv_data1/oa_pdf/56/45/onci-1-954.PMC3489757.pdf
Br J Cancer  2007; 96:1879-87; PMID:17565341; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/45/onci-1-954.PMC3489757.pdf
Immunology 2003; 108:211-9; PMID:12562330;  http://dx.doi.org/10.1046/j.1365-2567.2003.01575.x.,Non-OADS,/arxiv_data1/oa_pdf/56/45/onci-1-954.PMC3489757.pdf
Immunol Rev 2011; 239:109-24; PMID:21198668;  http://dx.doi.org/10.1111/j.1600-065X.2010.00968.x.,Non-OADS,/arxiv_data1/oa_pdf/56/45/onci-1-954.PMC3489757.pdf
"Keywords:  CD137, NK cell, ADCC, synergy, antibody *Correspondence to: Ron Levy; Email: levy@stanford.edu Submitted: 03/08/12; Accepted: 03/09/12http://dx.doi.org/10.4161/onci.19974stimulatory mAb directed against CD137  enhances NK cell-mediated ADCC against tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/c0/7e/onci-1-957.PMC3489758.pdf
Nat Med 2000; 6:443-6;  PMID:10742152; http://dx.doi.org/10.1038/74704.,OADS,/arxiv_data1/oa_pdf/c0/7e/onci-1-957.PMC3489758.pdf
J Clin Oncol  2008; 26:1789-96; PMID:18347005; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c0/7e/onci-1-957.PMC3489758.pdf
J Clin Oncol 2003; 21:3940- 7; PMID:12975461; http://dx.doi.org/10.1200/JCO.2003.05.013.,Non-OADS,/arxiv_data1/oa_pdf/c0/7e/onci-1-957.PMC3489758.pdf
Blood 2011; 117:2423-32; PMID:21193697;  http://dx.doi.org/10.1182/blood-2010-08-301945.,Non-OADS,/arxiv_data1/oa_pdf/c0/7e/onci-1-957.PMC3489758.pdf
J Clin Invest 2012; 122:1066- 75; PMID:22326955; http://dx.doi.org/10.1172/ JCI61226.,Non-OADS,/arxiv_data1/oa_pdf/c0/7e/onci-1-957.PMC3489758.pdf
T rends Pharmacol  Sci 2008; 29:383-90; PMID:18599129; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c0/7e/onci-1-957.PMC3489758.pdf
Cancer Metastasis  Rev 2011; 30:97-109; PMID:21271352; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c0/7e/onci-1-957.PMC3489758.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992; http://dx.doi.org/10.1056/NEJMoa1003466.,OADS,/arxiv_data1/oa_pdf/c0/7e/onci-1-957.PMC3489758.pdf
N Engl J  Med 2011; 364:2517-26; PMID:21639810; http://dx.doi.org/10.1056/NEJMoa1104621.How might one improve the efficacy  of anti-CD137 therapy in combination with a tumor-specific mAb?,Non-OADS,/arxiv_data1/oa_pdf/c0/7e/onci-1-957.PMC3489758.pdf
"Taylor; Email: rpt@virginia.edu Submitted: 04/10/12; Accepted: 04/12/12http://dx.doi.org/10.4161/onci.20368that activate caspases in targeted cells.6  Thus, it is our contention that there is no  reliable evidence to support apoptosis as an independent stand-alone cytotoxic mecha - nism for Type I CD20 mAbs.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/onci-1-959.PMC3489759.pdf
J Immunol  2012; 188:3532-41; PMID:22368276; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/53/onci-1-959.PMC3489759.pdf
Arch Biochem Biophys  2012; PMID:22387378; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8a/53/onci-1-959.PMC3489759.pdf
Springer Seminars in  Immunopathology 2006; 28:351-64; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/53/onci-1-959.PMC3489759.pdf
Cancer Res 2010; 70:3209-17;  PMID:20354182; http://dx.doi.org/10.1158/0008- 5472.CAN-09-4109.,Non-OADS,/arxiv_data1/oa_pdf/8a/53/onci-1-959.PMC3489759.pdf
Cancer Cell 2011; 19:101- 13; PMID:21251615; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/8a/53/onci-1-959.PMC3489759.pdf
J Immunol  2004; 172:3280-8; PMID:14978136; http://dx.doi.org/10.1016/j.jim.2004.08.004.,OADS,/arxiv_data1/oa_pdf/8a/53/onci-1-959.PMC3489759.pdf
J Immunol 2006; 177:7435- 43; PMID:17082663; http://dx.doi.org/http://www.jimmunol.org/content/177/10/7435.full.html.9.,OADS,/arxiv_data1/oa_pdf/8a/53/onci-1-959.PMC3489759.pdf
J Clin Invest 1972; 51:575- 82; PMID:4536807; http://dx.doi.org/10.1172/ JCI106846.,Non-OADS,/arxiv_data1/oa_pdf/8a/53/onci-1-959.PMC3489759.pdf
"3 This has prompted researchers DNA methylation markers   for breast cancer prognosis Unmasking the immune component Sarah Dedeurwaerder and François Fuks* Laboratory of Cancer e pigenetics; u niversité Libre de Bruxelles; Faculty of Medicine; Brussels, Belgium Keywords:  breast cancer, DNA methylome, epigenomics, lymphocyte infiltration, tumor microenvironment Abbreviations:  ECM, extracellular matrix; ER, estrogen receptor; TAFs, tumor-associated fibroblasts; Th, T-helper lymphocyte *Correspondence to: François Fuks; Email: ffuks@ulb.ac.be Submitted: 03/12/12; Accepted: 03/12/12http://dx.doi.org/10.4161/onci.19996to evaluate the epigenetic component of  cancers, and notably breast cancers.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/onci-1-962.PMC3489760.pdf
N Engl J Med 2009; 360:790-800; PMID:19228622; http://dx.doi.org/10.1056/ NEJMra0801289.,OADS,/arxiv_data1/oa_pdf/fc/0f/onci-1-962.PMC3489760.pdf
Carcinogenesis 2010; 31:27-36; PMID:19752007; http://dx.doi.org/10.1093/carcin/bgp220.,Non-OADS,/arxiv_data1/oa_pdf/fc/0f/onci-1-962.PMC3489760.pdf
Epigenomics 2009; 1:177-200; PMID:22122642; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/0f/onci-1-962.PMC3489760.pdf
Epigenomics  2011; 3:771-84; PMID:22126295; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/0f/onci-1-962.PMC3489760.pdf
Nat Rev Immunol  2009; 9:91-105; PMID:19151746; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/0f/onci-1-962.PMC3489760.pdf
J Clin Oncol  2010; 28:105-13; PMID:19917869; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/0f/onci-1-962.PMC3489760.pdf
Nat Med  2008; 14:518-27; PMID:18438415; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/0f/onci-1-962.PMC3489760.pdf
EMBO Mol Med 2011; 3:726- 41; PMID:21910250; http://dx.doi.org/10.1002/ emmm.201100801.,Non-OADS,/arxiv_data1/oa_pdf/fc/0f/onci-1-962.PMC3489760.pdf
"emeagi, Kris t hielemans and Karine Breckpot* Laboratory of Molecular and Cellular t herapy; Department of Immunology-Physiology; Vrije u niversiteit Brussel; Laarbeeklaan, Belgium Keywords:  SMAC, lentiviral vector, dendritic cell, T cell, cancer Abbreviations:  ATP, adenosine triphosphate; CTL, cytotoxic T lymphocyte; CRT, calreticulin; DC, dendritic cell; HMGB1, high  mobility group box 1; IAP, inhibitor of apoptosis protein; LV, lentiviral vector; TLR, toll-like receptor; treg, regulatory T cell;  SMAC, second mitochondria-derived activator of caspases *Correspondence to: Karine Breckpot; Email: kbreckpo@vub.ac.be Submitted: 04/12/12; Accepted: 04/12/12http://dx.doi.org/10.4161/onci.20369the mode of tumor cell killing and linked  herewith the levels of cell death and com - ponents present within the dying tumor, determines whether or not tumor-resident immune cells, such as dendritic cells (DCs) engulf dying cells and become acti - vated, hence are able to stimulate tumor-specific CD8 + cytotoxic T lymphocytes  (CTLs).",Non-OADS,/arxiv_data1/oa_pdf/72/64/onci-1-965.PMC3489761.pdf
Anticancer Drugs 2009; 20:646- 58; PMID:19550293; http://dx.doi.org/10.1097/ CAD.0b013e32832ced78.,Non-OADS,/arxiv_data1/oa_pdf/72/64/onci-1-965.PMC3489761.pdf
J Mol Med (Berl) 1999; 77:824-33; PMID:10682318;  http://dx.doi.org/10.1007/s001099900066.,Non-OADS,/arxiv_data1/oa_pdf/72/64/onci-1-965.PMC3489761.pdf
Cell  2010; 140:798-804; PMID:20303871; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/72/64/onci-1-965.PMC3489761.pdf
PLoS One 2011; 6:21556;  PMID:21738708; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/72/64/onci-1-965.PMC3489761.pdf
Cancer Res 2006; 66:4987-90;  PMID:16707417; http://dx.doi.org/10.1158/0008- 5472.CAN-05-4676.7.,Non-OADS,/arxiv_data1/oa_pdf/72/64/onci-1-965.PMC3489761.pdf
BMC  Cancer 2010; 10:327; PMID:20576118; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/64/onci-1-965.PMC3489761.pdf
Hum Gene Ther  2007; 18:536-46; PMID:17576158; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/72/64/onci-1-965.PMC3489761.pdf
Cancer Res 2012; 72:1342-52;  PMID:22379024; http://dx.doi.org/10.1158/0008- 5472.CAN-11-2400.,Non-OADS,/arxiv_data1/oa_pdf/72/64/onci-1-965.PMC3489761.pdf
"Conejo-Garcia4,* 1Department of Medicine; w eill Cornell Medical College; New York, NY u SA; 2the r agon Institute of MG h; MIt and h arvard; Charlestown, MA u SA; 3Department of Medicine;  Dartmouth Medical School; Lebanon, N h uSA; 4tumor Microenvironment and Metastasis Program; t he w istar Institute; Philadelphia, PA u SA Keywords:  microRNA, immunosuppression, dendritic cell, tumor immunology, ovarian cancer *Correspondence to: Jose R. Conejo-Garcia; Email: jrconejo@Wistar.org Submitted: 03/09/12; Accepted: 03/12/12http://dx.doi.org/10.4161/onci.20020immunosuppression, thereby promoting  malignant progression.2,3 More relevant  for translational purposes, we also showed that tumor-associated DCs can be trans - formed into effective antigen-presenting cells in the right milieu.",Non-OADS,/arxiv_data1/oa_pdf/99/dd/onci-1-968.PMC3489762.pdf
Proc Natl Acad Sci USA  2008; 105:7004-9; PMID:18458333; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/dd/onci-1-968.PMC3489762.pdf
Cell Cycle 2010;  9:260-8; PMID:20023378; http://dx.doi.org/10.4161/ cc.9.2.10430.,OADS,/arxiv_data1/oa_pdf/99/dd/onci-1-968.PMC3489762.pdf
J Exp Med 2012; 209:495- 506; PMID:22351930; http://dx.doi.org/10.1084/jem.20111413.4.,Non-OADS,/arxiv_data1/oa_pdf/99/dd/onci-1-968.PMC3489762.pdf
Science 2007; 316:608- 11; PMID:17463290; http://dx.doi.org/10.1126/sci- ence.1139253.,OADS,/arxiv_data1/oa_pdf/99/dd/onci-1-968.PMC3489762.pdf
Cancer Res 2012; (Epub ahead of press); PMID:22307839; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/dd/onci-1-968.PMC3489762.pdf
Future Oncol 2009; 5:1189-92; PMID:19852731; http://dx.doi.org/10.2217/ fon.09.101.,Non-OADS,/arxiv_data1/oa_pdf/99/dd/onci-1-968.PMC3489762.pdf
N Engl J Med 2003; 348:203-13; PMID:12529460;  http://dx.doi.org/10.1056/NEJMoa020177.,OADS,/arxiv_data1/oa_pdf/99/dd/onci-1-968.PMC3489762.pdf
Science 2011; 331:1612- 6; PMID:21436454; http://dx.doi.org/10.1126/sci- ence.1198443.,OADS,/arxiv_data1/oa_pdf/99/dd/onci-1-968.PMC3489762.pdf
"3 CD200 - CD200R interaction is involved in lim - iting the cellular functions of myeloid The role of tumor expression of CD200 in tumor  formation, metastasis and susceptibility to   T lymphocyte adoptive transfer therapy Fatemeh t alebian and Xue-Feng Bai* Department of Pathology and Comprehensive Cancer Center; t he Ohio State u niversity; Columbus, O h uSA Keywords:  CD200, CD200R, tumor associated myeloid cells, T lymphocytes, agonistic antibody *Correspondence to: Xue-Feng Bai; Email: Xue-Feng.Bai@osumc.edu Submitted: 03/12/12; Accepted: 03/14/12http://dx.doi.org/10.4161/onci.20034lineage of cells, as CD200 deficient mice  were found to have hyper activation of macrophages and enhanced inflammation in autoimmune disease models.",Non-OADS,/arxiv_data1/oa_pdf/a9/8f/onci-1-971.PMC3489763.pdf
Blood 2006; 108:4194-7;  PMID:16946299; http://dx.doi.org/10.1182/blood- 2006-06-029355.,Non-OADS,/arxiv_data1/oa_pdf/a9/8f/onci-1-971.PMC3489763.pdf
Eur J Immunol 2010; 40:2569-79; PMID:20662098;  http://dx.doi.org/10.1002/eji.201040472.,Non-OADS,/arxiv_data1/oa_pdf/a9/8f/onci-1-971.PMC3489763.pdf
PLoS One 2012; 7:31442;  PMID:22319630; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/a9/8f/onci-1-971.PMC3489763.pdf
Cancer Res 2010; 70:2962-72; PMID:20332223; http://dx.doi.org/10.1158/0008- 5472.CAN-09-4380.References 1.,Non-OADS,/arxiv_data1/oa_pdf/a9/8f/onci-1-971.PMC3489763.pdf
Cell 2010; 141:39- 51; PMID:20371344; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a9/8f/onci-1-971.PMC3489763.pdf
Immunol Today 1992; 13:265-70;  PMID:1388654; http://dx.doi.org/10.1016/0167- 5699(92)90008-U.,Non-OADS,/arxiv_data1/oa_pdf/a9/8f/onci-1-971.PMC3489763.pdf
T rends Immunol 2002; 23:285- 90; PMID:12072366; http://dx.doi.org/10.1016/ S1471-4906(02)02223-8.,Non-OADS,/arxiv_data1/oa_pdf/a9/8f/onci-1-971.PMC3489763.pdf
"Therefore, NK cells might play a further important How melanoma cells inactivate NK cells Gabriella Pietra,1 Massimo Vitale,2 Lorenzo Moretta3,* and Maria Cristina Mingari1,2,4 1Dipartimento di Medicina Sperimentale; u niversità di Genova; Genova, Italy; 2IrCCS Azienda Ospedaliera u niversitaria San Martino—IS t; Istituto Nazionale per la r icerca sul  Cancro; Genova, Italy; 3Istituto Giannina Gaslini; Genova, Italy; 4Centro di e ccellenza per la r icerca Biomedica; Genova, Italy Keywords:  NK cells, melanoma cells, tumor escape, IDO, PGE2 *Correspondence to: Lorenzo Moretta; Email: lorenzomoretta@ospedale-gaslini.ge.it Submitted: 04/14/12; Accepted: 04/16/12http://dx.doi.org/10.4161/onci.20405role in the elimination of tumors that  evade T-cell killing by MHC Class I anti - gen loss or downregulation.",Non-OADS,/arxiv_data1/oa_pdf/50/55/onci-1-974.PMC3489764.pdf
Cancer Res 2011; 71:5412-22;  PMID:21708957; http://dx.doi.org/10.1158/0008- 5472.CAN-10-4179.,Non-OADS,/arxiv_data1/oa_pdf/50/55/onci-1-974.PMC3489764.pdf
Eur J Immunol 2012; In press; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/50/55/onci-1-974.PMC3489764.pdf
Cancer Res 2012; 72:1407-15; PMID:22258454; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/50/55/onci-1-974.PMC3489764.pdf
Blood 2008; 111:1327- 33; PMID:17951526; http://dx.doi.org/10.1182/ blood-2007-02-074997.,Non-OADS,/arxiv_data1/oa_pdf/50/55/onci-1-974.PMC3489764.pdf
J Exp Med  2002; 195:343-51; PMID:11828009; http://dx.doi.org/10.1084/jem.20011149.possibly resulting in an altered DC edit - ing.,Non-OADS,/arxiv_data1/oa_pdf/50/55/onci-1-974.PMC3489764.pdf
Annu Rev Immunol 2011; 29:235-71;  PMID:21219185; http://dx.doi.org/10.1146/annurev- immunol-031210-101324.,Non-OADS,/arxiv_data1/oa_pdf/50/55/onci-1-974.PMC3489764.pdf
Lancet 2000; 356:1795-9;  PMID:11117911; http://dx.doi.org/10.1016/S0140- 6736(00)03231-1.,OADS,/arxiv_data1/oa_pdf/50/55/onci-1-974.PMC3489764.pdf
J Intern Med 2009; 266:154-81; PMID:19614820;  http://dx.doi.org/10.1111/j.1365-2796.2009.02121.x.,Non-OADS,/arxiv_data1/oa_pdf/50/55/onci-1-974.PMC3489764.pdf
"J Clin Invest 2011;  121:3609-22; http://dx.doi.org/10.1172/JCI45816; PMID:21841316.which in turn become resistant to further  NK lysis.6 Notably, the inhibitory effect of mela - noma on NK cell function is reminiscent of previous data on mesenchymal stem cell (MSC)-NK cell interactions.",Non-OADS,/arxiv_data1/oa_pdf/50/55/onci-1-974.PMC3489764.pdf
"2 Tumor cells that undergo autophagy  release autophagosomes, which are impor - tant tumor antigen sources for cross-prim - ing of tumor-specific CD8+ T cells, into  the culture media.3 By inducing autophagy  and blocking protein degradation through proteasome and lysosome inhibition, Autophagy-assisted antigen cross-presentation Autophagosome as the argo of shared tumor-specific  antigens and DAMPs Yongxiang Yi,1 Zhenxian Zhou,1 Su Shu,1 Yuan Fang,1 Chris t witty,2 traci L. h ilton,5 Sandra Aung,5 walter J. u rba,4 Bernard A.  Fox,2 hong-Ming h u1,3,* and Yuhuan Li3,* 1Cancer r esearch and Biotherapy Center; Second Affiliated h ospital of Southeast u niversity; Nanjing, China; 2Laboratory of Molecular and t umor Immunology; e arle A. Chiles  research Institute; Providence Portland Medical Center; Portland, O r uSA; 3Laboratory of Cancer Immunobiology; e arle A. Chiles r esearch Institute; Providence Portland  Medical Center; Portland, O r uSA; 4earle A. Chiles r esearch Institute; Providence Portland Medical Center; Portland, O r uSA; 5ubivac; Portland, O r uSA Keywords:  autophagosome, DAMP, c-type lectin, dendritic cells, cross-presentation *Correspondence to: Hong-Ming Hu and Yuhuan Li; Email: hhu@providence.org and Yuhuan.Li@providence.org Submitted: 03/15/12; Accepted: 03/19/12http://dx.doi.org/10.4161/onci.20059we demonstrated that large amounts of  secreted autophagosomes contain abun - dant ubiquitinated antigens.",Non-OADS,/arxiv_data1/oa_pdf/76/d0/onci-1-976.PMC3489765.pdf
Biochim Biophys Acta 2009; 1793:1524- 32; PMID:19371598; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/76/d0/onci-1-976.PMC3489765.pdf
Cancer Res 2008; 68:6889-95;  PMID:18757401; http://dx.doi.org/10.1158/0008- 5472.CAN-08-0161.,Non-OADS,/arxiv_data1/oa_pdf/76/d0/onci-1-976.PMC3489765.pdf
Clin Cancer Res 2011; 17:7047-57; PMID:22068657;  http://dx.doi.org/10.1158/1078-0432.CCR-11-0951.,Non-OADS,/arxiv_data1/oa_pdf/76/d0/onci-1-976.PMC3489765.pdf
Nat Rev Immunol 2010; 10:403- 14; PMID:20498667; http://dx.doi.org/10.1038/ nri2780.5.,Non-OADS,/arxiv_data1/oa_pdf/76/d0/onci-1-976.PMC3489765.pdf
Clin  Cancer Res 2011; 17:6467-81; PMID:21810919;  http://dx.doi.org/10.1158/1078-0432.CCR-11-0812.,Non-OADS,/arxiv_data1/oa_pdf/76/d0/onci-1-976.PMC3489765.pdf
J Exp Med 2009; 206:1983-94;  PMID:19703986; http://dx.doi.org/10.1084/ jem.20090480.,Non-OADS,/arxiv_data1/oa_pdf/76/d0/onci-1-976.PMC3489765.pdf
Nature  2007; 449:564-9; PMID:17873860; http://dx.doi.org/10.1038/nature06116.8.,OADS,/arxiv_data1/oa_pdf/76/d0/onci-1-976.PMC3489765.pdf
Curr Opin Immunol  2005; 17:359-65; PMID:15955682; http://dx.doi.org/10.1016/j.coi.2005.06.002.,OADS,/arxiv_data1/oa_pdf/76/d0/onci-1-976.PMC3489765.pdf
Science 2011; 334:1573- 7; PMID:22174255; http://dx.doi.org/10.1126/sci- ence.1208347.,OADS,/arxiv_data1/oa_pdf/76/d0/onci-1-976.PMC3489765.pdf
Nat  Rev Drug Discov 2012; 11:215-33; PMID:22301798;  http://dx.doi.org/10.1038/nrd3626.,OADS,/arxiv_data1/oa_pdf/76/d0/onci-1-976.PMC3489765.pdf
"One exception is oncolytic adenovirus cod - ing for granulocyte-macrophage colony-stimulating factor (GMCSF), as Syrian hamsters seem semipermissive to both Oncolytic adenoviruses A potent form of tumor immunovirotherapy Vincenzo Cerullo,1,2,* Markus Vähä-Koskela2 and Akseli h emminki2,* 1Laboratory of Immunovirotherapy; u niversity of h elsinki; h elsinki, Finland; 2Cancer Gene t herapy Group, Molecular Cancer Biology Program & t ransplantation Laboratory   & haartman Institute; u niversity of h elsinki; h elsinki, Finland Keywords:  adenoviruses, oncolytic adenoviruses, immunotherapy, oncoimmunology, immunovirotherapy Abbreviations:  OV, oncolytic adenovirus; DC, dendritic cell; APC, antigen presenting cell; GMCSF, granulocyte-macrophage  colony-stimulating factor; ATAP, advanced therapy access program; NK, natural killer cells; T reg, regulatory T cell *Correspondence to: Vincenzo Cerullo and Akseli Hemminki; Email: vincenzo.cerullo@helsinki.fi and akseli.hemminki@helsinki.fi Submitted: 03/27/12; Accepted: 03/27/12http://dx.doi.org/10.4161/onci.20172components.",Non-OADS,/arxiv_data1/oa_pdf/bf/73/onci-1-979.PMC3489766.pdf
Cancer Res 2010; 70:4297-309; PMID:20484030;  http://dx.doi.org/10.1158/0008-5472.CAN-09-3567.,Non-OADS,/arxiv_data1/oa_pdf/bf/73/onci-1-979.PMC3489766.pdf
Nat Med 2011; 17:96- 104; PMID:21151137; http://dx.doi.org/10.1038/ nm.2270.,OADS,/arxiv_data1/oa_pdf/bf/73/onci-1-979.PMC3489766.pdf
Mol Ther 2010; 18:1874- 84; PMID:20664527; http://dx.doi.org/10.1038/mt.2010.161.4.,Non-OADS,/arxiv_data1/oa_pdf/bf/73/onci-1-979.PMC3489766.pdf
Virology 2005; 333:215- 25; PMID:15721356; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/bf/73/onci-1-979.PMC3489766.pdf
Virology  1990; 179:228-33; PMID:2171206; http://dx.doi.org/10.1016/0042-6822(90)90292-Y.8.,Non-OADS,/arxiv_data1/oa_pdf/bf/73/onci-1-979.PMC3489766.pdf
Mol Ther 2011; 19:1737- 46; PMID:21673660; http://dx.doi.org/10.1038/ mt.2011.113.,Non-OADS,/arxiv_data1/oa_pdf/bf/73/onci-1-979.PMC3489766.pdf
Mol Ther 2011; 19:1858-66; PMID:21792178; http://dx.doi.org/10.1038/ mt.2011.144.,Non-OADS,/arxiv_data1/oa_pdf/bf/73/onci-1-979.PMC3489766.pdf
"2 As regula - tory T cells (Treg) inhibit the function of effector T cells this would also go in line with the idea that a specific anti-tumoral immune reaction takes place in HNSCC, which can be suppressed by Treg.Radiochemotherapy fosters a favorable pattern   of inflammatory cells in head and neck tumors Luitpold Distel1,* and Maike Büttner2 1Department of r adiation Oncology; u niversity h ospitals; Friedrich-Alexander- university of e rlangen-Nürnberg; e rlangen, Germany; 2Institute of Pathology, Department   of Nephropathology; u niversity h ospitals; Friedrich-Alexander- university of e rlangen-Nürnberg; e rlangen, Germany Keywords:  radiochemotherapy, head and neck squamous cell carcinomas, regulatory T cells, cytotoxic T-cells Abbreviations:  RCT, radiochemotherapy; HNSSC, head and neck squamous cell carcinomas; Treg, regulatory T cells;   CTL, cytotoxic T-lymphocytes *Correspondence to: Luitpold Distel; Email: luitpold.distel@uk-erlangen.de Submitted: 03/27/12; Accepted: 03/28/12http://dx.doi.org/10.4161/onci.20200Little is known of the effect RCT has  on the intra-tumoral inflammatory infil - trate.",Non-OADS,/arxiv_data1/oa_pdf/74/b4/onci-1-982.PMC3489767.pdf
Am J Surg Pathol 2005; 29:167- 78; PMID:15644773; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/74/b4/onci-1-982.PMC3489767.pdf
Clin Cancer Res 2007; 13:4345-54; PMID:17671115;  http://dx.doi.org/10.1158/1078-0432.CCR-07-0472.,Non-OADS,/arxiv_data1/oa_pdf/74/b4/onci-1-982.PMC3489767.pdf
Oral Oncol 2009; 45:167- 74; PMID:19576838; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/74/b4/onci-1-982.PMC3489767.pdf
Oral Oncol  2012; PMID:22356894; http://dx.doi.org/10.1016/j.oraloncology.2012.01.024.,Non-OADS,/arxiv_data1/oa_pdf/74/b4/onci-1-982.PMC3489767.pdf
"Therefore, novel therapeutic A novel strategy for modulation of MDSC   to enhance cancer immunotherapy tomar Ghansah university of South Florida; Department of Molecular Medicine; t ampa, FL u SA Keywords:  myeloid-derived suppressor cells, pancreatic cancer, Src homology inositol phosphatase, immune suppression,   anti-tumor immunity Correspondence to: Tomar Ghansah; Email: tghansah@health.usf.edu Submitted: 03/27/12; Accepted: 03/28/12http://dx.doi.org/10.4161/onci..20201strategies, that can specifically restore  MDSC immune homeostasis and enhance immunotherapy responses in patients with MDSC-related cancers, are warranted.",Non-OADS,/arxiv_data1/oa_pdf/ba/b6/onci-1-984.PMC3489768.pdf
Cancer J 2010; 16:348- 53; PMID:20693846; http://dx.doi.org/10.1097/ PPO.0b013e3181eb3358.,Non-OADS,/arxiv_data1/oa_pdf/ba/b6/onci-1-984.PMC3489768.pdf
J Immunol 2009; 182:4499-506; PMID:19342621;  http://dx.doi.org/10.4049/jimmunol.0802740.,Non-OADS,/arxiv_data1/oa_pdf/ba/b6/onci-1-984.PMC3489768.pdf
Biochem Pharmacol 2011; 82:1320- 34; PMID:21672530; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ba/b6/onci-1-984.PMC3489768.pdf
Blood 2010; 116:428-36;  PMID:20445019; http://dx.doi.org/10.1182/blood-2009-10-250217.,Non-OADS,/arxiv_data1/oa_pdf/ba/b6/onci-1-984.PMC3489768.pdf
PLoS One 2011; 6:27729; PMID:22132131; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ba/b6/onci-1-984.PMC3489768.pdf
Proc Natl Acad Sci USA 2009; 106:7113- 8; PMID:19359473; http://dx.doi.org/10.1073/ pnas.0902636106.,OADS,/arxiv_data1/oa_pdf/ba/b6/onci-1-984.PMC3489768.pdf
Eur J Immunol  2010; 40:2599-607; PMID:20602434; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ba/b6/onci-1-984.PMC3489768.pdf
"How to favor lymphocyte infiltration in tumors Matteo Bellone,1,3,* Arianna Calcinotto1,3,4 and Angelo Corti1,2,3 1Cellular Immunology u nit; San r affaele Scientific Institute; Milan, Italy; 2tumor Biology and Vascular t argeting u nit; San r affaele Scientific Institute; Milan, Italy; 3Program of  Immunology, Gene t herapy and Bio-Immunotherapy of Cancer (PIBIC); San r affaele Scientific Institute; Milan, Italy; 4università Vita-Salute San r affaele; Milan, Italy Keywords:  tumor, T cells, immunotherapy, cell trafficking, endothelial cells *Correspondence to: Matteo Bellone; Email: bellone.matteo@hsr.it Submitted: 03/29/12; Accepted: 03/29/12http://dx.doi.org/10.4161/onci.20213aminopeptidase N (CD13) isoform selec - tively expressed by EC in tumor vessels.3  Because of these properties this drug  (originally developed by our group and called NGR-TNF) can increase the pen - etration of various chemotherapy agents in tumors.",Non-OADS,/arxiv_data1/oa_pdf/5f/f8/onci-1-986.PMC3489769.pdf
Cancer Res 2010; 70:6171-80;  PMID:20631075; http://dx.doi.org/10.1158/0008- 5472.CAN-10-0153.,Non-OADS,/arxiv_data1/oa_pdf/5f/f8/onci-1-986.PMC3489769.pdf
Clin Cancer Res 2007; 13:3951-9; PMID:17606729; http://dx.doi.org/10.1158/1078- 0432.CCR-07-0374.,Non-OADS,/arxiv_data1/oa_pdf/5f/f8/onci-1-986.PMC3489769.pdf
Science 2005; 307:58-62; PMID:15637262; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/f8/onci-1-986.PMC3489769.pdf
J Immunol 2012; 188:2687-94;  PMID:22323546; http://dx.doi.org/10.4049/jimmu- nol.1101877.,Non-OADS,/arxiv_data1/oa_pdf/5f/f8/onci-1-986.PMC3489769.pdf
FASEB J 2006; 20:621-30; PMID:16581970; http://dx.doi.org/10.1096/fj.05- 4493com.,Non-OADS,/arxiv_data1/oa_pdf/5f/f8/onci-1-986.PMC3489769.pdf
Clin Cancer Res 2006; 12:6808-16;  PMID:17121902; http://dx.doi.org/10.1158/1078- 0432.CCR-06-1558.References 1.,Non-OADS,/arxiv_data1/oa_pdf/5f/f8/onci-1-986.PMC3489769.pdf
Nat Biotechnol 2000; 18:1185-90; PMID:11062439;  http://dx.doi.org/10.1038/81183.,Non-OADS,/arxiv_data1/oa_pdf/5f/f8/onci-1-986.PMC3489769.pdf
Nat Rev Cancer 2010; 10:505-14; PMID:20574450;  http://dx.doi.org/10.1038/nrc2868.,Non-OADS,/arxiv_data1/oa_pdf/5f/f8/onci-1-986.PMC3489769.pdf
T rends Immunol 2008; 29:235- 41; PMID:18375183; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5f/f8/onci-1-986.PMC3489769.pdf
"Studies using tumor cells tagged with the ovalbumin protein, which Turning the tumor microenvironment   into a self vaccine site Delia J. Nelson Immunology and Cancer Group; School of Biomedical Sciences; Curtin u niversity; Kent St.; Bentley; Perth, w A Australia; western Australian Biomedical r esearch Institute;  Bentley; Perth, w A Australia; Curtin h ealth Innovation r esearch Institute; Bentley; Perth, w A Australia Keywords:  inflammation, innate immune cells, T cells, B cells, tumor endothelia, immunotherapy Correspondence to: Delia Nelson; Email: delia.nelson@curtin.edu.au Submitted: 03/15/12; Accepted: 03/30/12http://dx.doi.org/10.4161/onci.20238acts as a cancer neo-antigen, were used to  track tumor specific immune responses.",Non-OADS,/arxiv_data1/oa_pdf/fa/31/onci-1-989.PMC3489770.pdf
Int Immunol 2012; PMID:22354912;  http://dx.doi.org/10.1093/intimm/dxs005.,OADS,/arxiv_data1/oa_pdf/fa/31/onci-1-989.PMC3489770.pdf
J Clin Invest  2008; 118:1691-9; PMID:18398504; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fa/31/onci-1-989.PMC3489770.pdf
Int Immunol 2008; 20:1467-79;  PMID:18824504; http://dx.doi.org/10.1093/intimm/ dxn104.,Non-OADS,/arxiv_data1/oa_pdf/fa/31/onci-1-989.PMC3489770.pdf
Cancer Immunol  Immunother 2012; 61:549-60; PMID:22002241;  http://dx.doi.org/10.1007/s00262-011-1120-5.3.,Non-OADS,/arxiv_data1/oa_pdf/fa/31/onci-1-989.PMC3489770.pdf
Eur Respir J 2009; 34:162-75; PMID:19251786; http://dx.doi.org/10.1183/09031936.00101008.,Non-OADS,/arxiv_data1/oa_pdf/fa/31/onci-1-989.PMC3489770.pdf
Immunol Cell Biol 1999; 77:552-8; PMID:10571677;  http://dx.doi.org/10.1046/j.1440-711.1999.00876.x.,Non-OADS,/arxiv_data1/oa_pdf/fa/31/onci-1-989.PMC3489770.pdf
Immunol Cell Biol 2011; 89:255- 67; PMID:20628372; http://dx.doi.org/10.1038/ icb.2010.88.,Non-OADS,/arxiv_data1/oa_pdf/fa/31/onci-1-989.PMC3489770.pdf
"In this system, purified T cells added acutely to human lung tumor slices behave exactly like TIL already present in the resected tumor: they Within tumors, interactions between T cells   and tumor cells are impeded   by the extracellular matrix hélène Salmon and e mmanuel Donnadieu* Institut Cochin; u niversité Paris Descartes; CN rS (uMr 8104); Inserm; u 1016; Paris, France Keywords:  T lymphocyte, human lung tumor, stroma, chemokines, extracellular matrix, migration *Correspondence to: Emmanuel Donnadieu; Email: emmanuel.donnnadieu@inserm.fr Submitted: 03/30/12; Accepted: 04/02/12http://dx.doi.org/10.4161/onci.20239migrate preferentially in the stroma, very  rarely in the tumor islets.",Non-OADS,/arxiv_data1/oa_pdf/85/7c/onci-1-992.PMC3489771.pdf
J Clin Invest 2012; 122:899- 910; PMID:22293174; http://dx.doi.org/10.1172/ JCI45817.,Non-OADS,/arxiv_data1/oa_pdf/85/7c/onci-1-992.PMC3489771.pdf
J Exp Med  2011; 208:1949-62; PMID:21930770; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/7c/onci-1-992.PMC3489771.pdf
J Clin Oncol  2008; 26:4410-7; PMID:18802153; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/7c/onci-1-992.PMC3489771.pdf
J Cell Biol 2012; 196:395-406; PMID:22351925; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/7c/onci-1-992.PMC3489771.pdf
Cell 2011; 146:148- 63; PMID:21729786; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/85/7c/onci-1-992.PMC3489771.pdf
Cancer Cell 2012; 21:418- 29; PMID:22439937; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/85/7c/onci-1-992.PMC3489771.pdf
Cell  2009; 139:891-906; PMID:19931152; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/7c/onci-1-992.PMC3489771.pdf
Proc Natl Acad Sci USA  2011; 108:2909-14; PMID:21282607; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/7c/onci-1-992.PMC3489771.pdf
"Partial cross-protection against Sound efficacy of prophylactic HPV vaccination Basics and implications Matti Lehtinen1,* and Jorma Paavonen2 1university of t ampere; t ampere, Finland; 2university of h elsinki; h elsinki, Finland Keywords:  papillomavirus, cervical neoplasia, persistent infection, cervical cancer, vaccination, vaccine efficacy *Correspondence to: Matti Lehtinen; Email: matti.lehtinen@uta.fi Submitted: 02/29/12; Accepted: 03/12/12http://dx.doi.org/10.4161/onci.20011HPV31/33/35/45/51 and associated  sequelae is the key to the overall efficacy.6,7 The basis for the cross-protection may  be comparable conformational structure close to the major neutralizing VLP epi - topes that are recognized by HPV16.V5 and HPV18.J4 antibodies in the FG and HI loops of the corresponding viral pen - tamers.",Non-OADS,/arxiv_data1/oa_pdf/de/b5/onci-1-995.PMC3489772.pdf
Scand J Infect  Dis 2005; 37:873-6; PMID:16308223; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/b5/onci-1-995.PMC3489772.pdf
J Biol Chem 2007; 282:31803- 11; PMID:17804402; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/de/b5/onci-1-995.PMC3489772.pdf
J Gen Virol 2008; 89:117-29; PMID:18089735;  http://dx.doi.org/10.1099/vir.0.83145-0.,Non-OADS,/arxiv_data1/oa_pdf/de/b5/onci-1-995.PMC3489772.pdf
Proc Natl Acad Sci USA  1983; 80:3812-5; PMID:6304740; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/b5/onci-1-995.PMC3489772.pdf
N Engl J Med 2002; 347:1645-51; PMID:12444178; http://dx.doi.org/10.1056/ NEJMoa020586.,OADS,/arxiv_data1/oa_pdf/de/b5/onci-1-995.PMC3489772.pdf
"3 BRAFi have response  rates of approximately 50%, although by 6 mo 50% of patients develop resis - tance 4 to the BRAFi principally through Combined targeted therapy and immunotherapy  in the treatment of advanced melanoma James S. w ilmott,1,2,* richard A. Scolyer,1,2,3 Georgina V. Long1,2,4 and Peter h ersey1,2,5 1Melanoma Institute Australia; Sydney, NS w Australia; 2university of Sydney; Sydney, NS w Australia; 3royal Prince Alfred h ospital; Sydney, NS w Australia; 4westmead h ospital;  Sydney, NS w Australia; 5Kolling Institute; r oyal North Shore h ospital; Sydney, NS w Australia Keywords:  BRAF, BRAF mutation, CTLA-4, immunotherapy, immune response, melanoma, pathology, tumor infiltrating  lymphocytes, targeted therapy *Correspondence to: James S. Wilmott; Email: james.wilmott@smu.org.au Submitted: 02/29/12; Accepted: 03/12/12http://dx.doi.org/10.4161/onci.19865oncogenic-rerouting.5 These two new  clinically efficacious agents have differ - ent mechanisms of action in treatment of  metastatic melanoma; one is an immune-modulator enhancing the body’s immune-response against the tumor and the other inhibits a signal transduction pathway and directly inhibits tumor proliferation.",Non-OADS,/arxiv_data1/oa_pdf/ef/3f/onci-1-997.PMC3489773.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;  http://dx.doi.org/10.1056/NEJMoa1003466.,OADS,/arxiv_data1/oa_pdf/ef/3f/onci-1-997.PMC3489773.pdf
J Clin Oncol 2011; 29:1239- 46; PMID:21343559; http://dx.doi.org/10.1200/ JCO.2010.32.4327.,Non-OADS,/arxiv_data1/oa_pdf/ef/3f/onci-1-997.PMC3489773.pdf
N Engl J Med 2011; 364:2507- 16; PMID:21639808; http://dx.doi.org/10.1056/ NEJMoa1103782.,OADS,/arxiv_data1/oa_pdf/ef/3f/onci-1-997.PMC3489773.pdf
Biochem Pharmacol 2011; 82:201- 9; PMID:21635872; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ef/3f/onci-1-997.PMC3489773.pdf
Clin Cancer Res 2012; 18:1386-94;  PMID:22156613; http://dx.doi.org/10.1158/1078- 0432.CCR-11-2479.,Non-OADS,/arxiv_data1/oa_pdf/ef/3f/onci-1-997.PMC3489773.pdf
J Exp Med  2006; 203:1651-6; PMID:16801397; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/3f/onci-1-997.PMC3489773.pdf
Proc Natl Acad Sci USA 2010; 107:4275-80; PMID:20160101; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/3f/onci-1-997.PMC3489773.pdf
http://www.cbs.nl/nl-NL/menu/themas/ bevolking/cijfers/default.htm .,Non-OADS,/arxiv_data1/oa_pdf/07/65/10608_2011_Article_9407.PMC3490066.pdf
"The hydrophobic amino acids involved in the interdomain  association of phospholipase D1 regulate the shuttling of phospholipase D1 from vesicular organelles into the nucleus Young Hoon Jang1 and Do Sik Min1,2,3  1Department of Molecular Biology College of Natural SciencePusan National UniversityBusan 609-735, Korea 2Translational Research Center for Protein Function Control Yonsei UniversitySeoul 137-701, Korea 3Corresponding author: Tel, 82-51-510-3682;  Fax, 82-51-513-9258; E-mail, minds@pusan.ac.kr http://dx.doi.org/10.38 58/emm.2012.44.10.065 Accepted 18 July 2012 Available Online 24 July 2012 Abbreviations: CF-PLD1, C-terminal fragment-PLD1; HEK293,  human embryonic kidney 293; Lamp1, lysosomal-associated  membrane protein 1; LC3, microtubule associated protein light c hain  3; NF-PLD1, N-terminal fragment-PLD1; NLS, nuclear localization   sequence; PA, phosphatidic acid; PLD1, phospholipase D1; RFP,  red fluorescence protein  Abstract Phospholipase D (PLD) catalyzes the hydrolysis of  phosphatidylcholine to generate the lipid second mes-senger, phosphatidic acid.",Non-OADS,/arxiv_data1/oa_pdf/41/b5/emm-44-571.PMC3490078.pdf
"Peroxisome proliferator-activated receptor δ agonist  attenuates hepatic steatosis by anti-inflammatory mechanism Mi Young Lee1, Ran Choi1, Hong Min Kim1,  Eun Ju Cho1, Bo Hwan Kim2, Yeon Sik Choi1,  Jarinyaporn Naowaboot1, Eun Young Lee3,  Young Chul Yang4, Jang Yel Shin1,  Young Goo Shin1 and Choon Hee Chung1,5,6  1Department of Internal Medicine Yonsei University Wonju College of MedicineWonju 220-701, Korea 2Department of Nursing Gachon University of Medicine and ScienceIncheon 406-799, Korea 3Department of Internal Medicine Soonchunhyang University College of MedicineCheonan 336-745, Korea 4Department of Anatomy 5Institute of Lifestyle Medicine Yonsei University Wonju College of MedicineWonju 220-701, Korea 6Corresponding author: Tel, 82-33-741-0506;  Fax, 82-33-731-5884; E-mail, cchung@yonsei.ac.krhttp://dx.doi.org/10.38 58/emm.2012.44.10.066 Accepted 19 July 2012 Available Online 24 July 2012 Abbreviations: ALT, alanine transaminase; AST, aspartate trans- aminase; CPT-1, carnitine palmityl transferase-1; IPGTT, intra- peritoneal glucose tolerance test; IVITT, intravenous insulin t oler- ance test; LETO, Long-Evans Tokushima Otsuka; MCP-1, monocyte chemo-attractant protein-1; NAFLD, non-alcoholic fatty liver di sease;  NASH, nonalcoholic steatohepatitis; OLETF, Otsuka Long-Evans  Tokushima Fatty; PGC-1 α, peroxisome proliferator-activated re- ceptor-γ coactivator-1 α; PPAR, peroxisome proliferator-activated re- ceptors; PPRE, peroxisome proliferators response element; RXR,  retinoid X-receptor; TG, triglyceride  Abstract Although peroxisome proliferator receptor (PPAR)- α  and PPAR- γ agonist have been developed as chemical  tools to uncover biological roles for the PPARs such as lipid and carbohydrate metabolism, PPAR- δ has  not been fully investigated.",Non-OADS,/arxiv_data1/oa_pdf/ee/d8/emm-44-578.PMC3490079.pdf
Supplemental data Supplemental data include a table and can be found with  this article online at http://e-emm.or.kr/article/article_files/  SP-44-10-02.pdf.,OADS,/arxiv_data1/oa_pdf/ee/d8/emm-44-578.PMC3490079.pdf
")*These authors contributed equally to this work.http://dx.doi.org/10.38 58/emm.2012.44.10.067 Accepted 30 July 2012 Available Online 31 July 2012 Abbreviations: DCF-DA, 2 ',7'-dichlorofluorescein diacetate; MDA,  malondialdehyde; PTD, protein transduction domain; ROS, reactiv e  oxygen species  Abstract Reactive oxygen species (ROS) contribute to the devel- opment of a number of neuronal diseases including  ischemia.",Non-OADS,/arxiv_data1/oa_pdf/04/6a/emm-44-586.PMC3490080.pdf
"Increased arginase II activity contributes to endothelial  dysfunction through endothelial nitric oxide synthase uncoupling in aged mice Woosung Shin1, Dan E. Berkowitz2,3  and Sungwoo Ryoo1,4 1Department of Biology College of Natural SciencesKangwon National UniversityChuncheon 200-701, Korea 2Department of Anesthesiology and Critical Care Medicine 3Department of Biomedical Engineering Johns Hopkins Medical InstitutionsBaltimore, MD 21287, USA 4Corresponding author: Tel, 82-33-250-8534;  Fax, 82-33-251-3990; E-mail, ryoosw08@kangwon.ac.kr http://dx.doi.org/10.38 58/emm.2012.44.10.068 Accepted 27 July 2012 Available Online 2 August 2012 Abbreviations: ABH, 2 (S)-amino-6-boronohexanoic acid; Ach,  acetylcholine; Arg I, arginase I; ArgII, arginase II; DAF, 4-am ino-  5-methylamino-2 ', 7'-difluorescein; DHE, dihydroethidium; L-arg,  L-arginine; L-NAME, L-NG-nitroarginine methyl ester; MnTBAP, Mn  (III)tetrakis (4-benzoic acid) porphyrin chloride; ns, not sign ificant;  ROS, reactive oxygen species; siArgII, siRNA to arginase II  Abstract The incidence of cardiovascular disease is predicted  to increase as the population ages.",Non-OADS,/arxiv_data1/oa_pdf/c8/77/emm-44-594.PMC3490081.pdf
"Antiobesity activity of a sphingosine 1-phosphate analogue  FTY720 observed in adipocytes and obese mouse model Myung-Hee Moon, Jae-Kyo Jeong,  Ju-Hee Lee, Yang-Gyu Park, You-Jin Lee,  Jae-Won Seol and Sang-Youel Park1 Biosafty Research Institute College of Veterinary MedicineChonbuk National UniversityJeonju 561-756, Korea 1Corresponding author: Tel, 82-63-270-3886;  Fax, 82-63-270-3780; E-mail, sypark@chonbuk.ac.kr http://dx.doi.org/10.38 58/emm.2012.44.10.069 Accepted 2 August 2012 Available Online 3 August 2012 Abbreviations: ATGL, adipose TG lipase; C/EBP, CCAAT/enhancer  binding proteins; cAMP, cyclic AMP; DG, diglycerides; GSK3, glycogen synthase kinase 3; HSL, hormone-sensitive lipase; PPAR γ,  peroxisome proliferator-activated receptor γ; S1P, sphingosine-1-  phosphate; TGs, triglycerides  Abstract Higher levels of body fat are associated with an  increased risk for development numerous adverse  health conditions.",Non-OADS,/arxiv_data1/oa_pdf/83/53/emm-44-603.PMC3490082.pdf
"Effects of echinomycin on endothelin-2 expression and  ovulation in immature rats primed with gonadotropins Zhengchao Wang1,3, Zhenghong Zhang1,2,  Yanqing Wu1, Liyun Chen1, Qianping Luo1,  Jisen Zhang1, Jiajie Chen1, Zimiao Luo1,  Xiaohong Huang1 and Yong Cheng2 1Provincial Key Laboratory for Developmental Biology  and NeurosciencesCollege of Life SciencesFujian Normal UniversityFuzhou 350007, P. R. China 2Provincial Research Center for  Animal Transgenesis and Biopharm ing College of Veterinary MedicineYangzhou UniversityYangzhou 225009, P. R. China 3Corresponding author: Tel, 86-591-22868203;  Fax, 86-591-22868199; E-mail, zcwang@fjnu.edu.cnhttp://dx.doi.org/10.38 58/emm.2012.44.10.070 Accepted 7 August 2012 Available Online 8 August 2012 Abbreviations: dsODN, oligodeoxynucleotide; ET-2, endothelin-2;   HIF-1, hypoxia-inducible factor-1 α; HRE, hypoxia-response element;  OHSS, ovarian hyperstimulation syndrome; PCOS, polycystic ovari an  syndrome  Abstract Echinomycin is a small-molecule inhibitor of hypo- xia-inducible factor-1 DNA-binding activity, which plays a crucial role in ovarian ovulation in mammalians.",Non-OADS,/arxiv_data1/oa_pdf/25/dc/emm-44-615.PMC3490083.pdf
"Hepatic STAMP2 decreases hepatitis B virus X  protein-associated metabolic deregulation Hye Young Kim1, Hyun Kook Cho1,  Seong Keun Yoo2 and JaeHun Cheong1,3,4  1Department of Molecular Biology College of Natural SciencesPusan National UniversityBusan 609-735, Korea 2Department of Biological Sciences College of Life Science and BioengineeringKorea Advanced Institute of Science and TechnologyDeajeon 305-701, Korea  3Mitochondria Hub Regulation Center Busan 602-714, Korea 4Corresponding author: Tel, 82-51-510-2277;  Fax, 82-51-513-9258; E-mail, molecule85@pusan.ac.krhttp://dx.doi.org/10.38 58/emm.2012.44.10.071 Accepted 27 July 2012 Available Online 8 October 2012 Abbreviations: COX-2, cyclooxygenase-2; HBx, hepatitis B virus  X protein; HCC, hepatocellular carcinoma; IR, insulin receptor;  I R S ,   insulin receptor substrate; PI3K, phosphatidylinositol 3-kinase ; PKB,  protein kinase B; SREBP1, sterol regulatory element-binding pro tein  1; STAMP2, six transmembrane protein of prostate 2; STEAP4, six transmembrane epithelial antigen of prostate 4  Abstract Six transmembrane protein of prostate 2 (STAMP2)  plays a key role in linking inflammatory and diet-de-rived signals to systemic metabolism.",Non-OADS,/arxiv_data1/oa_pdf/f9/5a/emm-44-622.PMC3490084.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2012 665 Korean J Urol 2012;53:665-672www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.10.665 Review Article Chemoprevention of Prostate Cancer: Soy Isoflavones and  Curcumin Shigeo Horie Department of Urology, Teikyo University School of Medicine, Tokyo, Japan The burden of increasing morbid ity and mortality due to prostate cancer imposes a need  for new, effective measures of prevention in daily life.",Non-OADS,/arxiv_data1/oa_pdf/84/84/kju-53-665.PMC3490085.pdf
"Key Words:  Chemoprevention; Curcumin; Isof lavones; Prostate neoplasms This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 10 September, 2012 accepted 28 September, 2012 Corresponding Author: Shigeo HorieDepartment of Urology, Teikyo  University School of Medicine,  2-11-1, Kaga, Itabashi-ku, Tokyo 173-8605, Japan TEL: +81-3-3964-2497 FAX: +81-3-3964-8934E-mail: shorie@med.teikyo-u.ac.jp INTRODUCTION Prostate cancer is a growing threat to Asian men’s health  [1].",Non-OADS,/arxiv_data1/oa_pdf/84/84/kju-53-665.PMC3490085.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2012 673 Korean J Urol 2012;53:673-679www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.10.673 Urological Oncology Influence of Nonregional Lymph Node Metastasis as a Prognostic  Factor in Metastatic Prostate Cancer Patients Seok Cho, Sung Gu Kang, Bum Sik Tae, Jun Cheon Department of Urology, Korea Univ ersity Anam Hospital, Seoul, Korea Purpose:  In advanced prostate cancer, malignant  cells generally tend to spread into  the bone, and metastasis into nonregional ly mph nodes (NRLNs) at the time of initial  diagnosis is relatively rare.",Non-OADS,/arxiv_data1/oa_pdf/09/45/kju-53-673.PMC3490086.pdf
"Key Words:  Lymphatic metastasis; Prog nosis; Prostatic neoplasm This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 5 June, 2012 accepted 31 July, 2012 Corresponding Author: Jun Cheon Department of Urology, Korea  University Anam Hospital, 73 Inchon-ro, Seongbuk-gu, Seoul  136-705, Korea TEL: +82-2-920-5367FAX: +82-2-928-7864 E-mail: jcheon@korea.ac.kr INTRODUCTION Prostate cancer is the most commonly diagnosed nonskin  malignancy in men and is the second leading cause of can-cer-related death in the United States [1].",Non-OADS,/arxiv_data1/oa_pdf/09/45/kju-53-673.PMC3490086.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2012 680 Korean J Urol 2012;53:680-685www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.10.680 Urological Oncology Changes in Prostate Cancer Aggressiveness over a 12-Year Period  in Korea Doejung Kim, Daeheon Choi, Ju Hyun Lim, Jong Hyun Yoon1, In Gab Jeong, Dalsan You,  Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 1National Medical Center, Seoul, Korea Purpose:  To investigate whether tumor aggressive ness in patients with prostate cancer  has changed in Korea since the introduction of prostate-specific antigen (PSA) testing.",Non-OADS,/arxiv_data1/oa_pdf/a7/ff/kju-53-680.PMC3490087.pdf
"Key Words:  Korea; Neoplasm gradin g; Prostatic neoplasms  This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 5 June, 2012 accepted 16 August, 2012 Corresponding Author: Choung-Soo Kim  Department of Urology, Asan Medical  Center, University of Ulsan College of  Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea TEL: +82-2-3010-3734 FAX: +82-2-477-8928E-mail: cskim@amc.seoul.kr INTRODUCTION Prostate cancer is a very common cancer in Western  populations.",Non-OADS,/arxiv_data1/oa_pdf/a7/ff/kju-53-680.PMC3490087.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2012 686 Korean J Urol 2012;53:686-690www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.10.686 Urological Oncology The Prostate Cancer Detection Rate on the Second Prostate Biopsy  according to Prostate-Specific Antigen Trend Hyung-Sang Kim, Chang-Yong Lee, Dong-Hun Lim, Chul-Sung Kim, Seung Baik Department of Urology, Chosun University School of Medicine, Gwangju, Korea Purpose:  To identify the prostate cancer detect ion rate on the patients who had second  prostate biopsy out of the patients who were  reported negative in their first biopsy.",Non-OADS,/arxiv_data1/oa_pdf/92/a8/kju-53-686.PMC3490088.pdf
"Key Words:  Biopsy; Prostate; Prostate-specific antigen; Prostatic neoplasms This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 21 June, 2012 accepted 30 July, 2012 Corresponding Author: Seung Baik Department of Urology, Chosun  University Hospital, Chosun University School of Medicine, 365 Pilmun-  daero, Dong-gu, Gwangju 501-717,  KoreaTEL: +82-62-220-3218 FAX: +82-62-232-3210 E-mail: luve98@hanmail.net INTRODUCTION Prostate cancer is diagnosed through prostate needle biop- sy when there is an abnorma l finding in screening tests  such as prostate-specific antigen (PSA), digital rectal ex-amination (DRE), or transrectal ultrasonography (TRUS).",Non-OADS,/arxiv_data1/oa_pdf/92/a8/kju-53-686.PMC3490088.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2012 691 Korean J Urol 2012;53:691-698www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.10.691 Voiding Dysfunction Ultrasound Characteristics of Patients with Urinary Stress  Incontinence with or without Genital Prolapse Vesna S. Antovska Department for Urogynaecology and Pelvic Floor Disorders, University Clinic for Gynaecology and Obstetrics, Medical Faculty, Un iversity  ""Saint Cyril and Methodius"", Skopje, Republic of Macedonia, Europe Purpose:  The study purpose was to evaluate the clinical and ultrasound characteristics  of women with urinary stress incontinence (U SI) with or without ge nital prolapse (GP).",Non-OADS,/arxiv_data1/oa_pdf/9a/65/kju-53-691.PMC3490089.pdf
"Key Words:  Pelvic organ prolapsed; POP-Q ; Ul trasonography; Urinary incontinence  stress This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 28 February, 2012 accepted 12 April, 2012 Corresponding Author: Vesna S. Antovska Department for Urogynaecology and  Pelvic Floor Disorders, University Clinic  for Gynaecology and Obstetrics, Medical Faculty, University ""Saint Cyril  and Methodius"", ul.",Non-OADS,/arxiv_data1/oa_pdf/9a/65/kju-53-691.PMC3490089.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2012 699 Korean J Urol 2012;53:699-704www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.10.699 Urolithiasis Impact of Tamsulosin on Ureter Stone Expulsion in Korean  Patients: A Meta-Analysis of Randomized Controlled Studies Jung Keun Lee, Chang Wook Jeong, Seong Jin Jeong, Sung Kyu Hong, Seok-Soo Byun,  Sang Eun Lee Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea Purpose:  Using meta-analysis, the study’s aim wa s to evaluate the e fficacy of tamsulo- sin, an alpha-blocker, in the treatment of ureteral stones with or without shockwave  lithotripsy (SWL) in  Korean patients.",Non-OADS,/arxiv_data1/oa_pdf/f8/7c/kju-53-699.PMC3490090.pdf
"Key Words:  Adrenergic alpha-antago nists; Extracorporeal shock wave lithotripsy;  Meta-analysis; Tamsul osin; Ureteral calculi This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 30 April, 2012 accepted 25 July, 2012 Corresponding Author: Chang Wook JeongDepartment of Urology, Seoul National  University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu,  Seongnam 463-707, Korea TEL: +82-31-787-7347FAX: +82-31-787-4057 E-mail: drboss@snubh.org INTRODUCTION Urinary stone disease affects 5 to 10% of the world’s pop- ulation, and it is one of the most common reasons for pa-tients to visit a urologic clin ic [1].",Non-OADS,/arxiv_data1/oa_pdf/f8/7c/kju-53-699.PMC3490090.pdf
2.11.0 (http://www.r-project.org/).,Non-OADS,/arxiv_data1/oa_pdf/f8/7c/kju-53-699.PMC3490090.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2012 705 Korean J Urol 2012;53:705-710www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.10.705 Infertility Effects of Carthamus tinctorius on Semen Quality and Gonadal  Hormone Levels in Partially Sterile Male Rats Soghra Bahmanpour, Zahra Vojdani, Mohamad Reza Panjehshahin1, Hassan Hoballah, Hamza Kassas Departments of Anatomical Sciences and 1Pharmacology, Shiraz University of Medical Sciences, Shiraz, Iran Purpose:  Traditional herbal medicine is just one of the many different approaches using  plants in the remedy of diseases.",Non-OADS,/arxiv_data1/oa_pdf/2a/95/kju-53-705.PMC3490091.pdf
"Key Words:  Carthamus tinctorius; Gonadal hormones; Rats; Semen analysis This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 8 May, 2012 accepted 10 August, 2012 Corresponding Author: Soghra Bahmanpour Department of Anatomical Sciences,  School of Medicine, Shiraz University  of Medical Sciences, Zand street, Shiraz 71344, Iran TEL: +98-711-2304372 FAX: +98-711-2304372E-mail: bahmans@sums.ac.ir INTRODUCTION Herbal medicine is a complementary therapy that uses  plants to treat disease.",Non-OADS,/arxiv_data1/oa_pdf/2a/95/kju-53-705.PMC3490091.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2012 711 Korean J Urol 2012;53:711-715www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.10.711 Pediatric Urology Risk Factors for the Development of Urethrocutaneous Fistula after  Hypospadias Repair: A Retrospective Study Jae-Wook Chung, Seock Hwan Choi, Bum Soo Kim, Sung Kwang Chung Department of Urology, Kyungpook National University School of Medicine, Daegu, Korea Purpose:  The purpose of this study was to investigate the risk factors for urethrocuta- neous fistula development after hypospadias repair.",Non-OADS,/arxiv_data1/oa_pdf/c4/38/kju-53-711.PMC3490092.pdf
"Key Words:  Fistula; Hypospadias; Risk factors This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 21 November, 2011 accepted 27 June, 2012 Corresponding Author: Sung Kwang Chung Department of Urology, Kyungpook National University Hospital,  Kyungpook National University School  of Medicine, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, Korea  TEL: +82-53-420-8541 FAX: +82-53-421-9618E-mail: skchung@mail.knu.ac.kr INTRODUCTION Urethrocutaneous fistulas after hypospadias repair re- main a significant problem for pediatric urologists despite advances in surgical techni ques.",Non-OADS,/arxiv_data1/oa_pdf/c4/38/kju-53-711.PMC3490092.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2012 716 Korean J Urol 2012;53:716-720www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.10.716 Pediatric Urology Abnormal Dimercaptosuccinic Acid Scan May Be Related to  Persistence of Vesicoureteral Reflux in Children with Febrile Urinary Tract Infection Hyun Chong Ki, Sun-Ouck Kim, Dong Hun Yoo, In Sang Hwang, Eu Chang Hwang, Kyung Jin Oh,  Seung Il Jung, Taek Won Kang, Dongdeuk Kwon, Kwangsung Park, Soo Bang Ryu Department of Urology, Chonnam National University Medical School, Gwangju, Korea Purpose:  This study assessed whether 99mtechnetium dimercaptosuccinic acid (DMSA)  scintigraphy used for the assessment of re nal sequelae after febrile urinary tract in- fection (UTI) has any prognostic value for outcome measurement of vesicoureteral re-flux (VUR) by retrospectively evaluating the correlation between abnormal DMSA scin- tigraphy results and persistence of  VUR in children with febrile UTI.",Non-OADS,/arxiv_data1/oa_pdf/2c/7e/kju-53-716.PMC3490093.pdf
"Key Words:  Technetium Tc 99m dimercaptosucci nic acid; Urinary tract infections;  Vesico-ureteral reflux This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 15 January, 2012 accepted 9 August, 2012 Corresponding Author: Sun-Ouck Kim Department of Urology, Chonnam  National University Hospital, Chonnam  National University Hospital and Medical School, 42 Jebong-ro,  Dong-gu, Gwangju 501-757, Korea TEL: +82-62-220-6705FAX: +82-62-227-1643 E-mail: seinsena@hanmail.net INTRODUCTION Urinary tract infection (UTI) is one of the most common dis- eases in children [1], and vesi coureteral reflux (VUR) is es- timated to occur in 25 to 50% of children with febrile UTI  [2,3].",Non-OADS,/arxiv_data1/oa_pdf/2c/7e/kju-53-716.PMC3490093.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2012 721 Korean J Urol 2012;53:721-725www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.10.721 Transplantation Clinical Assessment of Follow-Up Cystatin C-Based eGFR in Live  Kidney Donors Hyun Ho Han, Kyung Hwa Choi, Seung Choul Yang, Woong Kyu Han Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea Purpose:  We aimed to compare the cystatin C- based estimated glomerular filtration  rate (eGFR) and the serum creatinine-based eGFR and to investigate the clinical roles  of the cystatin C-based eGFR in assessing th e follow-up renal function of kidney donors.",Non-OADS,/arxiv_data1/oa_pdf/2b/b6/kju-53-721.PMC3490094.pdf
"Key Words:  Kidney function tests; Kidney transp lantation; Living donors; Nephrectomy  This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 25 May, 2012 accepted 8 August, 2012 Corresponding Author: Woong Kyu HanDepartment of Urology, Urological  Science Institute, Yonsei University  College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752,  Korea TEL: +82-2-2228-2325FAX: +82-2-312-2538 E-mail: hanwk@yuhs.ac  INTRODUCTION Long-term studies of healthy kidney donors have shown  that living kidney donation is safe and rarely affects the in- dividual’s health [1].",Non-OADS,/arxiv_data1/oa_pdf/2b/b6/kju-53-721.PMC3490094.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2012 726 Korean J Urol 2012;53:726-732www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.10.726 Investigative Urology Synergistic Effect of Mesenchymal Stem Cells Infected with  Recombinant Adenovirus Expressing Human BDNF on Erectile Function in a Rat Model of Cavernous Nerve Injury  Su Jin Kim, Sae Woong Choi, Kyung Jae Hur, Sang Hoon Park1, Young Chul Sung1, Y-Shin Ha,  Hyuk Jin Cho, Sung-Hoo Hong, Ji Youl Lee, Tae-Kon Hwang, Sae Woong Kim Department of Urology, The Catholic University of Korea School of Medicine, Seoul, 1Division of Molecular and Life Science, Integrative  Bioscience and Biotechnology, WCU, Pohang University of Science and Technology (POSTECH), Pohang, Korea Purpose:  To evaluate the combined role of me scenchymal stem cells (MSCs) infected  with recombinant adenoviruses expressing human BDNF (rAd/hBDNF) on the erectile  dysfunction in rat with cavernous nerve injury.",Non-OADS,/arxiv_data1/oa_pdf/a3/50/kju-53-726.PMC3490095.pdf
"Key Words:  Brain-derived growth factor; Erectile dysfunction; Stem cells This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 2 July, 2012 accepted 6 September, 2012 Corresponding Author: Sae Woong Kim Department of Urology, Seoul St.  Mary’s Hospital, The Catholic  University of Korea School of Medicine,  222 Banpo-daero, Seocho-gu, Seoul  137-701, KoreaTEL: +82-2-2258-6226 FAX: +82-2-599-7839 E-mail: ksw1227@catholic.ac.kr INTRODUCTION At present, the number of radical prostatectomy proce- dures has been increasing because of the increased de-tection of prostate-confined disease owing to earlier diag-nosis by prostate-specific antigen screening.",Non-OADS,/arxiv_data1/oa_pdf/a3/50/kju-53-726.PMC3490095.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2012 733 Korean J Urol 2012;53:733-736www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.10.733 Case Report Primary Undifferentiated Penile Sarcoma in Adolescence Young Hoon Choi, Hyeon Woo Kim, Jae Hyun Ahn, Dae Sung Hwang, Jung Woo Lee, Byung Ki Lee1,  So Eun Jun1, Young Tak Lim1, Sang Don Lee, Hong Koo Ha Departments of Urology and 1Pediatrics, Pusan National Un iversity Hospital, Busan, Korea We report a case of primary penile undiffe rentiated sarcoma.",Non-OADS,/arxiv_data1/oa_pdf/e2/af/kju-53-733.PMC3490096.pdf
"Key Words:  Adolescence; Penile cancer; Sarcoma This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 24 April, 2012 accepted 16 July, 2012 Corresponding Author: Hong Koo HaDepartment of Urology, Pusan National  University Hospital, 179 Gudeok-ro, Seo-gu, Busan 602-739, Korea TEL: +82-51-240-7344 FAX: +82-51-247-5443E-mail: hongkooha@pusan.ac.kr Primary penile sarcoma is a rare disease.",Non-OADS,/arxiv_data1/oa_pdf/e2/af/kju-53-733.PMC3490096.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2012 737 Korean J Urol 2012;53:737-740www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.10.737 Case Report Tubal Buccal Mucosa Graft without Anastomosis of the Proximal  Urethra for Long Segment Posterior Urethral Defect Repair Byung-Dal Min, Eui-Tai Lee1, Won-Tae Kim, Yong-June Kim, Seok Joong Yun, Sang Cheol Lee,  Wun-Jae Kim Departments of Urology and 1Plastic and Reconstructive Surgery, Chungbuk National University College of Medicine, Cheongju, Korea A 31-year-old man was referred for further management of a urethral stricture.",Non-OADS,/arxiv_data1/oa_pdf/fa/60/kju-53-737.PMC3490097.pdf
"Key Words:  Mouth mucosa; Transplant s; Urethral stricture This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 9 June, 2011 accepted 4 October, 2011 Corresponding Author: Seok Joong YunDepartment of Urology, Institute for  Tumor Research, Chungbuk National University College of Medicine, 52  Naesudong-ro, Heungdeok-gu,  Cheongju 361-804, KoreaTEL: +82-43-269-6142 FAX: +82-43-269-6144 E-mail: sjyun@chungbuk.ac.kr Although most urethral strictures can be treated by endo- scopic or open surgical techniques, the management of a long segment urethral defect, especially a posterior ure-thral lesion, needs a strategic surgical plan owing to the  high rate of failure or complications.",Non-OADS,/arxiv_data1/oa_pdf/fa/60/kju-53-737.PMC3490097.pdf
"415© 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920 The small intestine is the largest part of the digestive system.",Non-OADS,/arxiv_data1/oa_pdf/9f/ea/kjpathol-46-415.PMC3490110.pdf
"Department of Pathology, Kyungpook National  University School of Medicine, 680  Gukchaebosang-ro, Jung-gu, Daegu 700-842,  Korea Tel: +82-53-420-4855 Fax: +82-53-422-9774 E-mail: gsyoon@knu.ac.krThe Korean Journal of Pathology  2012; 46: 415-422 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.415▒ ORIGINAL ARTICLE  ▒",Non-OADS,/arxiv_data1/oa_pdf/9f/ea/kjpathol-46-415.PMC3490110.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.415416 • Lee SJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/9f/ea/kjpathol-46-415.PMC3490110.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.415DPC4 in the Small Intestinal Adenocarcinomas  • 417 Statistical analysis Statistical analyses were calculated using SAS ver.,OADS,/arxiv_data1/oa_pdf/9f/ea/kjpathol-46-415.PMC3490110.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.415418 • Lee SJ, et al.",OADS,/arxiv_data1/oa_pdf/9f/ea/kjpathol-46-415.PMC3490110.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.415DPC4 in the Small Intestinal Adenocarcinomas  • 419 parative genomic hybridization, microsatellite analysis, and  SMAD4  mutational analysis.",Non-OADS,/arxiv_data1/oa_pdf/9f/ea/kjpathol-46-415.PMC3490110.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.415420 • Lee SJ, et al.",OADS,/arxiv_data1/oa_pdf/9f/ea/kjpathol-46-415.PMC3490110.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.415DPC4 in the Small Intestinal Adenocarcinomas  • 421 Table 4.,Non-OADS,/arxiv_data1/oa_pdf/9f/ea/kjpathol-46-415.PMC3490110.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.415422 • Lee SJ, et al.",OADS,/arxiv_data1/oa_pdf/9f/ea/kjpathol-46-415.PMC3490110.pdf
"478pISSN 1738-1843 eISSN 2092-8920 © 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/b6/kjpathol-46-478.PMC3490111.pdf
"Department of Pathology, West China Hospital of  Stomatology, Sichuan University, Sichuan 610041,  China  Tel: +86-28-61153399 Fax: +86-28-61153399 E-mail: chen_yuhx@163.comThe Korean Journal of Pathology  2012; 46: 478-482 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.478▒ CASE REPORT  ▒",Non-OADS,/arxiv_data1/oa_pdf/41/b6/kjpathol-46-478.PMC3490111.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.478A GCOC Arising from CCOT  • 479 A B CFig.,Non-OADS,/arxiv_data1/oa_pdf/41/b6/kjpathol-46-478.PMC3490111.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.478480 • Zhu Z-Y , et al.",OADS,/arxiv_data1/oa_pdf/41/b6/kjpathol-46-478.PMC3490111.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.478A GCOC Arising from CCOT  • 481 DISCUSSION GCOC is a rare malignant tumor with no more than 30 cases  reported in the English language medical literature.,Non-OADS,/arxiv_data1/oa_pdf/41/b6/kjpathol-46-478.PMC3490111.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.478482 • Zhu Z-Y , et al.",OADS,/arxiv_data1/oa_pdf/41/b6/kjpathol-46-478.PMC3490111.pdf
"429© 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920 Gallbladder carcinoma is the fifth most common malignancy  of the alimentary system and most common malignant tumor  of the biliary tract.1 Due to its nonspecific symptoms, early di - agnosis is difficult, and it is therefore usually diagnosed at an  advanced and inoperable state.",Non-OADS,/arxiv_data1/oa_pdf/63/c8/kjpathol-46-429.PMC3490112.pdf
"Department of Pathology, Kosin University Gospel  Hospital, Kosin University College of Medicine, 262  Gamcheon-ro, Seo-gu, Busan 602-702, Korea Tel: +82-51-990-6744 Fax: +82-51-241-7420 E-mail: hurbang@ns.kosinmed.or.krThe Korean Journal of Pathology  2012; 46: 429-435 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.429▒ ORIGINAL ARTICLE  ▒",Non-OADS,/arxiv_data1/oa_pdf/63/c8/kjpathol-46-429.PMC3490112.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.429430 • Kim S-M, et al.",Non-OADS,/arxiv_data1/oa_pdf/63/c8/kjpathol-46-429.PMC3490112.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.429MUC1, MUC4, Gallbladder Adenocarcinoma  • 431 A B C D Fig.",Non-OADS,/arxiv_data1/oa_pdf/63/c8/kjpathol-46-429.PMC3490112.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.429432 • Kim S-M, et al.",OADS,/arxiv_data1/oa_pdf/63/c8/kjpathol-46-429.PMC3490112.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.429MUC1, MUC4, Gallbladder Adenocarcinoma  • 433 Fig.",Non-OADS,/arxiv_data1/oa_pdf/63/c8/kjpathol-46-429.PMC3490112.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.429434 • Kim S-M, et al.",OADS,/arxiv_data1/oa_pdf/63/c8/kjpathol-46-429.PMC3490112.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.429MUC1, MUC4, Gallbladder Adenocarcinoma  • 435 with	a	new	morphological 	classification 	of	cholangiocarcinoma.",Non-OADS,/arxiv_data1/oa_pdf/63/c8/kjpathol-46-429.PMC3490112.pdf
"443© 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920 The National Cancer Registration Program, which began as  the Korea Central Cancer Registry in 1980, plays an important role in determining the incidence of cancer and in forming pu­ blic policies related to cancer in Korea.",Non-OADS,/arxiv_data1/oa_pdf/ac/10/kjpathol-46-443.PMC3490113.pdf
"Department of Pathology, Kangbuk Samsung  Hospital, Sungkyunkwan University School of  Medicine, 29 Saemunan-ro, Jongno-gu,   Seoul 110-746, Korea Tel:+82-2-2001-2391 Fax: +82-2-2001-2398 E-mail: jhpath.sohn@samsung.com * So-Young Jin and Jin Hee Sohn contributed  equally to this work.The Korean Journal of Pathology  2012; 46: 443-453 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.443▒ ORIGINAL ARTICLE  ▒",Non-OADS,/arxiv_data1/oa_pdf/ac/10/kjpathol-46-443.PMC3490113.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.443444 • Jung ES, et al.",OADS,/arxiv_data1/oa_pdf/ac/10/kjpathol-46-443.PMC3490113.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.443Update of a Guideline for Cancer Registration  • 445 need modification.,Non-OADS,/arxiv_data1/oa_pdf/ac/10/kjpathol-46-443.PMC3490113.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.443446 • Jung ES, et al.",OADS,/arxiv_data1/oa_pdf/ac/10/kjpathol-46-443.PMC3490113.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.443Update of a Guideline for Cancer Registration  • 447 all gastric NETs were classified as tumors showing malignant  behavior (/3), regardless of size or type, and in the 2010 WHO  classification, all gastric NET were also classified as /3 as well.",Non-OADS,/arxiv_data1/oa_pdf/ac/10/kjpathol-46-443.PMC3490113.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.443448 • Jung ES, et al.",OADS,/arxiv_data1/oa_pdf/ac/10/kjpathol-46-443.PMC3490113.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.443Update of a Guideline for Cancer Registration  • 449 ble 5).,Non-OADS,/arxiv_data1/oa_pdf/ac/10/kjpathol-46-443.PMC3490113.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.443450 • Jung ES, et al.",OADS,/arxiv_data1/oa_pdf/ac/10/kjpathol-46-443.PMC3490113.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.443Update of a Guideline for Cancer Registration  • 451 T4.,Non-OADS,/arxiv_data1/oa_pdf/ac/10/kjpathol-46-443.PMC3490113.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.443452 • Jung ES, et al.",OADS,/arxiv_data1/oa_pdf/ac/10/kjpathol-46-443.PMC3490113.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.443Update of a Guideline for Cancer Registration  • 453 Appendix 1.,Non-OADS,/arxiv_data1/oa_pdf/ac/10/kjpathol-46-443.PMC3490113.pdf
"503© 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920 Castleman’s disease, also known as angiofollicular hyperplasia  or giant lymph node hyperplasia, is an uncommon benign lym - phoproliferative disorder, and can be histologically classified  into two distinct types: the hyaline vascular type and the plas - ma cell type.1 The hyaline vascular type is the more common of  the two, and presents microscopically with small hyaline folli - cles and intrafollicular capillary proliferation.",Non-OADS,/arxiv_data1/oa_pdf/1f/08/kjpathol-46-503.PMC3490114.pdf
"Department of Pathology, Hanyang University  College of Medicine,  222 Wangsimni-ro,  Seongdong-gu, Seoul 133-791, Korea Tel: +82-2-2290-8252  Fax: +82-2-2296-7502 E-mail: sspaik@hanyang.ac.krThe Korean Journal of Pathology  2012; 46: 503-506 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.503▒ CASE REPORT  ▒",Non-OADS,/arxiv_data1/oa_pdf/1f/08/kjpathol-46-503.PMC3490114.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.503504 • Jang SM, et al.",OADS,/arxiv_data1/oa_pdf/1f/08/kjpathol-46-503.PMC3490114.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.503Castleman’s Disease Arising in the Renal Sinus  • 505 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/1f/08/kjpathol-46-503.PMC3490114.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.503506 • Jang SM, et al.",OADS,/arxiv_data1/oa_pdf/1f/08/kjpathol-46-503.PMC3490114.pdf
"489© 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920 Rosai-Dorfman disease (RDD) is a proliferative lesion of his - tiocytes and its etiology has not been elucidated.1 It usually  shows a self-limiting clinical course but rare fatal cases with  systemic involvement have been reported.1,2 The characteristic  histologic finding in the lymph node is dilatation of sinuses  filled with numerous histiocytes accompanied by lymphoplas - ma cell infiltrates.",Non-OADS,/arxiv_data1/oa_pdf/15/79/kjpathol-46-489.PMC3490115.pdf
"Department of Pathology, Yonsei University College  of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul  120-752, Korea Tel: +82-2-2228-1772 Fax: +82-2-362-0860 E-mail: KJS1976@yuhs.acThe Korean Journal of Pathology  2012; 46: 489-493 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.489▒ CASE REPORT  ▒",Non-OADS,/arxiv_data1/oa_pdf/15/79/kjpathol-46-489.PMC3490115.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.489490 • Cha YJ, et al.",OADS,/arxiv_data1/oa_pdf/15/79/kjpathol-46-489.PMC3490115.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.489Rosai-Dorfman Disease in the Breast  • 491 A B CFig.,Non-OADS,/arxiv_data1/oa_pdf/15/79/kjpathol-46-489.PMC3490115.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.489492 • Cha YJ, et al.",OADS,/arxiv_data1/oa_pdf/15/79/kjpathol-46-489.PMC3490115.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.489Rosai-Dorfman Disease in the Breast  • 493 the first report of overlapping findings between the two diseas - es.5-7,13 Plasmacytic infiltration is a relatively consistent finding  in RDD, and fibrosis is also common in extranodal cases.",Non-OADS,/arxiv_data1/oa_pdf/15/79/kjpathol-46-489.PMC3490115.pdf
http://dx.doi.org/10.1007/s12282-010-0225-6.,Non-OADS,/arxiv_data1/oa_pdf/15/79/kjpathol-46-489.PMC3490115.pdf
"507© 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920 Ependymoma is a slowly-growing tumor composed of neo - plastic ependymal cells, and it accounts for 2-9% of all neuro - epithelial tumors.",Non-OADS,/arxiv_data1/oa_pdf/9a/03/kjpathol-46-507.PMC3490116.pdf
*Dr. Yoon consulted this case to Dr. Kim.The Korean Journal of Pathology  2012; 46: 507-513 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.507▒ CASE REPORT  ▒,Non-OADS,/arxiv_data1/oa_pdf/9a/03/kjpathol-46-507.PMC3490116.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.507508 • Koh MJ, et al.",OADS,/arxiv_data1/oa_pdf/9a/03/kjpathol-46-507.PMC3490116.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.507Cytologic Features of Giant Cell Ependymoma  • 509 Fig.,Non-OADS,/arxiv_data1/oa_pdf/9a/03/kjpathol-46-507.PMC3490116.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.507510 • Koh MJ, et al.",OADS,/arxiv_data1/oa_pdf/9a/03/kjpathol-46-507.PMC3490116.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.507Cytologic Features of Giant Cell Ependymoma  • 511 A B C D Fig.,Non-OADS,/arxiv_data1/oa_pdf/9a/03/kjpathol-46-507.PMC3490116.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.507512 • Koh MJ, et al.",OADS,/arxiv_data1/oa_pdf/9a/03/kjpathol-46-507.PMC3490116.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.507Cytologic Features of Giant Cell Ependymoma  • 513 14.,Non-OADS,/arxiv_data1/oa_pdf/9a/03/kjpathol-46-507.PMC3490116.pdf
"499© 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920 Perivascular epithelioid cell tumors (PEComa) comprise a  family of tumors including angiomyolipoma, lymphangiomyo - matosis, clear cell “sugar” tumor of the lung, and other visceral  and soft tissue lesions composed of distinctive perivascular epi - thelioid cells.1 Among these, angiomyolipomas are traditionally  characterized as common mesenchymal tumors of the kidneys  composed of spindle or epithelioid smooth muscle-like cells,  abnormally thick-walled and hyalinized blood vessels, and adi - pose tissue.",Non-OADS,/arxiv_data1/oa_pdf/e6/f8/kjpathol-46-499.PMC3490117.pdf
"Department of Pathology, Korea University Guro  Hospital, Korea University College of Medicine,   148 Gurodong-ro, Guro-gu, Seoul 152-703, Korea Tel: +82-2-2626-1485 Fax: +82-2-2626-1486 E-mail: pathjwy@gmail.comThe Korean Journal of Pathology  2012; 46: 499-502 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.499▒ CASE REPORT  ▒",Non-OADS,/arxiv_data1/oa_pdf/e6/f8/kjpathol-46-499.PMC3490117.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.499500 • Chang H, et al.",OADS,/arxiv_data1/oa_pdf/e6/f8/kjpathol-46-499.PMC3490117.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.499Pigmented PEComa of the Kidney  • 501 DISCUSSION In contrast to reports of epithelioid angiomyolipoma, the  black cut-surface due to heavy melanin pigmentation was a dis - tinguishing feature in this case; the differential diagnoses con - sidered for this case included malignant melanoma, pigmented  clear cell renal cell carcinoma, and composite paraganglioma.",Non-OADS,/arxiv_data1/oa_pdf/e6/f8/kjpathol-46-499.PMC3490117.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.499502 • Chang H, et al.",OADS,/arxiv_data1/oa_pdf/e6/f8/kjpathol-46-499.PMC3490117.pdf
"423© 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920 The fusion between the ETS related gene ( ERG), and the pro­ moter of the highly ­expressed transmembrane protease serine 2  (TMPRSS2 ) gene, is the most common recurrent genetic rear ­ rangement in prostate adenocarcinoma.1 It occurs in 15.3 ­72%2,3  of prostate cancers in the western population, but only in about  20.9 to 28% in Korean and Japanese populations.4­6 Studies on  the relationship between the TMPRSS2-ERG  fusion and clini ­ cal outcome in prostate adenocarcinoma yielded conflicting re ­ sults.",Non-OADS,/arxiv_data1/oa_pdf/88/3c/kjpathol-46-423.PMC3490118.pdf
"Department of Pathology, Kidney Research Institute,  Medical Research Center, Seoul National University  College of Medicine, 103 Daehak-ro, Jongno-gu,  Seoul 110-799, Korea  Tel: +82-2-2072-1767 Fax: +82-2-743-5530 E-mail: blue7270@snu.ac.krThe Korean Journal of Pathology  2012; 46: 423-428 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.423▒ ORIGINAL ARTICLE  ▒",Non-OADS,/arxiv_data1/oa_pdf/88/3c/kjpathol-46-423.PMC3490118.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.423424 • Suh JH, et al.",OADS,/arxiv_data1/oa_pdf/88/3c/kjpathol-46-423.PMC3490118.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.423ERG Immunohistochemistry in Prostate Cancer  • 425 A B C D Fig.,Non-OADS,/arxiv_data1/oa_pdf/88/3c/kjpathol-46-423.PMC3490118.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.423426 • Suh JH, et al.",OADS,/arxiv_data1/oa_pdf/88/3c/kjpathol-46-423.PMC3490118.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.423ERG Immunohistochemistry in Prostate Cancer  • 427 89.8%, and the specificity is 96.4%.",Non-OADS,/arxiv_data1/oa_pdf/88/3c/kjpathol-46-423.PMC3490118.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.423428 • Suh JH, et al.",OADS,/arxiv_data1/oa_pdf/88/3c/kjpathol-46-423.PMC3490118.pdf
"436pISSN 1738-1843 eISSN 2092-8920 © 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/c0/kjpathol-46-436.PMC3490119.pdf
"Department of Pathology, Kangbuk Samsung  Medical Center, Sungkyunkwan University School of  Medicine, 29 Saemunan-ro, Jongno-gu, Seoul  110-746, Korea Tel: +82-2-2001-2391 Fax: +82-2-2001-2398 E-mail: jhpath.sohn@samsung.com * Changyoung Yoo and Chang Suk Kang contributed  equally to this work.The Korean Journal of Pathology  2012; 46: 436-442 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.436▒ ORIGINAL ARTICLE  ▒",Non-OADS,/arxiv_data1/oa_pdf/17/c0/kjpathol-46-436.PMC3490119.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.436Guideline for Cancer Registration  • 437 for tumor or cancer registries for coding the site (topography)  and the histology (morphology) of neoplasms, which are usually  obtained from a pathologic report.",Non-OADS,/arxiv_data1/oa_pdf/17/c0/kjpathol-46-436.PMC3490119.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.436438 • Yoo C, et al.",OADS,/arxiv_data1/oa_pdf/17/c0/kjpathol-46-436.PMC3490119.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.436Guideline for Cancer Registration  • 439 gory, CCMMT was suggested to be a benign disease and the  behavior code -/0 was applied.",Non-OADS,/arxiv_data1/oa_pdf/17/c0/kjpathol-46-436.PMC3490119.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.436440 • Yoo C, et al.",OADS,/arxiv_data1/oa_pdf/17/c0/kjpathol-46-436.PMC3490119.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.436Guideline for Cancer Registration  • 441 ior code of -/0.,Non-OADS,/arxiv_data1/oa_pdf/17/c0/kjpathol-46-436.PMC3490119.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.436442 • Yoo C, et al.",OADS,/arxiv_data1/oa_pdf/17/c0/kjpathol-46-436.PMC3490119.pdf
"454pISSN 1738-1843 eISSN 2092-8920 © 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/45/kjpathol-46-454.PMC3490120.pdf
"Department of Pathology, Chonbuk National  University Medical School, 20 Geonji-ro,   Deokjin-gu, Jeonju 561-712, Korea  Tel: +82-63-270-3073 Fax: +82-63-270-3135 E-mail: hspark@jbnu.ac.kr The Korean Journal of Pathology  2012; 46: 454-462 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.454▒ ORIGINAL ARTICLE  ▒",Non-OADS,/arxiv_data1/oa_pdf/7c/45/kjpathol-46-454.PMC3490120.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.454Cortactin and FAK in CRCs  • 455 the amplified chromosome 11q13 region13 and is also frequent - ly amplified in human malignancies such as breast carcinoma,  head and neck carcinoma, and gastric adenocarcinoma.8,9,14 In  some studies, the amplification of 11q13 and overexpression of  cortactin correlate with poor prognosis for patients with lymph  node metastasis.9,14 However, overexpression has also been re - ported in tumors without that amplification.12 FAK is a 125 kDa protein tyrosine kinase which is a critical  mediator of signaling events between cells and their extracellu - lar matrix, and plays a central role in cell migration.15 FAK is  typically located at structures known as focal adhesions that are  multi-protein structures linking the extracellular matrix to the  cytoplasmic cytoskeleton.16 Additional components of focal ad - hesions include actin, filamin, cinculin, talin, paxillin, and ten - sin.17 In tumor cells, FAK is thought to have a dual function of  promoting tumor cell adhesion and inhibiting apoptosis.15 In- creased expression of FAK has been detected in tumors of the  breast, prostate, colon, and brain.16,18 Colorectal carcinoma is one of the most common carcinomas  in the world.",Non-OADS,/arxiv_data1/oa_pdf/7c/45/kjpathol-46-454.PMC3490120.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.454456 • Kim YN, et al.",OADS,/arxiv_data1/oa_pdf/7c/45/kjpathol-46-454.PMC3490120.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.454Cortactin and FAK in CRCs  • 457 microarray tissue of normal colorectal mucosa and CRC are  shown in Fig.,Non-OADS,/arxiv_data1/oa_pdf/7c/45/kjpathol-46-454.PMC3490120.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.454458 • Kim YN, et al.",OADS,/arxiv_data1/oa_pdf/7c/45/kjpathol-46-454.PMC3490120.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.454Cortactin and FAK in CRCs  • 459 in CRCs predicted neither shorter overall nor shorter relapse- free survival.,Non-OADS,/arxiv_data1/oa_pdf/7c/45/kjpathol-46-454.PMC3490120.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.454460 • Kim YN, et al.",OADS,/arxiv_data1/oa_pdf/7c/45/kjpathol-46-454.PMC3490120.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.454Cortactin and FAK in CRCs  • 461 ences in methodologies (e.g., different antibodies used to evalu - ate FAK expression) and to the fact that FAK expression does not  reflect its enzymatic activity.",Non-OADS,/arxiv_data1/oa_pdf/7c/45/kjpathol-46-454.PMC3490120.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.454462 • Kim YN, et al.",OADS,/arxiv_data1/oa_pdf/7c/45/kjpathol-46-454.PMC3490120.pdf
"494pISSN 1738-1843 eISSN 2092-8920 © 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/91/kjpathol-46-494.PMC3490121.pdf
"Department of Pathology, Asan Medical Center,  University of Ulsan College of Medicine, 88  Olympic-ro 43-gil, Songpa-gu, Seoul 138-736,  Korea Tel: +82-2-3010-4514 Fax: +82-2-472-7898 E-mail: krkim@amc.seoul.krThe Korean Journal of Pathology  2012; 46: 494-498 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.494▒ CASE REPORT  ▒",Non-OADS,/arxiv_data1/oa_pdf/3f/91/kjpathol-46-494.PMC3490121.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.494Pseudosarcomatous Polyp of Vagina  • 495 Grossly, the soft polyp measured 3.0 ×1.6×1.2 cm.",Non-OADS,/arxiv_data1/oa_pdf/3f/91/kjpathol-46-494.PMC3490121.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.494496 • Song JS, et al.",OADS,/arxiv_data1/oa_pdf/3f/91/kjpathol-46-494.PMC3490121.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.494Pseudosarcomatous Polyp of Vagina  • 497 tion is based on the fact that these lesions have no clearly de - fined margins.2 Another hypothesis is based on the finding that  the stromal cells of FSPs can express ER and the PR, suggest - ing that hormonal influences could play a role in the pathogen - esis of this lesion.2 Notably, in the study of Nucci et al.,2 14 out  of 33 patients were pregnant, while 4 others were taking hor - monal agents such as tamoxifen or oral progesterone.",Non-OADS,/arxiv_data1/oa_pdf/3f/91/kjpathol-46-494.PMC3490121.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.494498 • Song JS, et al.",OADS,/arxiv_data1/oa_pdf/3f/91/kjpathol-46-494.PMC3490121.pdf
"483© 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920 Extraskeletal chondrosarcoma is a rare neoplasm, which was  first described in the surgical pathologic record of Henry Hos - pital in 1919.1 There are two histological types of extraskeletal  chondrosarcomas, namely, the myxoid and mesenchymal types.",Non-OADS,/arxiv_data1/oa_pdf/b5/da/kjpathol-46-483.PMC3490122.pdf
"Department of Orthopedic Surgery, Chonnam  National University Hospital, Chonnam National  University Medical School, 42 Jebong-ro, Dong-gu,  Gwangju 501-757, Korea Tel: +82-62-227-1640  Fax: +82-62-225-7794  E-mail: stjung@chonnam.ac.krThe Korean Journal of Pathology  2012; 46: 483-488 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.483▒ CASE REPORT  ▒",Non-OADS,/arxiv_data1/oa_pdf/b5/da/kjpathol-46-483.PMC3490122.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.483484 • Seo C-Y , et al.",OADS,/arxiv_data1/oa_pdf/b5/da/kjpathol-46-483.PMC3490122.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.483EMC in the Axillary Region  • 485 diotherapy (6,000 cGy over 30 treatment sessions) was initiated.",Non-OADS,/arxiv_data1/oa_pdf/b5/da/kjpathol-46-483.PMC3490122.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.483486 • Seo C-Y , et al.",OADS,/arxiv_data1/oa_pdf/b5/da/kjpathol-46-483.PMC3490122.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.483EMC in the Axillary Region  • 487 conventional chondrosarcoma, for which only 1% of tumors are  extraskeletal, mesenchymal chondrosarcoma developed in soft  tissues in almost half of reported cases.",Non-OADS,/arxiv_data1/oa_pdf/b5/da/kjpathol-46-483.PMC3490122.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.483488 • Seo C-Y , et al.",OADS,/arxiv_data1/oa_pdf/b5/da/kjpathol-46-483.PMC3490122.pdf
"470pISSN 1738-1843 eISSN 2092-8920 © 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/85/kjpathol-46-470.PMC3490123.pdf
"Department of Pathology, Soonchunhyang  University College of Medicine, 31 Suncheonhyang  6-gil, Dongnam-gu, Cheonan 330-721, Korea Tel: +82-41-570-3582 Fax: +82-41-570-2455 E-mail: mhoh0212@hanmail.netThe Korean Journal of Pathology  2012; 46: 470-477 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.470▒ ORIGINAL ARTICLE  ▒",Non-OADS,/arxiv_data1/oa_pdf/e0/85/kjpathol-46-470.PMC3490123.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.470Ezrin Expression in Non-small Cell Lung Cancer  • 471 8.0; range, 42 to 82 years), and the mean tumor size was 3.8 cm  (standard deviation 1.9; range, 1.0 to 8.6 cm).",OADS,/arxiv_data1/oa_pdf/e0/85/kjpathol-46-470.PMC3490123.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.470472 • Lee HW, et al.",OADS,/arxiv_data1/oa_pdf/e0/85/kjpathol-46-470.PMC3490123.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.470Ezrin Expression in Non-small Cell Lung Cancer  • 473 Survival analysis At the time of analysis, the number of cancer-specific deaths  was 64 (57.1%).",OADS,/arxiv_data1/oa_pdf/e0/85/kjpathol-46-470.PMC3490123.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.470474 • Lee HW, et al.",OADS,/arxiv_data1/oa_pdf/e0/85/kjpathol-46-470.PMC3490123.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.470Ezrin Expression in Non-small Cell Lung Cancer  • 475 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/e0/85/kjpathol-46-470.PMC3490123.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.470476 • Lee HW, et al.",OADS,/arxiv_data1/oa_pdf/e0/85/kjpathol-46-470.PMC3490123.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.470Ezrin Expression in Non-small Cell Lung Cancer  • 477 German	J	Clin	Oncol	2010;	9:	381-4.,Non-OADS,/arxiv_data1/oa_pdf/e0/85/kjpathol-46-470.PMC3490123.pdf
"407© 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920 Cystic and cavitary pulmonary lesions are commonly encoun - tered during chest radiography, and their differential diagnoses  include diverse benign and malignant diseases caused by many  different processes of acquired or congenital origin.1,2 Morgagni  firstly described the term “pulmonary cyst” in 1769, and Grawitz  made the first attempt to classify this group of pathologies in  1880.3 Traditionally, the term “cyst” is used to describe an air- containing space surrounded by a relatively thin wall (less than  4 mm), and the term “cavity” is used to describe an air-contain - ing space within a pulmonary consolidation with a relatively  thick wall (more than 4 mm) or within a surrounding infiltrate  or mass identified upon radiological examination.1 Pulmonary  cystic and cavitary lesions may coexist.",Non-OADS,/arxiv_data1/oa_pdf/19/da/kjpathol-46-407.PMC3490124.pdf
"Department of Pathology, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81  Irwon-ro, Gangnam-gu, Seoul 135-710, Korea Tel: +82-2-3410-2765 Fax: +82-2-3410-6393  E-mail: hanjho@skku.edu The Korean Journal of Pathology  2012; 46: 407-414 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.407▒ REVIEW  ▒",Non-OADS,/arxiv_data1/oa_pdf/19/da/kjpathol-46-407.PMC3490124.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.407408 • Kim NR and Han J sions is congenital, such as bronchopulmonary foregut malfor - mation.10-12 This condition includes bronchogenic cysts, pul - monary sequestration, congenital pulmonary airway malforma - tion (CPAM), congenital lobar emphysema or congenital lobar  over-inflation, bronchial atresia, and congenital pulmonary cysts.",Non-OADS,/arxiv_data1/oa_pdf/19/da/kjpathol-46-407.PMC3490124.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.407Cystic and Cavitary Lung Diseases  • 409 showing bronchial atresia and deficiency of cartilage in the in - volved lobe suggests developmental emphysema rather than an  acquired one.14 Lymphoid interstitial pneumonia (LIP) is a rare  disease with a pathology of diffuse pulmonary lymphohistiocyt - ic proliferation and characterized by predominant interstitial  involvement sparing blood vessels and airways as well as rela - tive preservation of the pulmonary architecture.15 LIP is the most  common form of classically described interstitial pneumonia in  children and is most often associated with underlying autoim - mune disease and immunodeficiency status.16 Thin-walled peri - vascular cysts may be found in the advanced stage of LIP .17 Pe- ripheral cyst of pulmonary maldevelopment in Down syndrome  consists of rare intrathoracic cystic lesions in neonates and chil - dren.10 Neoplasms, such as pleuropulmonary blastoma or post- traumatic or post-infectious cysts,1 are also rare causes of cystic  lesions in children, and aneurysmal dilation of pulmonary small  arteries is one of the congenital causes of cavitary pulmonary le - sions in neonates and children.1,18 The causes of cystic and cavitary pulmonary lesions differ in  adults in whom a simple cystic pathology is most common.3 In  some cases, CPAM may be a rare congenital malformation di - agnosed during adulthood in patients that usually present with  recurrent respiratory infections and thin-walled multi-septated  cystic lesions.14 However, these congenital malformations are  not prevalent in adults.",Non-OADS,/arxiv_data1/oa_pdf/19/da/kjpathol-46-407.PMC3490124.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.407410 • Kim NR and Han J Fig.,OADS,/arxiv_data1/oa_pdf/19/da/kjpathol-46-407.PMC3490124.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.407Cystic and Cavitary Lung Diseases  • 411 maximal wall thicknesses of 5 to 15 mm are equally divided  between benignity and malignancy.,Non-OADS,/arxiv_data1/oa_pdf/19/da/kjpathol-46-407.PMC3490124.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.407412 • Kim NR and Han J lungs, and therefore appear as diffuse cystic and cavitary lesions,  though there is radiologic preponderance of the lower lung.",Non-OADS,/arxiv_data1/oa_pdf/19/da/kjpathol-46-407.PMC3490124.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.407Cystic and Cavitary Lung Diseases  • 413 genol	2005;	184:	1247-52.,Non-OADS,/arxiv_data1/oa_pdf/19/da/kjpathol-46-407.PMC3490124.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.407414 • Kim NR and Han J 35.,Non-OADS,/arxiv_data1/oa_pdf/19/da/kjpathol-46-407.PMC3490124.pdf
"463© 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920 The endoplasmic reticulum (ER) is an essential intracellular  organelle that serves important cellular functions.",Non-OADS,/arxiv_data1/oa_pdf/d7/be/kjpathol-46-463.PMC3490125.pdf
"Department of Pathology, Chonbuk National  University Medical School, 567 Baekje-daero,  Deokjin-gu, Jeonju 561-756, Korea Tel: +82-63-270-3072 Fax: +82-63-270-3135  E-mail: mjchung@jbnu.ac.kr The Korean Journal of Pathology  2012; 46: 463-469 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.463▒ ORIGINAL ARTICLE  ▒",Non-OADS,/arxiv_data1/oa_pdf/d7/be/kjpathol-46-463.PMC3490125.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.463464 • Chu HH, et al.",OADS,/arxiv_data1/oa_pdf/d7/be/kjpathol-46-463.PMC3490125.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.463CHOP in Cervical Squamous Tumors  • 465 overnight at 4ºC.,Non-OADS,/arxiv_data1/oa_pdf/d7/be/kjpathol-46-463.PMC3490125.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.463466 • Chu HH, et al.",OADS,/arxiv_data1/oa_pdf/d7/be/kjpathol-46-463.PMC3490125.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.463CHOP in Cervical Squamous Tumors  • 467 ma.5 De Marco et al.16 reported that ERp57, an ER stress mark - er, was significantly elevated in squamous cell carcinoma tissues  compared with both dysplastic and control tissues of uterine  cervix.",Non-OADS,/arxiv_data1/oa_pdf/d7/be/kjpathol-46-463.PMC3490125.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.463468 • Chu HH, et al.",OADS,/arxiv_data1/oa_pdf/d7/be/kjpathol-46-463.PMC3490125.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2012.46.5.463CHOP in Cervical Squamous Tumors  • 469 77.,Non-OADS,/arxiv_data1/oa_pdf/d7/be/kjpathol-46-463.PMC3490125.pdf
"Bennett at sbennet@uottawa.ca URL: http://www.jove.com/video/4389 DOI: doi:10.3791/4389 Keywords: Medicine, Issue 67, Biochemistry, Immunology, Microbiology, Physiology, Anatomy, estrous cycle, vaginal cytology, hormonal status, murine reproduction, 17-beta-estradiol, progesterone, luteinizing hormone, follicle-stimulating hormone, prolactin Date Published: 9/15/2012 Citation: McLean, A.C., Valenzuela, N., Fai, S., Bennett, S.A.",Non-OADS,/arxiv_data1/oa_pdf/be/b0/jove-67-4389.PMC3490233.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4389/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/be/b0/jove-67-4389.PMC3490233.pdf
"Cheng1, Ning Su1, M. Cynthia Goh1,2 1Department of Chemistry, University of Toronto 2Institute for Optical Sciences, University of Toronto Correspondence to: M. Cynthia Goh at cgoh@chem.utoronto.ca URL: http://www.jove.com/video/4417 DOI: doi:10.3791/4417 Keywords: Bioengineering, Issue 67, Chemistry, Biochemistry, Tissue Engineering, Collagen, Self-assembly, Native, Fibrous long spacing, Segmental long spacing, AFM, atomic force microscopy Date Published: 9/20/2012 Citation: Loo, R.W., Goh, J.B., Cheng, C.C., Su, N., Goh, M.C.",Non-OADS,/arxiv_data1/oa_pdf/cc/14/jove-67-4417.PMC3490236.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4417/ Introduction Collagen is a class of structural proteins that have a triple helical structure formed from three polypeptide chains.,Non-OADS,/arxiv_data1/oa_pdf/cc/14/jove-67-4417.PMC3490236.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2012 |  67  | e3822 | Page 1 of 7Video Article Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay Derek Tilley1, Irina Levit2, John A. Samis1,3 1Applied Bioscience Program, Faculty of Science, University of Ontario Institute of Technology 2Nursing Program, Faculty of Health Sciences, University of Ontario Institute of Technology 3Medical Laboratory Science Program, Faculty of Health Sciences, University of Ontario Institute of Technology Correspondence to: John A. Samis at John.Samis@UOIT.ca URL: http://www.jove.com/video/3822 DOI: doi:10.3791/3822 Keywords: Immunology, Issue 67, Factor V, Microplate, Coagulation assay, Human plasma, Disseminated intravascular coagulation (DIC), blood clotting Date Published: 9/9/2012 Citation: Tilley, D., Levit, I., Samis, J.A.",Non-OADS,/arxiv_data1/oa_pdf/1d/13/jove-67-3822.PMC3490243.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/3822/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/1d/13/jove-67-3822.PMC3490243.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2012 |  67  | e4137 | Page 1 of 5Video Article Mouse Islet of Langerhans Isolation using a Combination of Purified Collagenase and Neutral Protease Natalie D. Stull1, Andrew Breite2, Robert McCarthy2, Sarah A. Tersey1, Raghavendra G. Mirmira1,3,4 1Department of Pediatrics and the Herman B Wells Center for Pediatric Research, Indiana University School of Medicine 2VITACYTE, LLC 3Department of Medicine, Indiana University School of Medicine 4Department of Cellular and Integrative Physiology, Indiana University School of Medicine Correspondence to: Raghavendra G. Mirmira at rmirmira@iupui.edu URL: http://www.jove.com/video/4137 DOI: doi:10.3791/4137 Keywords: Cellular Biology, Issue 67, Islet, collagenase, mouse, insulin, fluorescence Date Published: 9/7/2012 Citation: Stull, N.D., Breite, A., McCarthy, R., Tersey, S.A., Mirmira, R.G.",Non-OADS,/arxiv_data1/oa_pdf/85/06/jove-67-4137.PMC3490250.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4137/ Protocol A.,Non-OADS,/arxiv_data1/oa_pdf/85/06/jove-67-4137.PMC3490250.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2012 |  67  | e3851 | Page 1 of 6Video Article Method for the Isolation and Identification of mRNAs, microRNAs and Protein Components of Ribonucleoprotein Complexes from Cell Extracts using RIP- Chip Garrett M. Dahm1,2, Matthew M. Gubin1,2, Joseph D. Magee2, Patsharaporn Techasintana1,2, Robert Calaluce2, Ulus Atasoy1,2,3 1Molecular Microbiology and Immunology, University of Missouri 2Department of Surgery, University of Missouri 3Child Health, University of Missouri Correspondence to: Ulus Atasoy at atasoyu@missouri.edu URL: http://www.jove.com/video/3851 DOI: doi:10.3791/3851 Keywords: Genetics, Issue 67, Molecular Biology, Cellular Biology, RNA, mRNA, Ribonucleoprotein, immunoprecipitation, microarray, PCR, RIP- Chip Date Published: 9/29/2012 Citation: Dahm, G.M., Gubin, M.M., Magee, J.D., Techasintana, P., Calaluce, R., Atasoy, U.",Non-OADS,/arxiv_data1/oa_pdf/18/1e/jove-67-3851.PMC3490259.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/3851/ Protocol Experiment preparation Before starting experiment, it is critical to have all reagents, containers and utensils RNase free.",Non-OADS,/arxiv_data1/oa_pdf/18/1e/jove-67-3851.PMC3490259.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2012 |  67  | e4427 | Page 1 of 6Video Article Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects Johanna Hamel1,2, Antje Kraft1, Sven Ohl3, Sophie De Beukelaer1, Heinrich J. Audebert1,2, Stephan A. Brandt1 1Department of Neurology, Universitätsmedizin Charité 2Center for Stroke Research Berlin (CSB), Universitätsmedizin Charité 3Berlin School of Mind and Brain, Humboldt Universität zu Berlin Correspondence to: Johanna Hamel at johanna.hamel@charite.de URL: http://www.jove.com/video/4427 DOI: doi:10.3791/4427 Keywords: Medicine, Issue 67, Neuroscience, Physiology, Anatomy, Ophthalmology, compensatory oculomotor behavior, driving simulation, eye movements, homonymous hemianopia, stroke, visual field defects, visual field enlargement Date Published: 9/18/2012 Citation: Hamel, J., Kraft, A., Ohl, S., De Beukelaer, S., Audebert, H.J., Brandt, S.A. Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects.",Non-OADS,/arxiv_data1/oa_pdf/ff/98/jove-67-4427.PMC3490261.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4427/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/ff/98/jove-67-4427.PMC3490261.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2012 |  67  | e3928 | Page 1 of 8Video Article Using Unfixed, Frozen Tissues to Study Natural Mucin Distribution Miriam Cohen1, Nissi M. Varki1, Mark D. Jankowski2, Pascal Gagneux1 1Department of Cellular and Molecular Medicine, University of California, San Diego 2Biosecurity and Public Health, Los Alamos National Laboratory Correspondence to: Miriam Cohen at micohen@ucsd.edu , Pascal Gagneux at pgagneux@ucsd.edu URL: http://www.jove.com/video/3928 DOI: doi:10.3791/3928 Keywords: Medicine, Issue 67, Cellular Biology, Molecular Biology, Immunology, Biomedical Engineering, mucus, lectins, OCT, imaging, sialic acids, glycosylation Date Published: 9/21/2012 Citation: Cohen, M., Varki, N.M., Jankowski, M.D., Gagneux, P. Using Unfixed, Frozen Tissues to Study Natural Mucin Distribution.",Non-OADS,/arxiv_data1/oa_pdf/2c/fa/jove-67-3928.PMC3490269.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/3928/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/2c/fa/jove-67-3928.PMC3490269.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2012 |  67  | e4083 | Page 1 of 6Video Article A Protocol for the Identification of Protein-protein Interactions Based on 15N Metabolic Labeling, Immunoprecipitation, Quantitative Mass Spectrometry and Affinity Modulation Stefan Schmollinger1,2, Daniela Strenkert1,2, Vittoria Offeddu1,2, André Nordhues1,2, Frederik Sommer1,2, Michael Schroda1,2 1Max Planck Institute of Molecular Plant Physiology 2University of Kaiserslautern Correspondence to: Michael Schroda at Schroda@biologie.uni-kl.de URL: http://www.jove.com/video/4083 DOI: doi:10.3791/4083 Keywords: Genetics, Issue 67, Molecular Biology, Physiology, Plant Biology, 15N metabolic labeling, QUICK, protein cross-linking, Chlamydomonas, co-immunoprecipitation, molecular chaperones, HSP70 Date Published: 9/24/2012 Citation: Schmollinger, S., Strenkert, D., Offeddu, V., Nordhues, A., Sommer, F., Schroda, M. A Protocol for the Identification of Protein-protein Interactions Based on 15N Metabolic Labeling, Immunoprecipitation, Quantitative Mass Spectrometry and Affinity Modulation.",Non-OADS,/arxiv_data1/oa_pdf/50/71/jove-67-4083.PMC3490270.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4083/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/50/71/jove-67-4083.PMC3490270.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2012 |  67  | e4277 | Page 1 of 6Video Article Substrate Generation for Endonucleases of CRISPR/Cas Systems Judith Zoephel1, Srivatsa Dwarakanath1, Hagen Richter1, André Plagens1, Lennart Randau1 1Prokaryotic Small RNA Biology, Max-Planck-Institute for Terrestrial Microbiology Correspondence to: Lennart Randau at lennart.randau@mpi-marburg.mpg.de URL: http://www.jove.com/video/4277 DOI: doi:10.3791/4277 Keywords: Molecular biology, Issue 67, CRISPR/Cas, endonuclease, in vitro  transcription, crRNA, Cas6 Date Published: 9/8/2012 Citation: Zoephel, J., Dwarakanath, S., Richter, H., Plagens, A., Randau, L. Substrate Generation for Endonucleases of CRISPR/Cas Systems.",Non-OADS,/arxiv_data1/oa_pdf/87/b3/jove-67-4277.PMC3490271.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4277/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/87/b3/jove-67-4277.PMC3490271.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2012 |  68  | e4281 | Page 1 of 6Video Article Patch Clamp Recordings in Inner Ear Hair Cells Isolated from Zebrafish Rachel Einarsson1, Marshall Haden1, Gabrielle DiCiolli1, Andrea Lim1, Kolina Mah-Ginn1, Kathleen Aguilar1, Lucy Yazejian1, Bruce Yazejian1 1Natural Science Division, Pepperdine University Correspondence to: Bruce Yazejian at Bruce.Yazejian@pepperdine.edu URL: http://www.jove.com/video/4281 DOI: doi:10.3791/4281 Keywords: Neuroscience, Issue 68, Physiology, Anatomy, Cellular Biology, zebrafish, Danio rerio , hair cells, electrophysiology, patch clamp, auditory, vestibular, inner ear Date Published: 10/17/2012 Citation: Einarsson, R., Haden, M., DiCiolli, G., Lim, A., Mah-Ginn, K., Aguilar, K., Yazejian, L., Yazejian, B. Patch Clamp Recordings in Inner Ear Hair Cells Isolated from Zebrafish.",Non-OADS,/arxiv_data1/oa_pdf/68/08/jove-68-4281.PMC3490287.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4281/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/68/08/jove-68-4281.PMC3490287.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2012 |  68  | e4321 | Page 1 of 8Video Article Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer Rongying Li1,2, Kazuhiro Oka1,2,3, Vijay Yechoor1,2,3 1Department of Medicine, Baylor College of Medicine 2Division of Diabetes, Endocrinology & Metabolism, Diabetes & Endocrinology Research Center, Baylor College of Medicine 3Department of Molecular & Cellular Biology, Baylor College of Medicine Correspondence to: Vijay Yechoor at vyechoor@bcm.edu URL: http://www.jove.com/video/4321 DOI: doi:10.3791/4321 Keywords: Medicine, Issue 68, Genetics, Physiology, Gene therapy, Neurogenin3, Betacellulin, helper-dependent adenoviral vectors, Type 1 diabetes, islet neogenesis Date Published: 10/10/2012 Citation: Li, R., Oka, K., Yechoor, V. Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer.",Non-OADS,/arxiv_data1/oa_pdf/8f/ae/jove-68-4321.PMC3490299.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4321/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/8f/ae/jove-68-4321.PMC3490299.pdf
"Footnote: The viral vectors and the cell lines described here are available from the Vector Production Core Laboratory, Diabetes Research Center, Baylor College of Medicine (http://www.bcm.edu/mcb/index.cfm?pmid=7731).",Non-OADS,/arxiv_data1/oa_pdf/8f/ae/jove-68-4321.PMC3490299.pdf
"Correspondence to: He Li at hli@usuhs.mil URL: http://www.jove.com/video/3361 DOI: doi:10.3791/3361 Keywords: Medicine, Issue 68, Genetics, Physiology, Neuroscience, Immunology, PTSD, biomarker, stress, fear, startle, corticosterone, animal model, RNA, RT-PCR, gene chip, cDNA microarray, oligonucleotide microarray, amygdala, prefrontal cortex, hippocampus, cingulate cortex, hypothalamus, white blood cell Date Published: 10/10/2012 Citation: Jia, M., Meng, F., Smerin, S.E., Xing, G., Zhang, L., Su, D.M., Benedek, D., Ursano, R., Su, Y.A., Li, H. Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD.",Non-OADS,/arxiv_data1/oa_pdf/4b/bf/jove-68-3361.PMC3490307.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/3361/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/4b/bf/jove-68-3361.PMC3490307.pdf
4.Plasma CORT concentration is tested and analyzed with Active Rat Cort EIA (Diagnostic Systems Labs Inc. http://www.beckmancoulter.com/) as follows: 1.Mark the microtitration strips to be used.,Non-OADS,/arxiv_data1/oa_pdf/4b/bf/jove-68-3361.PMC3490307.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2012 |  68  | e3852 | Page 1 of 5Video Article Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood Mario A. Inchiosa Jr.1,2, Suryanarayana Pothula2, Keshar Kubal1,2, Vajubhai T. Sanchala2, Iris Navarro2 1Department of Pharmacology, New York Medical College 2Department of Anesthesiology, New York Medical College Correspondence to: Mario A. Inchiosa Jr. at mario_inchiosa@nymc.edu URL: http://www.jove.com/video/3852 DOI: doi:10.3791/3852 Keywords: Medicine, Issue 68, Immunology, Physiology, Pharmacology, low-molecular-weight-heparin, low-molecular-weight-heparin assay, LMWH point-of-care assay, anti-Factor-Xa activity, enoxaparin, heparinase, whole blood, assay Date Published: 10/12/2012 Citation: Inchiosa, M.A., Pothula, S., Kubal, K., Sanchala, V.T., Navarro, I.",Non-OADS,/arxiv_data1/oa_pdf/0c/84/jove-68-3852.PMC3490316.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/3852/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/0c/84/jove-68-3852.PMC3490316.pdf
"96, SCA39 http://www.scahq.org/sca3/events/2003/annual/abstracts/A39.pdf.",Non-OADS,/arxiv_data1/oa_pdf/0c/84/jove-68-3852.PMC3490316.pdf
"102, SCA10 http://test2.societyhq.com/sca3/events/2006/annual/SCA_2006_Abstracts.pdf#page=16 .",Non-OADS,/arxiv_data1/oa_pdf/0c/84/jove-68-3852.PMC3490316.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2012 |  68  | e4214 | Page 1 of 6Video Article Cell Specific Analysis of Arabidopsis  Leaves Using Fluorescence Activated Cell Sorting Jesper T. Grønlund1, Alison Eyres1, Sanjeev Kumar1, Vicky Buchanan-Wollaston1,2, Miriam L. Gifford1,2 1School of Life Sciences, University of Warwick 2Warwick Systems Biology, University of Warwick Correspondence to: Jesper T. Grønlund at j.t.gronlund@warwick.ac.uk URL: http://www.jove.com/video/4214 DOI: doi:10.3791/4214 Keywords: Plant Biology, Issue 68, Cellular Biology, Molecular Biology, Leaf protoplasts, fluorescence activated cell sorting, FACS, green fluorescent protein, GFP, cell type specificity, developmental stage specificity Date Published: 10/4/2012 Citation: Grønlund, J.T., Eyres, A., Kumar, S., Buchanan-Wollaston, V., Gifford, M.L.",Non-OADS,/arxiv_data1/oa_pdf/c7/7a/jove-68-4214.PMC3490320.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4214/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/c7/7a/jove-68-4214.PMC3490320.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2012 |  68  | e4093 | Page 1 of 7Video Article Expansion of Embryonic and Adult Neural Stem Cells by In Utero Electroporation or Viral Stereotaxic Injection Benedetta Artegiani*1, Christian Lange*1, Federico Calegari1 1DFG - Research Center and Cluster of Excellence for Regenerative Therapies Dresden, Germany *These authors contributed equally Correspondence to: Federico Calegari at federico.calegari@crt-dresden.de URL: http://www.jove.com/video/4093 DOI: doi:10.3791/4093 Keywords: Stem Cell Biology, Issue 68, Neuroscience, Developmental Biology, Neural stem cells (NSC), brain development, adult neurogenesis, cyclin-dependent kinase 4 (cdk4), cyclin D1, in utero  electroporation, viral stereotaxic injection Date Published: 10/6/2012 Citation: Artegiani, B., Lange, C., Calegari, F. Expansion of Embryonic and Adult Neural Stem Cells by In Utero  Electroporation or Viral Stereotaxic Injection.",Non-OADS,/arxiv_data1/oa_pdf/de/79/jove-68-4093.PMC3490322.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4093/ Protocol Preliminary note Surgery must be performed by fully trained investigators upon approval from the local authorities for animal welfare.,Non-OADS,/arxiv_data1/oa_pdf/de/79/jove-68-4093.PMC3490322.pdf
"2011 )(http://omabrowser.org ,l a s t accessed March 25, 2011).",Non-OADS,/arxiv_data1/oa_pdf/54/92/evs082.PMC3490412.pdf
Supplementary Material Supplementary ﬁgure S1 andtables S1–S8 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe .oxfordjournals.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/92/evs082.PMC3490412.pdf
Available at http://www.python.org .,OADS,/arxiv_data1/oa_pdf/54/92/evs082.PMC3490412.pdf
"This is an Open Access article distrib uted under the terms of the Creative Co mmons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial reuse, distribution, and reproduction in any medium, provide d the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/64/evs078.PMC3490414.pdf
The nucleotide sequences obtained were processed with the Phred/Phrap/Consed package ( http://www.phrap.org/phredphrapconsed .html ).,OADS,/arxiv_data1/oa_pdf/62/64/evs078.PMC3490414.pdf
"Putative Trichomonas pro- tein kinases and peptidases were identiﬁed by sequence com- parison with datasets downloaded from the KinBase ( http:// www.kinase.com )a n dt h eM E R O P S( http://merops.sanger.ac .uk) databases, respectively.",OADS,/arxiv_data1/oa_pdf/62/64/evs078.PMC3490414.pdf
The results of all experiments are available in the Array- Express database ( http://www.ebi.ac.uk/arrayexpress/ ) under the array design name TvArray v1.0.,OADS,/arxiv_data1/oa_pdf/62/64/evs078.PMC3490414.pdf
The complete dataset including genes expression of which was not affected by iron was de-posited in the ArrayExpress database ( http://www.ebi.ac.uk/ arrayexpress/ ) under the array design name TvArray v1.0.,OADS,/arxiv_data1/oa_pdf/62/64/evs078.PMC3490414.pdf
Supplementary Material Supplementary ﬁgure S1 and tables S1–S4 are available atGenome Biology and Evolution online ( http://www.gbe .oxfordjournals.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/64/evs078.PMC3490414.pdf
"This is an Open Access article distrib uted under the terms of the Creative Co mmons Attribution Non-Commercial Lic ense (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/c1/evs058.PMC3490415.pdf
Supplementary Material Supplementary ﬁgure S1 andtables S1–S13 are available at Genome Biology and Evolution online ( http://www.gbe .oxfordjournals.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/20/evs077.PMC3490416.pdf
"This is an Open Access article distrib uted under the terms of the Creative Co mmons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial reuse, distribution, and reproduction in any medium, provide d the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/70/evs076.PMC3490417.pdf
"This is an Open Access article distrib uted under the terms of the Creative Co mmons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial reuse, distribution, and reproduction in any medium, provide d the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/a5/evs070.PMC3490418.pdf
"All genomes were downloaded from Ensembl genome browser ( http://www.ensembl.org , release 59, last accessed October 3, 2012) ( Flicek et al.",OADS,/arxiv_data1/oa_pdf/c5/a5/evs070.PMC3490418.pdf
"Genome Size Data on genome size were retrieved from the Animal Genome Size Database ( http://www.genomesize.com , last accessed October 3, 2012).",OADS,/arxiv_data1/oa_pdf/c5/a5/evs070.PMC3490418.pdf
"To account for the evolutionary nonin-dependence of trait data, we used the program BayesTraits(http://www.evolution.rdg.ac.uk , last accessed October 3, 2012), which integrates PGLS in a Bayesian framework(Pagel 1999 ).",OADS,/arxiv_data1/oa_pdf/c5/a5/evs070.PMC3490418.pdf
Available from: http://www.emea.europa.eu/htms/human/epar/a.htm     Janssen Products LP .,Non-OADS,/arxiv_data1/oa_pdf/05/c0/LAL-053-2151.PMC3490475.pdf
"[14]  Available from: http://emc.medicines.org.uk     Bennett CL, Silver SM, Djulbegovic B, et   al.",Non-OADS,/arxiv_data1/oa_pdf/05/c0/LAL-053-2151.PMC3490475.pdf
"Available from: http://www.fda.gov/ohrms/dockets/ac/08/briefi  ng/2008-4345b2-00-FDA-index.htm     Katodritou E, Verrou E, Hadjiaggelidou C, et   al.",Non-OADS,/arxiv_data1/oa_pdf/05/c0/LAL-053-2151.PMC3490475.pdf
[A detailed serial image movie can be seen at: http://www.shinshu-u.ac.jp/faculty/ medicine/chair/ent/MRIleft.mov]Comparison of diagnostic value in patients with Meniere ’s disease 143,Non-OADS,/arxiv_data1/oa_pdf/6b/62/OTO-132-0141.PMC3490481.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop- erly cited.Human Molecular Genetics, 2012, Vol.",Non-OADS,/arxiv_data1/oa_pdf/68/47/dds351.PMC3490514.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop- erly cited.Human Molecular Genetics, 2012, Vol.",Non-OADS,/arxiv_data1/oa_pdf/e8/24/dds357.PMC3490518.pdf
"The British control population consisted of 6894 subjects drawn from the British 1958 Birth Cohort (1958BC; http://wwww.cls.ioe.ac.uk/studies.asp?section=000100020003) and3059 subjects drawn from the UK Blood Services CommonControl Collection (UKBS-CC) ( 6,19).",Non-OADS,/arxiv_data1/oa_pdf/e8/24/dds357.PMC3490518.pdf
Statistical analysis All statistical analyses were performed in R (http://www.r-p roject.org) using the snpStats package available from the Bio-conductor project (http://www.bioconductor.org).,OADS,/arxiv_data1/oa_pdf/e8/24/dds357.PMC3490518.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop- erly cited.Human Molecular Genetics, 2012, Vol.",Non-OADS,/arxiv_data1/oa_pdf/89/e7/dds366.PMC3490522.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted   non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Dual Suppression of the Cyclin-Dependent  Kinase Inhibitors CDKN2C and CDKN1A  in Human Melanoma Ahmad Jalili, Christine Wagner , Mikhail Pashenkov , Gaurav Pathria,   Kirsten D. Mertz, Hans R. Widlund, Mathieu Lupien, Jean- Philippe Brunet,  Todd R. Golub, Georg Stingl, David E. Fisher , Sridhar Ramaswamy ,  Stephan N. Wagner Manuscript received March 3, 2012; revised July 18, 2012; accepted July 24, 2012.",Non-OADS,/arxiv_data1/oa_pdf/f6/50/djs373.PMC3490842.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted   non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Article Acceleration of Gastric tumorigenesis through MKrN1-Mediated  Posttranslational regulation of p14ArF Aram Ko, Ji-Young Shin, Jinho Seo, Kang-Duck Lee, Eun-Woo Lee, Min-Sik Lee, Han-Woong Lee, Il-Ju Choi, Jin Sook Jeong,  Kyung-Hee Chun, Jaewhan Song Manuscript received November 2, 2011; revised September 6, 2012; accepted September 7 , 2012.",Non-OADS,/arxiv_data1/oa_pdf/9c/99/djs424.PMC3490844.pdf
"*Correspondence to: Jeffrey Field; Email: jfield@upenn.edu Submitted: 02/02/12; Revised: 08/13/12; Accepted: 08/19/12 http://dx.doi.org/10.4161/cl.21882REVIEW Cellular Logistics 2:2, 105 –116; April/May/June 2012; G2012 Landes Bioscience www.landesbioscience.com Cellular Logistics 105",Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013 2.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Nature 2005; 436: 792; PMID:16094359; http://dx.doi.org/10.1038/ 436792a 4.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2002; 277:550-8; PMID:11668177; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Cytogenet Cell Genet 1997; 79:125- 31; PMID:9533029; http://dx.doi.org/10.1159/ 0001346996.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Oncogene 2007; 26:6997-7005; PMID:17486065; http://dx.doi.org/10.1038/sj.onc.1210506 8.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Cancer Biol Ther 2008; 7:1793-802; PMID:18836286; http://dx.doi.org/10.4161/cbt.7.11.6840 10.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Biochemistry 1997; 36:16059-64; PMID:9405039; http://dx.doi.org/10.1021/bi9717845 12.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2007; 282:15667-78; PMID: 17392278; http://dx.doi.org/10.1074/jbc.M700253200 13.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Mol Cell Biol 2001; 21:3523-33; PMID:11313478; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Oncogene 2010; 29:5883-94; PMID: 20697354; http://dx.doi.org/10.1038/onc.2010.329 18.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Oncogene 2006; 25:2931-6; PMID:16331248; http://dx.doi.org/10.1038/sj.onc.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Cell Biol 1999; 147:831- 44; PMID:10562284; http://dx.doi.org/10.1083/jcb.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2002; 277:40659-65; PMID:12189148; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Oncogene 2004; 23: 8118-27; PMID:15378030; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2004; 279: 1422-8; PMID:14530270; http://dx.doi.org/10.1074/ jbc.M309937200 24.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Oncogene 2012; 31:3397-408; PMID:22105362; http://dx.doi.org/10.1038/onc.2011.515 25.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Cancer Res 2006; 66:1694-701; PMID:16452229; http://dx.doi.org/10.1158/0008- 5472.CAN-05-2922 26.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
EMBO J 2002; 21:5437-47; PMID:12374744; http://dx.doi.org/10.1093/emboj/ cdf543 27.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
PLoS One 2010; 5:e15940; PMID:21209852; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Cell Sci 2007; 120:3700-12; PMID:17911169; http://dx.doi.org/10.1242/jcs.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Cell Signal 2011; 23:1794-805; PMID:21726627; http://dx.doi.org/10.1016/j.cellsig.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Mol Endocrinol 2011; 25:1565-78; PMID:21719533; http://dx.doi.org/10.1210/me.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Exp Med 1992; 175:217-25; PMID: 1346155; http://dx.doi.org/10.1084/jem.175.1.217 32.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Oncogene 2010; 29:5839-49; PMID:20711231; http://dx.doi.org/10.1038/onc.2010.318 33.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Cancer Cell 2004; 5:575-85; PMID:15193260; http://dx.doi.org/ 10.1016/j.ccr.2004.05.022 36.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
FEBS Lett 2003; 535:6-10; PMID:12560069; http://dx.doi.org/ 10.1016/S0014-5793(02)03846-2 37.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Nat Cell Biol 2002; 4:681-90; PMID:12198493; http://dx.doi.org/10.1038/ncb838 38.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Hum Mol Genet 2008; 17:3552-65; PMID:18716323; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Mol Cell 2010; 37:321-32; PMID:20159552; http://dx.doi.org/ 10.1016/j.molcel.2010.01.004 40.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Clin Cancer Res 2010; 16:1624-33; PMID: 20179234; http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Breast Cancer Res Treat 2011; 125:1-12; PMID:20213082; http://dx.doi.org/10.1007/s10549- 010-0798-y42.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Proc Natl Acad Sci U S A 1998; 95:5139-44; PMID:9560242; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Oncogene 2004; 23:580-7; PMID: 14724586; http://dx.doi.org/10.1038/sj.onc.1207142 44.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2002; 277:10394-9; PMID:11782491; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2002; 277:883-6; PMID:11719502; http://dx.doi.org/10.1074/jbc.C100553200 46.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2004; 279:18559- 66; PMID:14981079; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Cancer J 2004; 10:20-6; PMID: 15000491; http://dx.doi.org/10.1097/00130404- 200401000-00006 48.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Mol Cell 2003; 12:841-9; PMID: 14580336; http://dx.doi.org/10.1016/S1097-2765 (03)00382-4 49.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Oncogene 1998; 17: 2195-209; PMID:9811451; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Dev Cell 2001; 1:63-72; PMID:11703924; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Cancer Res 2008; 68:7932-7; PMID:18829550; http://dx.doi.org/10.1158/0008-5472.CAN-08-0866 52.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
PLoS One 2010; 5:e13791; PMID:21072183; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Clin Cancer Res 2004; 10:3448-56; PMID:15161701; http://dx.doi.org/10.1158/1078- 0432.CCR-03-0210 www.landesbioscience.com Cellular Logistics 113,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Int J Cancer 2009; 125:548-55; PMID:19415746; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Mol Cancer Res 2008; 6:1215-24; PMID:18644984; http://dx.doi.org/10.1158/1541-7786.MCR-08-0087 57.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Oncogene 2012; 31: 1001-12; PMID:21822311; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Biochim Biophys Acta 2010; 1803:1106- 13; PMID:20595063; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Cancer Res 2007; 67:8089-94; PMID:17804720; http://dx.doi.org/10.1158/0008-5472.CAN-07-2300 60.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Cell 2012; 150:251- 63; PMID:22817889; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Nat Genet 2012; 44:1006-14; PMID: 22842228; http://dx.doi.org/10.1038/ng.2359 62.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Mol Pharmacol 2007; 72:1124-31; PMID:17673571; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Cell Death Dis 2011; 2:e235; PMID:22130069; http://dx.doi.org/10.1038/cddis.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Cell Sci 2009; 122: 4150-9; PMID:19861492; http://dx.doi.org/10.1242/ jcs.057109 67.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2005; 280:36609-15; PMID:16129686; http://dx.doi.org/10.1074/jbc.M502306200 68.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
EMBO J 1997; 16:6426-38; PMID:9351825; http://dx.doi.org/ 10.1093/emboj/16.21.642669.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2003; 278:11221-6; PMID:12551923; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Nature 1998; 396:180-3; PMID:9823899; http://dx.doi.org/10.1038/24184 71.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2005; 280: 24698-705; PMID:15849194; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Cell Biochem 2008; 105:167-75; PMID:18465753; http://dx.doi.org/10.1002/jcb.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
PLoS One 2011; 6:e27637; PMID:22096607; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
EMBO J 2001; 20:1940- 51; PMID:11296227; http://dx.doi.org/10.1093/ emboj/20.8.1940 76.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Circ Res 2008; 103: 671-9; PMID:18669917; http://dx.doi.org/10.1161/ CIRCRESAHA.108.182097 78.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2000; 275:39779-85; PMID: 11016939; http://dx.doi.org/10.1074/jbc.M007617200 79.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Oncogene 2005; 24:1749-66; PMID: 15688034; http://dx.doi.org/10.1038/sj.onc.1208327 81.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Int J Cancer 2010; 127: 2230-7; PMID:20131316; http://dx.doi.org/10.1002/ ijc.25226 82.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Biol Chem 2006; 387:79-86; PMID:16497167; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Biol Cell 2006; 98:141-52; PMID:16480340; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Mol Cell Biol 2005; 25:9532- 42; PMID:16227603; http://dx.doi.org/10.1128/ MCB.25.21.9532-9542.2005 86.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Nat Struct Mol Biol 2009; 16:23-9; PMID: 19079265; http://dx.doi.org/10.1038/nsmb.1533 87.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Breast Cancer Res Treat 2003; 80:49-62; PMID:12889598; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Clin Cancer Res 2007; 13: 6603-9; PMID:18006760; http://dx.doi.org/10.1158/ 1078-0432.CCR-07-0145 90.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Natl Cancer Inst 2006; 98:671-80; PMID:16705121; http://dx.doi.org/10.1093/jnci/djj185 91.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Cancer Res 2007; 67: 3601-8; PMID:17440071; http://dx.doi.org/10.1158/ 0008-5472.CAN-06-3994 92.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Int J Cancer 2007; 121:1930-40; PMID:17621631; http://dx.doi.org/10.1002/ijc.22893 93.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Urol 2007; 178:1073-9; PMID:17644138; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Hum Pathol 2008; 39: 1630-6; PMID:18656238; http://dx.doi.org/10.1016/ j.humpath.2008.03.009 97.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Prostate 2008; 68:1510-6; PMID: 18642328; http://dx.doi.org/10.1002/pros.20787 98.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Invest Dermatol 2003; 121:618-27; PMID:12925224; http://dx.doi.org/10.1046/j.1523-1747.2003.12406.x 99.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Cancer Metastasis Rev 2009; 28:51-63; PMID:19165420; http://dx.doi.org/10.1007/s10555-008-9168-1 101.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Nat Rev Cancer 2006; 6:459-71; PMID:16723992; http://dx.doi.org/10.1038/nrc1892 102.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2002; 277:44417-30; PMID:12226077; http://dx.doi.org/10.1074/jbc.M203754200 103.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2000; 275: 1959-65; PMID:10636898; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 1998; 273:23433-9; PMID:9722579; http://dx.doi.org/ 10.1074/jbc.273.36.23433 106.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Biochem Biophys Res Commun 2002; 297:773-8; PMID:12359219; http://dx.doi.org/10.1016/S0006-291X(02)02302-1 107.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Biochem Biophys Res Commun 2000; 272: 712-6; PMID:10860820; http://dx.doi.org/10.1006/ bbrc.2000.2854 108.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2004; 279:18392-400; PMID:14970201; http://dx.doi.org/10.1074/jbc.M400084200 109.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Mol Cell 2005; 20:237-49; PMID:16246726; http://dx.doi.org/10.1016/j.molcel.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2001; 276:32115-21; PMID:11413130; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Science 1999; 283:2083-5; PMID:10092231; http://dx.doi.org/10.1126/science.283.5410.2083 112.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2000; 275:18366-74; PMID: 10748018; http://dx.doi.org/10.1074/jbc.M001339200 113.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2005; 280:12152-61; PMID:15684429; http://dx.doi.org/10.1074/jbc.M405073200 114.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2001; 276:1677-80; PMID:11058583; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
EMBO Rep 2004; 5:154-60; PMID:14749719; http://dx.doi.org/10.1038/sj.embor.7400079 116.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Mol Cell 2004; 15:117- 27; PMID:15225553; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Muscle Res Cell Motil 1998; 19:839-54; PMID:10047984; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
p21-activated kinase 1 regulates microtubule dynamics by phosphorylating tubulin cofactor B. Mol Cell Biol 2005; 25:3726-36; PMID:15831477; http://dx.doi.org/10.1128/MCB.25.9.3726-3736.2005 120.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Genes Cells 2002; 7:91-7; PMID:11895474; http://dx.doi.org/10.1046/j.1356- 9597.2001.00504.x 121.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2006; 281:34716- 24; PMID:16990256; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Biochem J 2005; 388:773-83; PMID: 15766329; http://dx.doi.org/10.1042/BJ20050065 123.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Am J Physiol Lung Cell Mol Physiol 2007; 292:L240-8; PMID:16997882; http://dx.doi.org/10.1152/ajplung.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Eur J Cell Biol 2002; 81:692-701; PMID:12553669; http://dx.doi.org/10.1078/0171- 9335-00281 125.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Biochemistry 2008; 47:1094-104; PMID:18161990; http://dx.doi.org/10.1021/bi701533j 126.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Mol Cell Biol 2004; 24:1582-94; PMID:14749374; http://dx.doi.org/10.1128/MCB.24.4.1582-1594.2004 129.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Mol Cell Biol 2005; 25:4466-75; PMID:15899852; http://dx.doi.org/10.1128/MCB.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Curr Biol 2000; 10:551-4; PMID: 10801448; http://dx.doi.org/10.1016/S0960-9822 (00)00475-9 131.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2002; 277:4395-405; PMID:11733498; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
EMBO Rep 2002; 3:767-73; PMID:12151336; http://dx.doi.org/10.1093/embo-reports/kvf157 134.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Cell Biol 2003; 162:281-91; PMID: 12876277; http://dx.doi.org/10.1083/jcb.200212141 136.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Mol Cell Biol 2004; 24:2308-17; PMID:14993270; http://dx.doi.org/10.1128/MCB.24.6.2308-2317.2004 137.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Oncogene 2002; 21: 2236-44; PMID:11948406; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2002; 277:45785- 92; PMID:12228228; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Oncogene 2008; 27: 4900-8; PMID:18427546; http://dx.doi.org/10.1038/ onc.2008.131 141.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
FEBS Lett 2002; 515:84-8; PMID:11943200; http://dx.doi.org/ 10.1016/S0014-5793(02)02444-4 142.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2001; 276:16624-34; PMID:11278362; http://dx.doi.org/ 10.1074/jbc.M007753200 143.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2000; 275:9106-9; PMID: 10734042; http://dx.doi.org/10.1074/jbc.275.13.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Mol Cell Biol 2000; 20:453-61; PMID:10611223; http://dx.doi.org/10.1128/MCB.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
EMBO J 2008; 27:970-81; PMID:18354494; http://dx.doi.org/10.1038/emboj.2008.59 146.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2007; 282:19820-30; PMID:17491012; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 1999; 274:31641-7; PMID:10531372; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Science 1995; 269:221-3; PMID:7618083; http://dx.doi.org/ 10.1126/science.7618083 149.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
Oncogene 2005; 24:4591-6; PMID:15824732; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Cell Biol 2003; 161:583-92; PMID:12732616; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 2002; 277:45473-9; PMID:12237306; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
p21- activated kinase increases the calcium sensitivity of rat triton-skinned cardiac muscle fiber bundles via a mechanism potentially involving novel phosphoryla- tion of troponin I. Circ Res 2002; 91:509-16; PMID:12242269; http://dx.doi.org/10.1161/01.RES.,Non-OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
J Biol Chem 1999; 274:8022-8; PMID:10075701; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e9/07/cl-2-105.PMC3490961.pdf
"In particular, Rho family GTPases, Rho, RAC and CDC42, play a*Correspondence to: Greg M. Cole; Email: gmcole@ucla.edu Submitted: 03/07/12; Revised: 07/12/12; 07/17/12; Accepted: 07/24/12 http://dx.doi.org/10.4161/cl.21602REVIEW Cellular Logistics 2:2, 117 –125; April/May/June 2012; G2012 Landes Bioscience www.landesbioscience.com Cellular Logistics 117",Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Neurology 2004; 63:1155-62; PMID: 15477531; http://dx.doi.org/10.1212/01.WNL.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Nat Neurosci 2005; 8:79-84; PMID: 15608634; http://dx.doi.org/10.1038/nn1372 4.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Nature 2006; 440:352-7; PMID:16541076; http://dx.doi.org/10.1038/nat- ure04533 5.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
"Ann Neurol 1999; 46:860-6; PMID:10589538; http://dx.doi.org/10.1002/1531- 8249(199912)46:6 ,860::AID-ANA8 .3.0.CO;2-M 7.",Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Nat Med 2005; 11:556- 61; PMID:15834427; http://dx.doi.org/10.1038/ nm1234 8.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Biol Chem 2008; 283:14132-43; PMID:18347024; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Nat Neurosci 2006; 9:234-42; PMID:16415866; http://dx.doi.org/10.1038/nn163010.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Trends Neurosci 2005; 28:182-7; PMID:15808352; http://dx.doi.org/10.1016/j.tins.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Cell Sci 2007; 120: 205-12; PMID:17215449; http://dx.doi.org/10.1242/ jcs.03337 12.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Neurochem Int 2007; 51:92-104; PMID:17590478; http://dx.doi.org/10.1016/j.neuint.2007.04.029 13.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
FEBS Lett 1997; 410:68-72; PMID:9247125; http://dx.doi.org/ 10.1016/S0014-5793(97)00317-7 14.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Neurochem 2007; 100: 314-23; PMID:17241154; http://dx.doi.org/10.1111/ j.1471-4159.2006.04215.x 16.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Neurosci 2012; 32:519-27; PMID:22238087; http://dx.doi.org/10.1523/JNEUROSCI.3252-11.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Biol Chem 2011; 286:40044-59; PMID: 21949127; http://dx.doi.org/10.1074/jbc.M111.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Mol Cell Biol 2011; 31:388-403; PMID: 21115725; http://dx.doi.org/10.1128/MCB.00969-10 19.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Trends Neurosci 2002; 25: 191-9; PMID:11998687; http://dx.doi.org/10.1016/ S0166-2236(00)02118-420.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
"Am J Med Genet 2000; 93:294-8; PMID:10946356; http://dx.doi.org/10.1002/1096- 8628(20000814)93:4 ,294::AID-AJMG8 .3.0.CO;2- F 21.",OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Nat Genet 1998; 20:25-30; PMID:9731525; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Neuron 2002; 35:121-33; PMID:12123613; http://dx.doi.org/ 10.1016/S0896-6273(02)00758-4 24.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Brain Res Brain Res Rev 2002; 39:29-54; PMID:12086707; http://dx.doi.org/10.1016/S0165- 0173(02)00158-3 25.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Neuropathol Exp Neurol 1999; 58:637-43; PMID:10374754; http://dx.doi.org/10.1097/ 00005072-199906000-00008 27.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Neurochem 2008; 104: 1065-80; PMID:17986220; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
PLoS One 2011; 6:e17397; PMID:21383850; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Biochem Biophys Res Commun 2008; 371:587-90; PMID: 18466762; http://dx.doi.org/10.1016/j.bbrc.2008.04.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Trends Cell Biol 2002; 12:598- 605; PMID:12495849; http://dx.doi.org/10.1016/ S0962-8924(02)02404-2 34.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Science 2003; 302:1215-7; PMID:14615541; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Neurochem 2007; 103:1132-44; PMID:17683481; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Brain 2008; 131:90-108; PMID:18000012; http://dx.doi.org/10.1093/brain/ awm260 40.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Front Endocrinol (Lausanne) 2011; 2:17; PMID:22649365; http://dx.doi.org/10.3389/fendo.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Neuron 2008; 57:94-107; PMID:18184567; http://dx.doi.org/10.1016/j.neuron.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Neurol Sci 2002; 200:11-8; PMID: 12127670; http://dx.doi.org/10.1016/S0022-510X (02)00087-4 45.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Neurobiol Aging 2009; 30:241-56; PMID:17673336; http://dx.doi.org/10.1016/j.neuro- biolaging.2007.06.011 46.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Neurosci 2007; 27: 2866-75; PMID:17360908; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Neurobiol Aging 2008; 29:1334-47; PMID: 17403556; http://dx.doi.org/10.1016/j.neurobiolaging.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Biol Chem 2001; 276:693-9; PMID: 11024032; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Mol Cell 1999; 3:639-48; PMID:10360180; http://dx.doi.org/ 10.1016/S1097-2765(00)80357-3 51.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Mol Carcinog 2011; 50:346-52; PMID: 21480388; http://dx.doi.org/10.1002/mc.20716 52.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Expert Opin Drug Saf 2005; 4:183-91; PMID:15794712; http://dx.doi.org/10.1517/ 14740338.4.2.183 54.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Cancer J 2002; 8:328- 36; PMID:12184411; http://dx.doi.org/10.1097/ 00130404-200207000-00009 55.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Biol Chem 2005; 280:5892-901; PMID:15590663; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Agric Food Chem 2010; 58:2095-9; PMID:20092313; http://dx.doi.org/ 10.1021/jf9024807 59.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
BMC Neurosci 2006; 7:78; PMID:17137520; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Med Genet 2001; 38:450-2; PMID:11432963; http://dx.doi.org/ 10.1136/jmg.38.7.450 62.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Am J Hum Genet 2001; 68:313-24; PMID: 11133364; http://dx.doi.org/10.1086/318207 63.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Biol Chem 2001; 276:14545-8; PMID:11278258; http://dx.doi.org/10.1074/jbc.C100044200 64.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Cell Sci 2009; 122:875-85; PMID:19240112; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Nat Struct Mol Biol 2007; 14: 332-40; PMID:17369839; http://dx.doi.org/10.1038/ nsmb1215 68.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Hum Mol Genet 2008; 17:895-905; PMID:18065495; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Neurol Sci 2010; 290:80-5; PMID: 19969308; http://dx.doi.org/10.1016/j.jns.2009.11.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Nat Genet 1998; 19:106-8; PMID: 9620758; http://dx.doi.org/10.1038/450 72.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Am J Med Genet 1996; 64:158-62; PMID:8826466; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Nat Genet 1998; 19:134-9; PMID:9620768; http://dx.doi.org/10.1038/487 74.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Cell 1995; 81:53-62; PMID:7536630; http://dx.doi.org/10.1016/0092-8674(95)90370-4 75.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Nat Genet 1997; 17:92-5; PMID:9288105; http://dx.doi.org/10.1038/ng0997-92 77.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
J Neurosci 2010; 30:10977-84; PMID:20720104; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Am J Hum Genet 2009; 85:503-14; PMID:19804849; http://dx.doi.org/10.1016/j.ajhg.2009.09.007 80.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Cell 1991; 67:1047-58; PMID: 1760838; http://dx.doi.org/10.1016/0092-8674(91) 90283-5 82.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Cell 1991; 65:905-14; PMID:1710175; http://dx.doi.org/10.1016/0092-8674(91)90397-H 83.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Genet Med 2008; 10:845-7; PMID:18941415; http://dx.doi.org/10.1097/GIM.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Hum Mol Genet 1995; 4: 783-9; PMID:7633436; http://dx.doi.org/10.1093/ hmg/4.5.783 85.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Nature 1993; 363:722-4; PMID: 8515814; http://dx.doi.org/10.1038/363722a0 86.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Neuron 2008; 60:201-14; PMID:18957214; http://dx.doi.org/10.1016/j.neuron.2008.10.004 87.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Mol Cell Neurosci 2010; 43:43-50; PMID:19837168; http://dx.doi.org/ 10.1016/j.mcn.2009.09.013 88.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
"Bassell GJ, Gross C. Reducing glutamate signaling pays off in fragile X. Nat Med 2008; 14:249-50; PMID: 18323845; http://dx.doi.org/10.1038/nm0308-24989.",Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Genes Brain Behav 2005; 4:350-9; PMID:16098134; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Brain Res 2010; 1355:221-7; PMID:20682298; http://dx.doi.org/10.1016/j.brainres.2010.07.090 92.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Behav Brain Res 2006; 168:172-5; PMID:16343653; http://dx.doi.org/ 10.1016/j.bbr.2005.11.004 94.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Hum Mol Genet 2000; 9:1145-59; PMID:10767339; http://dx.doi.org/10.1093/hmg/9.8.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Nat Struct Mol Biol 2010; 17:732-9; PMID:20473314; http://dx.doi.org/ 10.1038/nsmb.1815 96.,OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
Curr Alzheimer Res 2010; 7:200-6; PMID:20088809; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9b/b9/cl-2-117.PMC3490962.pdf
"The primary screen*Correspondence to: Joseph Kissil; Email: jkissil@scripps.edu Submitted: 06/28/12; Revised: 07/16/12; Accepted: 07/30/12 http://dx.doi.org/10.4161/cl.21667Cellular Logistics 2:2, 132 –135; April/May/June 2012; G2012 Landes Bioscience 132 Cellular Logistics Volume 2 Issue 2",Non-OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
Cell 2000; 103:239-52; PMID: 11057897; http://dx.doi.org/10.1016/S0092-8674(00) 00116-1 2.,OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
Int J Biochem Cell Biol 2002; 34: 713-7; PMID:11950587; http://dx.doi.org/10.1016/ S1357-2725(01)00158-3 3.,OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
J Mol Biol 2006; 361:312-26; PMID: 16837009; http://dx.doi.org/10.1016/j.jmb.2006.06.,OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
EMBO Rep 2012; 13:653-9; PMID:22653441; http://dx.doi.org/10.1038/embor.,OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
J Biol Chem 2003; 278: 33621-4; PMID:12860998; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
Chem Biol 2008; 15: 322-31; PMID:18420139; http://dx.doi.org/10.1016/ j.chembiol.2008.03.005 7.,OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
Mol Cancer Ther 2009; 8:2559-65; PMID: 19723886; http://dx.doi.org/10.1158/1535-7163.,Non-OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
Ann N Y Acad Sci 1999; 886:48-57; PMID:10667202; http://dx.doi.org/10.1111/j.1749- 6632.1999.tb09399.x11.,OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
Nat Rev Cancer 2011; 11:59-67; PMID:21160526; http://dx.doi.org/10.1038/nrc2966 12.,Non-OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
Cancer Res 2008; 68:7932-7; PMID:18829550; http://dx.doi.org/10.1158/0008-5472.CAN-08-0866 13.,Non-OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
Biochem J 2007; 408:297- 315; PMID:17850214; http://dx.doi.org/10.1042/ BJ20070797 14.,Non-OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
J Med Chem 1997; 40:1863-9; PMID:9191963; http://dx.doi.org/10.1021/jm970031d 15.,Non-OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
Nat Immunol 2009; 10:356-60; PMID:19295632; http://dx.doi.org/10.1038/ni.1701 16.,Non-OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
J Biol Chem 2001; 276:25302-8; PMID: 11325962; http://dx.doi.org/10.1074/jbc.M011601200 17.,OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
Mol Pharmacol 2007; 72: 1124-31; PMID:17673571; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
Cancer Res 2004; 64:4309-18; PMID:15205346; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
J Am Chem Soc 2008; 130:15764-5; PMID:18973295; http://dx.doi.org/10.1021/ja805555a 21.,OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
J Am Chem Soc 2011; 133:5976-86; PMID:21446733; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
J Med Chem 2012; 55:4728-39; PMID:22554206; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
Cancer Lett 2012; 317: 24-32; PMID:22085492; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
Cancer Metastasis Rev 2009; 28:51-63; PMID:19165420; http://dx.doi.org/ 10.1007/s10555-008-9168-1 26.,Non-OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
Oncogene 2009; 28: 2545-55; PMID:19465939; http://dx.doi.org/10.1038/ onc.2009.119 28.,Non-OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
Chem Biol 2005; 12:621-37; PMID: 15975507; http://dx.doi.org/10.1016/j.chembiol.2005.,OADS,/arxiv_data1/oa_pdf/12/90/cl-2-132.PMC3490963.pdf
"However, although inhibition of PAK1 kinase activity does profoundly reduce MEK1 Ser298 phosphorylation in response to epithermal growth factor (EGF), this inhibition does not prevent MEK1 activation by EGF.24Inhibiting group 1 PAKs also reduces the Ser338 phosphorylation of c-Raf in*Correspondence to: Ed Manser; Email: ed.manser@imb.a-star.edu.sg Submitted: 03/23/12; Revised: 07/26/12; 08/21/12; Accepted: 08/21/12 http://dx.doi.org/10.4161/cl.21912REVIEW Cellular Logistics 2:2, 59 –68; April/May/June 2012; G2012 Landes Bioscience www.landesbioscience.com Cellular Logistics 59",Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Nature 1994; 367:40-6; PMID: 8107774; http://dx.doi.org/10.1038/367040a0 3.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Molecular cloning and sequencing of the cytostatic G protein- activated protein kinase PAK I. J Biol Chem 1996; 271:6206-11; PMID:8626411; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Nature 1993; 363:364-7; PMID: 8497321; http://dx.doi.org/10.1038/363364a0 7.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 1995; 270:22731-7; PMID: 7559398; http://dx.doi.org/10.1074/jbc.270.39.22731 9.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
EMBO J 1998; 17:6527-40; PMID:9822598; http://dx.doi.org/ 10.1093/emboj/17.22.6527 11.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 2001; 276:1677-80; PMID:11058583; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Cell 1996; 87:519-29; PMID: 8898204; http://dx.doi.org/10.1016/S0092-8674(00) 81371-9 15.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Science 1996; 274:1374-6; PMID:8910277; http://dx.doi.org/ 10.1126/science.274.5291.1374 www.landesbioscience.com Cellular Logistics 65,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
EMBO J 1998; 17:4328-39; PMID:9687501; http://dx.doi.org/10.1093/emboj/ 17.15.4328 17.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Mol Cell 1998; 1:183-92; PMID:9659915; http://dx.doi.org/ 10.1016/S1097-2765(00)80019-2 18.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Mol Cell Biol 2000; 20: 2619-27; PMID:10713183; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Mol Cell Biol 2004; 24:3849-59; PMID:15082779; http://dx.doi.org/10.1128/MCB.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Mol Cell Biol 2000; 20:3906- 17; PMID:10805734; http://dx.doi.org/10.1128/ MCB.20.11.3906-3917.2000 22.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Mol Cell 2005; 20:237-49; PMID:16246726; http://dx.doi.org/10.1016/j.molcel.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Nat Rev Cancer 2006; 6:459-71; PMID:16723992; http://dx.doi.org/10.1038/nrc1892 24.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 2005; 280:36609-15; PMID:16129686; http://dx.doi.org/10.1074/jbc.M502306200 25.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biochem 2011; 149:361-79; PMID: 21324984; http://dx.doi.org/10.1093/jb/mvr021 26.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Int J Biochem Cell Biol 2002; 34: 713-7; PMID:11950587; http://dx.doi.org/10.1016/ S1357-2725(01)00158-3 28.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Biochem J 2005; 386:201-14; PMID: 15548136; http://dx.doi.org/10.1042/BJ20041638 29.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 1996; 271:25746-9; PMID:8824201; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 2003; 278:9388-93; PMID:12522133; http://dx.doi.org/10.1074/jbc.M20841420032.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Mol Cell 2010; 38:236-49; PMID:20417602; http://dx.doi.org/10.1016/j.molcel.2010.04.004 33.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Nature 2011; 469:107-11; PMID: 21170023; http://dx.doi.org/10.1038/nature09593 35.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Mol Cell 2010; 40: 493-500; PMID:21070974; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Structure 2010; 18:879-90; PMID: 20637424; http://dx.doi.org/10.1016/j.str.2010.04.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 1998; 273:8137-44; PMID: 9525917; http://dx.doi.org/10.1074/jbc.273.14.8137 39.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 1999; 274:32565-73; PMID:10551809; http://dx.doi.org/10.1074/jbc.274.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 1999; 274:8022-8; PMID:10075701; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Mol Biol Cell 2010; 21:2996-3006; PMID:20631255; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Oncogene 2006; 25:1311- 9; PMID:16278681; http://dx.doi.org/10.1038/sj.onc.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Chem Biol 2008; 15: 322-31; PMID:18420139; http://dx.doi.org/10.1016/ j.chembiol.2008.03.005 48.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Structure 2007; 15:201-13; PMID:17292838; http://dx.doi.org/10.1016/j.str.2007.01.001 49.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Trends Biochem Sci 2008; 33:394-403; PMID:18639460; http://dx.doi.org/10.1016/j.tibs.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
EMBO Rep 2012; 13:653-9; PMID:22653441; http://dx.doi.org/10.1038/embor.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Biochem J 2008; 416:231-41; PMID:18636970; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Mol Cell Biol 2009; 29: 3018-32; PMID:19289496; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 2004; 279:1922-31; PMID:14573606; http://dx.doi.org/10.1074/jbc.M311145200 54.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 2001; 276: 15345-53; PMID:11278661; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 2005; 280:3323-30; PMID:15550393; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Biochim Biophys Acta 2012; 1823:465-75; PMID: 22173096; http://dx.doi.org/10.1016/j.bbamcr.2011.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Cell Sci 2005; 118:1861-72; PMID:15827085; http://dx.doi.org/10.1242/jcs.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 2004; 279: 6182-9; PMID:14625312; http://dx.doi.org/10.1074/ jbc.M309579200 62.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Microbiol Mol Biol Rev 2007; 71:48-96; PMID: 17347519; http://dx.doi.org/10.1128/MMBR.00028- 06 63.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Genes Dev 1995; 9:1817-30; PMID: 7649470; http://dx.doi.org/10.1101/gad.9.15.1817 64.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Mol Microbiol 1997; 23:431-44; PMID:9044278; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Biochem Biophys Res Commun 2006; 347: 1145-50; PMID:16870141; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Proc Natl Acad Sci U S A 1999; 96:12679-84; PMID:10535982; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
EMBO Rep 2002; 3:735-40; PMID:12151331; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Genetics 2004; 166:1177-86; PMID:15082539; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 1998; 273: 25089-97; PMID:9737966; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Proc Natl Acad Sci U S A 1995; 92:6180-4; PMID:7597098; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 1998; 273: 18490-8; PMID:9660818; http://dx.doi.org/10.1074/ jbc.273.29.1849074.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Mol Microbiol 2002; 44: 325-34; PMID:11972773; http://dx.doi.org/10.1046/ j.1365-2958.2002.02882.x 75.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 1999; 274: 36052-7; PMID:10593886; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 1998; 273:18481-9; PMID:9660817; http://dx.doi.org/10.1074/jbc.273.29.18481 81.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 1998; 273:27911-7; PMID:9774403; http://dx.doi.org/10.1074/jbc.273.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Mol Cell 2001; 7: 937-47; PMID:11389841; http://dx.doi.org/10.1016/ S1097-2765(01)00247-7 84.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Muscle Res Cell Motil 2002; 23:751-63; PMID:12952073; http://dx.doi.org/ 10.1023/A:1024475628061 85.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 2001; 276: 47468-73; PMID:11579107; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Mol Biol Cell 2004; 15:5456-69; PMID: 15483055; http://dx.doi.org/10.1091/mbc.E04-04- 032387.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Cell 1999; 97: 853-63; PMID:10399914; http://dx.doi.org/10.1016/ S0092-8674(00)80798-9 89.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Cell 2000; 101:283-94; PMID:10847683; http://dx.doi.org/10.1016/S0092- 8674(00)80838-7 90.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Development 2010; 137:4177-89; PMID:21068057; http://dx.doi.org/10.1242/dev.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Genetics 2011; 187: 501-12; PMID:21098722; http://dx.doi.org/10.1534/ genetics.110.120998 92.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Curr Biol 1998; 8:1223-6; PMID:9811608; http://dx.doi.org/ 10.1016/S0960-9822(07)00514-3 93.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Development 2003; 130: 427-37; PMID:12490550; http://dx.doi.org/10.1242/ dev.00248 94.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Mech Dev 2007; 124:78-90; PMID:17097274; http://dx.doi.org/10.1016/j.mod.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Genetics 2011; 189:123-35; PMID:21705760; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 1996; 271: 26362-8; PMID:8824291; http://dx.doi.org/10.1074/ jbc.271.42.26362 97.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Development 2006; 133:4549-59; PMID:17050621; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
PLoS Genet 2008; 4: e1000269; PMID:19023419; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Nature 2011; 471:99-103; PMID:21368832; http://dx.doi.org/10.1038/nature09765 www.landesbioscience.com Cellular Logistics 67,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
PLoS One 2010; 5:e10125; PMID:20405038; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
PLoS One 2009; 4:e6025; PMID:19557173; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Mol Cell Biol 2010; 30:1971-83; PMID: 20154149; http://dx.doi.org/10.1128/MCB.01247-09 106.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 2000; 275:2367-75; PMID:10644687; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Dev Biol 2005; 277:472-92; PMID:15617688; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Neurosci 2005; 25:6641-50; PMID:16014725; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Cell Signal 2009; 21:384-93; PMID: 19036346; http://dx.doi.org/10.1016/j.cellsig.2008.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Am J Med Genet A 2007; 143A:2406- 16; PMID:17853471; http://dx.doi.org/10.1002/ ajmg.a.31956 112.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Annu Rev Neurosci 2002; 25: 103-26; PMID:12052905; http://dx.doi.org/10.1146/ annurev.neuro.25.112701.142758 113.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Neuropharmacology 2009; 56:73-80; PMID: 18644395; http://dx.doi.org/10.1016/j.neuropharm.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Mol Cell Biol 2011; 31:388-403; PMID:21115725; http://dx.doi.org/10.1128/MCB.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Nat Neurosci 2006; 9:234-42; PMID:16415866; http://dx.doi.org/10.1038/nn1630 116.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Neurosci 2010; 30:10977-84; PMID:20720104; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Cell Mol Neurobiol 2010; 30:1327-33; PMID: 21088884; http://dx.doi.org/10.1007/s10571-010- 9580-2 119.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Cell Biol 2006; 173:587-9; PMID: 16717130; http://dx.doi.org/10.1083/jcb.200509075 120.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Hum Mol Genet 2008; 17:3552-65; PMID:18716323; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Biol Chem 2003; 278:19220-9; PMID:12626503; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
J Neurosci 2011; 31:17123-33; PMID:22114281; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Nat Struct Biol 1998; 5:1098- 107; PMID:9846881; http://dx.doi.org/10.1038/ 4209 125.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
FEBS Lett 2003; 550:119-23; PMID:12935897; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
Cellular Log 2012; 2:95-104; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/66/cl-2-59.PMC3490964.pdf
"We evaluated one kinase domain structure each from group I and group II PAKs for the presence of ligand binding pockets*Correspondence to: Ramesh K. Jha; Email: rjha@lanl.gov Submitted: 02/06/12; Revised: 02/24/12; 07/10/12; 08/08/12; Accepted: 08/19/12 http://dx.doi.org/10.4161/cl.21883REVIEW Cellular Logistics 2:2, 69 –77; April/May/June 2012; G2012 Landes Bioscience www.landesbioscience.com Cellular Logistics 69",Non-OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Biochem J 2010; 425:465-73; PMID: 20070256; http://dx.doi.org/10.1042/BJ20091173 2.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Annu Rev Biochem 2003; 72:743-81; PMID: 12676796; http://dx.doi.org/10.1146/annurev.biochem.,Non-OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
EMBO Rep 2012; 13:653-9; PMID:22653441; http://dx.doi.org/10.1038/embor.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Crystal Structure of the Human P21-Activated Kinase 4. http://www.rcsb.org/pdb/explore/explore.do?,Non-OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Structure 2011; 19:1752-61; PMID: 22153498; http://dx.doi.org/10.1016/j.str.2011.10.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Structure 2005; 13:769-78; PMID:15893667; http://dx.doi.org/ 10.1016/j.str.2005.03.007 9.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Bioinformatics 2005; 21:1908-16; PMID: 15701681; http://dx.doi.org/10.1093/bioinformatics/ bti315 11.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
http://www.ctf.org/ pdf/ddi/2010-07-002.pdf 12.,Non-OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
J Mol Biol 2010; 400:257-70; PMID: 20460129; http://dx.doi.org/10.1016/j.jmb.2010.05.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Mol Cell 2002; 9:73-83; PMID:11804587; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
J Biol Chem 1996; 271:25746-9; PMID:8824201; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
J Biol Chem 2003; 278:9388-93; PMID:12522133; http://dx.doi.org/10.1074/jbc.M208414200 17.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Mol Cell 1998; 1:183-92; PMID:9659915; http://dx.doi.org/10.1016/ S1097-2765(00)80019-2 18.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
EMBO J 1998; 17:4328-39; PMID: 9687501; http://dx.doi.org/10.1093/emboj/17.15.,Non-OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
J Biol Chem 2000; 275:9106-9; PMID: 10734042; http://dx.doi.org/10.1074/jbc.275.13.9106 20.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Curr Biol 2002; 12:1233-9; PMID:12176334; http://dx.doi.org/10.1016/S0960- 9822(02)00956-9 21.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Curr Biol 2002; 12:1227-32; PMID:12176333; http://dx.doi.org/10.1016/S0960- 9822(02)00931-4 22.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Structure 2003; 11:1453-9; PMID:14604535; http://dx.doi.org/10.1016/j.str.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Biochemistry 2005; 44:10977-83; PMID: 16101281; http://dx.doi.org/10.1021/bi050374a24.,Non-OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
http://www.rcsb.org/pdb/ explore/explore.do?structureId=2qme 26.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
J Biol Chem 2008; 283:27314-24; PMID:18650427; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Mol Cell 2003; 12:841-9; PMID: 14580336; http://dx.doi.org/10.1016/S1097-2765(03) 00382-4 31.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Cancer J 2004; 10:20-6; PMID: 15000491; http://dx.doi.org/10.1097/00130404- 200401000-00006 32.,Non-OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
J Biol Chem 2004; 279: 46621-30; PMID:15333633; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
J Cell Biol 2007; 176:719-27; PMID:17312022; http://dx.doi.org/10.1083/jcb.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
J Am Chem Soc 2008; 130:15764-5; PMID:18973295; http://dx.doi.org/10.1021/ja805555a 35.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
http://www.rcsb.org/pdb/ explore/explore.do?structureId=2hy8 36.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Cancer J 2002; 8:328- 36; PMID:12184411; http://dx.doi.org/10.1097/ 00130404-200207000-00009 37.,Non-OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Cancer Biol Ther 2009; 8:1360-8; PMID:19448398; http://dx.doi.org/10.4161/cbt.8.14.8720 38.,Non-OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Biochem Pharmacol 2010; 80:683-9; PMID: 20302846; http://dx.doi.org/10.1016/j.bcp.2010.03.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
http://www.rcsb.,Non-OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
J Mol Biol 2011; 413:513-22; PMID: 21888918; http://dx.doi.org/10.1016/j.jmb.2011.08.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
J Mol Biol 2006; 361:312-26; PMID: 16837009; http://dx.doi.org/10.1016/j.jmb.2006.06.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
Angew Chem Int Ed Engl 2011; 50:11437- 40; PMID:22113802; http://dx.doi.org/10.1002/anie.,OADS,/arxiv_data1/oa_pdf/5d/ba/cl-2-69.PMC3490965.pdf
"Such Nf1+/−mast cells are normally hyperresponsive to kit ligand due to dysregulated Ras activation, and this augmented response is*Correspondence to: Jonathan Chernoff; Email: J_Chernoff@fccc.edu Submitted: 06/26/12; Revised: 06/29/12; Accepted: 07/05/12 http://dx.doi.org/10.4161/cl.21381Cellular Logistics 2:2, 84 –88; April/May/June 2012; G2012 Landes Bioscience 84 Cellular Logistics Volume 2 Issue 2",Non-OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Int J Biochem Cell Biol 2002; 34: 713-7; PMID:11950587; http://dx.doi.org/10.1016/ S1357-2725(01)00158-3 2.,OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
J Cell Sci 2004; 117:4343-54; PMID:15331659; http://dx.doi.org/10.1242/jcs.01392 5.,OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Blood 2009; 113:2695-705; PMID:19124833; http://dx.doi.org/10.1182/blood- 2008-06-160861 7.,Non-OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Blood 2008; 112:4646-54; PMID:18768391; http://dx.doi.org/10.1182/blood-2008-04-1550858.,Non-OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
J Cell Sci 2008; 121:3729-36; PMID: 18940914; http://dx.doi.org/10.1242/jcs.027680 9.,OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
J Biol Chem 2011; 286:41359-67; PMID: 21969371; http://dx.doi.org/10.1074/jbc.M111.291500 10.,OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Neuro- pharmacology 2009; 56:73-80; PMID:18644395; http://dx.doi.org/10.1016/j.neuropharm.2008.06.055 11.,Non-OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Circulation 2011; 124: 2702-15; PMID:22082674; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Cell Signal 2009; 21:384-93; PMID: 19036346; http://dx.doi.org/10.1016/j.cellsig.2008.11.,OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
J Neurosci 2005; 25:6641-50; PMID:16014725; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Oncogene 2010; 29:5839-49; PMID:20711231; http://dx.doi.org/10.1038/onc.2010.318 17.,Non-OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Mol Cell Biol 2011; 31:388-403; PMID: 21115725; http://dx.doi.org/10.1128/MCB.00969-10 18.,Non-OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
EMBO J 1998; 17:6527-40; PMID:9822598; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
J Cell Sci 2002; 115:3947-56; PMID:12244132; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Mol Cancer Res 2008; 6:1215-24; PMID:18644984; http://dx.doi.org/10.1158/1541-7786.MCR-08-0087 21.,Non-OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Mol Cell Biol 2003; 23:7122-33; PMID:14517283; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Mech Dev 2009; 126:710-20; PMID:19464366; http://dx.doi.org/10.1016/j.mod.2009.05.002 23.,OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Dev Biol 2011; 353:206-16; PMID:21382368; http://dx.doi.org/10.1016/j.ydbio.2011.02.02624.,OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Cerebrospinal Fluid Res 2008; 5:16; PMID: 18928559; http://dx.doi.org/10.1186/1743-8454-5-16 26.,Non-OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Neuroscience 2003; 122:129-43; PMID:14596855; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Mol Cell Biol 2003; 23: 7134-42; PMID:14517284; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Dev Biol 2008; 322:95-108; PMID:18675265; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Mol Cell 2011; 42:624-36; PMID: 21658603; http://dx.doi.org/10.1016/j.molcel.2011.03.,OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
Proc Natl Acad Sci U S A 2008; 105:20740-5; PMID:19074277; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f2/e7/cl-2-84.PMC3490966.pdf
"For example, it was found that receptors coupled to the inhibitory G proteins Gi, such as bradykinin and acetylcholine, were able to activate PAK1 indirectly.12-14Excellent evidence to support this comes from the observation that constitutively active PAK1 and ligands stimulating these receptors produce the*Correspondence to: Xin Wang; Email: xin.wang@manchester.ac.uk Submitted: 02/06/12; Revised: 02/23/12; Accepted: 07/15/12 http://dx.doi.org/10.4161/cl.21497REVIEW Cellular Logistics 2:2, 89 –94; April/May/June 2012; G2012 Landes Bioscience www.landesbioscience.com Cellular Logistics 89",Non-OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
FEBS Lett 1997; 403:23-5; PMID: 9038353; http://dx.doi.org/10.1016/S0014-5793(97) 00020-3 2.,OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Circ Res 2004; 94:194-200; PMID:14670848; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Circ Res 2007; 100:1317-27; PMID:17413045; http://dx.doi.org/10.1161/01.RES.,OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Am J Physiol Heart Circ Physiol 2007; 292:H1675-84; PMID:17209006; http://dx.doi.org/10.1152/ajpheart.01132.2006 5.,Non-OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Circulation 2011; 124: 2702-15; PMID:22082674; http://dx.doi.org/10.1161/ CIRCULATIONAHA.111.048785 7.,Non-OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Biologics 2008; 2:903-9; PMID:19707468; http://dx.doi.org/10.2147/BTT.S3870 8.,Non-OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
J Mol Cell Cardiol 2010; 48:406-14; PMID:19852968; http://dx.doi.org/10.1016/j.yjmcc.2009.10.009 9.,OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
J Biol Chem 1999; 274:32565-73; PMID: 10551809; http://dx.doi.org/10.1074/jbc.274.46.32565 11.,OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Am J Physiol Heart Circ Physiol 2010; 298:H1283-9; PMID:20154261; http://dx.doi.org/10.1152/ajpheart.,Non-OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Am J Physiol Cell Physiol 2005; 289:C1286-94; PMID:16033904; http://dx.doi.org/10.1152/ajpcell.,OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Am J Physiol Heart Circ Physiol 2012; 302:H675-87; PMID:22081703; http://dx.doi.org/10.1152/ajpheart.,Non-OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Cardiovasc Res 2011; 92:106-14; PMID:21727092; http://dx.doi.org/10.1093/cvr/cvr163 19.,Non-OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Ann N Y Acad Sci 2005; 1047:138-56; PMID:16093492; http://dx.doi.org/10.1196/annals.,Non-OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Cell 2000; 103:227-38; PMID:11057896; http://dx.doi.org/10.1016/S0092-8674(00)00115-X 23.,OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
J Biol Chem 1995; 270:23173-8; PMID:7559464; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Nature 2002; 417:949-54; PMID:12068308; http://dx.doi.org/10.1038/nature00766 25.,Non-OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Circulation 2004; 110:718-23; PMID:15289381; http://dx.doi.org/10.1161/01.CIR.,Non-OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Circulation 2009; 120:607-16; PMID:19652091; http://dx.doi.org/10.1161/ CIRCULATIONAHA.109.868554 28.,Non-OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Nat Genet 2001; 29:465-8; PMID:11704759; http://dx.doi.org/10.1038/ng772 29.,OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Nat Genet 2005; 37:1038-40; PMID:16170316; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
EMBO J 2003; 22: 5079-89; PMID:14517246; http://dx.doi.org/10.1093/ emboj/cdg474 31.,Non-OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Cardiovasc Res 2004; 63:467-75; PMID: 15276472; http://dx.doi.org/10.1016/j.cardiores.2004.,Non-OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Circulation 1986; 74:1124-36; PMID: 3769170; http://dx.doi.org/10.1161/01.CIR.74.5.1124 34.,Non-OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Cardiovasc Res 2007; 76:41-50; PMID:17610857; http://dx.doi.org/10.1016/j.cardiores.2007.05.029 35.,Non-OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Cardiovasc Res 2009; 83:285-93; PMID:19416991; http://dx.doi.org/10.1093/cvr/cvp137 37.,Non-OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
Genes Dev 2006; 20:3347-65; PMID: 17182864; http://dx.doi.org/10.1101/gad.1492806 38.,OADS,/arxiv_data1/oa_pdf/ff/4a/cl-2-89.PMC3490967.pdf
"2012 September;14(3):141~147 Received : 2 July 2012 Revised : 27 July 2012Accepted : 17 August 2012 Correspondence to Jae Hoon Kim, MD Department of Neurosurgery, Eulji  Hospital, 280-1 Hagye1-dong, Nowon-gu,  Seoul 139-711, Korea Tel : (001) 82-2-970-8268 Fax : (001) 82-2-979-8268 E-mail : grimi2@hanmail.net T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/28/jcen-14-141.PMC3491206.pdf
"Keywords Balloon, Thrombolysis, RecanalizationJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.141  Original Article INTRODUCTION The effectiveness of intraarterial thrombolysis (IAT)  with recombinant pro-urokinase for treatment of acute  ischemic stroke (AIS) has been demonstrated in a randomized controlled study; however, the disadvantages  of this treatment include increased risk of post- procedure hemorrhage, failure to restore blood flow in approximately one third of subjects, and excessive time requirements.",Non-OADS,/arxiv_data1/oa_pdf/6e/28/jcen-14-141.PMC3491206.pdf
"2012 September;14(3):148~156 Received : 30 May 2012 Revised : 29 June 2012 Accepted : 29 July 2012 Correspondence to Yong Bae Kim, MD Department of Neurosurgery, Gangnam  Severance Hospital, Yonsei University,  Seoul 135-720, Korea Tel : (001) 82-2-2019-3398 Fax : (001) 82-2-3461-9229 E-mail : ybkim69@yuhs.ac This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Keywords Antiplatelet agent premedication, Aspirin resistance, Clopidogrel resistance,  Thromboembolic complicationJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.148  Original Article INTRODUCTION The incidence of overall complication during elec-",Non-OADS,/arxiv_data1/oa_pdf/d7/34/jcen-14-148.PMC3491207.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/5f/jcen-14-157.PMC3491208.pdf
"Keywords Intracranial stenosis, Angioplasty, Stent implantation, Wingspan stentJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.157  Original Article INTRODUCTION With widespread access to magnetic resonance  imaging (MRI), computed tomographic angiography  (CTA), and cerebral angiography, intracranial arterial stenosis (ICS) is increasingly diagnosed as a cause of cerebral ischemia.",Non-OADS,/arxiv_data1/oa_pdf/b6/5f/jcen-14-157.PMC3491208.pdf
"2012 September;14(3):164~169 Received : 3 July 2012 Revised : 3 August 2012Accepted : 29 August 2012 Correspondence to Hyon-Jo Kwon, MD Department of Neurosurgery,  Cerebrovascular Center, Chungnam  National University Hospital, 282  Munhwa-ro, Jung-gu, Daejeon 301-721, Korea Tel : (001) 82-42-280-8372 Fax : (001) 82-42-280-7363E-mail : solesoul@daum.net This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/18/jcen-14-164.PMC3491209.pdf
"Keywords Acute ischemic stroke, Thrombectomy, Solitaire AB stentJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.164  Original Article INTRODUCTION In acute ischemic stroke, achievement of reperfusion  as soon as possible by recanalizing the occluded intra- cranial vessels is the most important priority.4)10)14)  However, intravenous infusion of recombinant tissue plasminogen activator (rTPA) has a relatively tight time limit and rates of recanalization are unsatisfactory.",Non-OADS,/arxiv_data1/oa_pdf/21/18/jcen-14-164.PMC3491209.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/4d/jcen-14-170.PMC3491210.pdf
"Keywords Cerebellar hemorrhage, Aspiration, Stereotactic, Navigation, OutcomeJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.170  Original Article INTRODUCTION Spontaneous hypertensive cerebellar hemorrhage  (SHCH) accounts for 5-10% of all cases of intra- cerebral hemorrhage (ICH).7) The mortality rate of  SHCH is reportedly 20-75% hi gher than that of supra- tentorial ICH.4) This high mortality rate results from  direct compression of the hematoma by the brain stem and acute hydrocephalus due to hematoma ex-tension into the fourth vent ricle or direct compression  of the fourth ventricle.",Non-OADS,/arxiv_data1/oa_pdf/72/4d/jcen-14-170.PMC3491210.pdf
"2012 September;14(3):175~180 Received : 2 July 2012 Revised : 23 August 2012Accepted : 4 September 2012 Correspondence to Jae Hoon Kim, MD Department of Neurosurgery, Eulji  Hospital, 280-1 Hagye1-dong, Nowon-gu,  Seoul 139-711, Korea Tel : (001) 82-2-970-8268 Fax : (001) 82-2-979-8268 E-mail : grimi2@hanmail.net This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/08/jcen-14-175.PMC3491211.pdf
"Keywords Aneurysm, Outcome, Risk factor, VertebrobasilarJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.175  Original Article INTRODUCTION Ruptured vertebrobasilar (VB) saccular aneurysms  account for 2.7-5% of ruptured intracranial aneurysms.8)18)  For the past several decades, surgical clipping has  been the standard treatment for ruptured VB aneurysms.",Non-OADS,/arxiv_data1/oa_pdf/ac/08/jcen-14-175.PMC3491211.pdf
"2012 September;14(3):181~185 Received : 19 July 2012 Revised : 15 August 2012 Accepted : 5 September 2012 Correspondence to Yong Cheol Lim, MD Department of Neurosurgery, Ajou  University School of Medicine, 5 San,  Woncheon-Dong, Yongtong-Ku, Suwon 442-721, Korea Tel : (001) 82-31-219-5232 Fax : (001) 82-31-219-5238E-mail : nsyclim@gmail.com This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/f0/jcen-14-181.PMC3491212.pdf
"Keywords Aneurysm, Middle cerebral artery, Intracerebral hematomaJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.181  Original Article INTRODUCTION An intracerebral hematoma (ICH) is described in 4%  to 42.6% of cases involving simultaneous occurrence  of subarachnoid hemorrhages (SAH) from ruptured cerebral aneurysms.",Non-OADS,/arxiv_data1/oa_pdf/78/f0/jcen-14-181.PMC3491212.pdf
"2012 September;14(3):186~191 Received : 11 July 2012 Revised : 29 August 2012 Accepted : 6 September 2012 Correspondence to Man-Bin Yim, MD Department of Neurosurgery, Keimyung  U n i v e r s i t y  S c h o o l  o f  M e d i c i n e ,  1 9 4   Dongsan-dong, Jung-gu, Daegu 700-712, Korea Tel : (001) 82-53-250-7332 Fax : (001) 82-53-250-7356E-mail : y760111@dsmc.or.kr This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/ac/jcen-14-186.PMC3491213.pdf
"Keywords Subarachnoid hemorrhage, Hemorrhage volume, VasospasmJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.186  Original Article INTRODUCTION Subarachnoid hemorrhage (SAH) from a ruptured  intracranial aneurysm is a devastating disease with a  high rate of mortality and morbidity.1) Apart from the  potentially disastrous effects of the initial hemorrhage and rebleeding from the ru ptured aneurysm, cerebral  vasospasm is a major contributor to death and dis- ability after SAH.",Non-OADS,/arxiv_data1/oa_pdf/a3/ac/jcen-14-186.PMC3491213.pdf
"2012 September;14(3):192~202 Received : 17 July 2012 Revised : 24 August 2012 Accepted : 10 September 2012 Correspondence to Seung Young Chung, MD Department of Neurosurgery, college of  Medicine, Eulji University, Dunsan-2dong,  Seogu, Daejeon 302-799, Korea Tel : (001) 82-42-611-3442 Fax : (001) 82-42-611-3444 E-mail : neurocsy@eulji.ac.kr This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/ee/jcen-14-192.PMC3491214.pdf
"Keywords Dural arteriovenous fistula, Signs and symptoms, TherapeuticsJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.192  Original Article INTRODUCTION Dural arteriovenous fistulas (DAVFs) are pathologic shunts that develop between the dural arteries and  dural venous sinuses, meningeal veins, or cortical veins.",Non-OADS,/arxiv_data1/oa_pdf/6e/ee/jcen-14-192.PMC3491214.pdf
"2012 September;14(3):203~209 Received : 9 August 2012 Revised : 5 September 2012Accepted : 11 September 2012 Correspondence to Jong Kook Rhim, MD Department of Neurosurgery, Bundang  Jesaeng General Hospital, 255-2,  Seohyun-Dong, Bundang-Gu, Sungnam-Si, Gyeonggi-Do 463-774, Korea Tel : (001) 82-31-779-0284 Fax : (001) 82-31-779-0895 E-mail : pedineur@dmc.or.kr This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/da/jcen-14-203.PMC3491215.pdf
"Keywords Atherosclerosis, Intervention, Stent, Stroke, Thrombectom yJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.203  Original Article INTRODUCTION The early recanalization of occluded vessels in acute  ischemic stroke (AIS) with intravenous thrombolysis  or endovascular recanalization improves the clinical  outcomes and reduces mortality.",Non-OADS,/arxiv_data1/oa_pdf/d6/da/jcen-14-203.PMC3491215.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/8d/jcen-14-210.PMC3491216.pdf
"Keywords Subarachnoid hemorrhage, Digital subtraction angiography, AneurysmJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.210  Original Article INTRODUCTION The incidence of initial digital subtraction angiog- raphy (DSA) negative subarachnoid hemorrhage (SAH)  is approximately 15% of all patients.4) Perimesencephalic  nonaneurysmal SAH (PN-SAH) was first described by Van Gijn et al.",Non-OADS,/arxiv_data1/oa_pdf/2d/8d/jcen-14-210.PMC3491216.pdf
"2012 September;14(3):216~222 Received : 2 August 2012 Revised : 5 September 2012Accepted : 19 September 2012 Correspondence to Sung Jin Cho, MD Department of Neurosurgery,  Soonchunhyang University Hospital, 657 Hannam-dong, Yongsan-Gu, Seoul  140-743, Korea Tel : (001) 82-2-709-9268 Fax : (001) 82-2-792-5976 E-mail : chosj@schmc.ac.kr This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Keywords Moyamoya disease, Cerebral revascularization, Indirect bypass surgery,  Combined bypass surger yJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.216 Original Article INTRODUCTION Moyamoya disease (MMD) is characterized by grad- ual stenosis or occlusion of the bilateral internal car- otid arteries; this occlusion induces development of  collateral circulation, called moyamoya vessels in the basal ganglia.19)24) Occurrence of this disease is more  frequent among young teenagers and adults in their  30s to 40s, and represents the most common cause of ischemic stroke in children.",Non-OADS,/arxiv_data1/oa_pdf/28/ca/jcen-14-216.PMC3491217.pdf
"2012 September;14(3):223~227 Received : 5 June 2012 Revised : 17 July 2012Accepted : 24 July 2012 Correspondence to Bae Ju Kwon, MD, PhD Department of Radiology, Myongji  Hospital, College of Medicine, Kwandong  University, 697-24 Hwajeong-Dong,  Dukyang-gu, Goyang 412-270, Korea Tel : (001) 82-31-810-5599  Fax : (001) 82-31-810-7171 E-mail : bjkwon74@gmail.com This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Keywords Posterior inferior cerebellar artery, Intracranial aneurysm, Endovascular  treatmentJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.223 Case Report INTRODUCTION Aneurysms at the origin of the posterior inferior cer- ebellar artery (PICA) remain a challenge for neuro- surgeons because the close proximity to the brainstem  and lower cranial nerves poses a high risk for surgical  clipping.1)14)15) Aside from such anatomic unchange- ability of adjacent structures, complex anatomic features of PICA origin aneurysms themselves also add high  risks for both surgical and endovascular treatments.",Non-OADS,/arxiv_data1/oa_pdf/4f/0a/jcen-14-223.PMC3491218.pdf
"2012 September;14(3):228~232 Received : 30 May 2012 Revised : 29 June 2012 Accepted : 29 July 2012 Correspondence to Hyun-Jin Woo, MD Department of Neurosurgery, School of  Medicine, Kyungpook National University,  50, Samduk-2-ga, Jung-gu, Daegu 700-721, Korea Tel : (001) 82-53-420-6524 Fax : (001) 82-53-423-0504E-mail : jraah@naver.com Keywords Dissection, Posterior inferior cerebellar artery, Vertebral arter yThis is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Journal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.228  Case Report A B Fig.",Non-OADS,/arxiv_data1/oa_pdf/7c/ed/jcen-14-228.PMC3491219.pdf
"2012 September;14(3):233~236 Received : 22 June 2012 Revised : 14 August 2012Accepted : 20 August 2012 Correspondence to Sung Nam Hwang, MD,  PhD Department of Neurosurgery, Chung-Ang  University College of Medicine, 224-1 Heukseok-dong, Dongjak-gu, Seoul  156-755, Korea Tel : (001) 82-2-6299-3189 Fax : (001) 82-2-821-8409 E-mail : tarheelk@hanmail.net This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/04/jcen-14-233.PMC3491220.pdf
"Keywords Intracranial thrombosis, Venous thrombosis, Cerebral infarction, Brain edemaJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.233  Case Report INTRODUCTION Deep cerebral venous thrombosis is an uncommon  but often fatal disease, which can result in possible  stroke, coma, and local neuropathies, with a mortality rate of 8-14%.",Non-OADS,/arxiv_data1/oa_pdf/63/04/jcen-14-233.PMC3491220.pdf
"2012 September;14(3):237~242 Received : 26 July 2012 Revised : 16 August 2012Accepted : 20 August 2012 Correspondence to Yoon-Soo Lee, MD Department of Neurosurgery, Daegu  Fatima Hospital, 576-31 Sinam-dong,  Dong-gu, Daegu 701-600, Korea Tel : (001) 82-53-940-7330, 7339 Fax : (001) 82-53-954-7417 E-mail : paulyoonsoolee@hanmail.net This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/35/jcen-14-237.PMC3491221.pdf
"Keywords Infraoptic, Anterior cerebral artery, Y-stentJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.237 Case Report INTRODUCTION The first segment (A1) of the anterior cerebral artery  (ACA) normally branches off from the terminal of the  internal carotid artery (ICA), runs above the optic  nerve, and courses anteromedially to join the anterior  communicating artery (ACoA).",Non-OADS,/arxiv_data1/oa_pdf/15/35/jcen-14-237.PMC3491221.pdf
"2012 September;14(3):243~246 Received : 20 March 2012 Revised : 1 May 2012 Accepted : 24 May 2012 Correspondence to Kil Sung Chae, MD Department of Neurosurgery, Bongseng  Memorial Hospital, Jwa Cheon 1-dong,  Dong-gu, Busan 601-723, Korea Tel : (001) 82-51-664-4104 Fax : (001) 82-51-631-8054 E-mail : drkschae@gmail.com Keywords Distal superior cerebellar artery aneurysm, Coil embolization, Thrombosed  aneurysmThis is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Journal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.243 Case Report INTRODUCTION The incidence of aneurysms from the distal superior  cerebellar artery (SCA) is only 0.2% of all intracranial  aneurysms.1) Several surgical procedures, including  parent artery occlusion, clipping of the aneurysmal neck, trapping of the bleeding site, and wrapping of the aneurysm have been proven effective in prevent-ing rupture of a distal SCA aneurysm.",Non-OADS,/arxiv_data1/oa_pdf/66/e2/jcen-14-243.PMC3491222.pdf
"2012 September;14(3):247~250 Received : 11 June 2012 Revised : 3 August 2012 Accepted : 25 August 2012 Correspondence to Chun-Sung Cho, MD, PhD Department of Neurosurgery, Dankook  University College of Medicine, 29 Anseo-dong, Cheonan 330-714, Korea Tel : (001) 82-41-550-6369 Fax : (001) 82-41-552-6870 E-mail : babyface@dankook.ac.kr Keywords Delayed self-expansion, Neuroform stent, Intracranial aneurysm, ComplicationThis is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Journal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.247 Case Report INTRODUCTION The Neuroform stent (NFS; Boston Scientific/Target,  Fremont, CA), a nickel-titanium alloy (Nitinol), pro- vides a high grade of elasticity and deformability, and  has been authorized for treatment of wide-necked  aneurysms under a humanita rian device exemption  by the Food and Drug Administration (FDA).",Non-OADS,/arxiv_data1/oa_pdf/ec/f3/jcen-14-247.PMC3491223.pdf
"2012 September;14(3):251~254 Received : 24 July 2012 Revised : 17 August 2012Accepted : 6 September 2012 Correspondence to Ki-Young Kwon, MD Department of Neurosurgery, Cheongju St.  Mary’s Hospital, 589-5 Jujung-dong,  Sangdang-gu, Cheongju 360-568, Korea Tel : (001) 82-43-219-8467 Fax : (001) 82-43-211-7925 E-mail : drkwon72@naver.com This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Keywords Cerebral venous thrombosis, Superior sagittal sinus, Hyperthyroidism,  Hypercoagulabilit yJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.251 Case Report INTRODUCTION Cerebral venous and sinus thrombosis is a rare con- dition accounting for < 1% of all strokes.7) Its annual  incidence is estimated at three to four cases per one  million members of the population, most often affect-ing young adults and children.",Non-OADS,/arxiv_data1/oa_pdf/c2/d0/jcen-14-251.PMC3491224.pdf
"2012 September;14(3):255~261 Received : 23 August 2012 Revised : 4 September 2012 Accepted : 10 September 2012 Correspondence to Yong Cheol Lim, MD, PhD Department of Neurosurgery, Ajou  University School of Medicine, 5 San,  Woncheon-Dong, Yongtong-Ku, Suwon 442-721, Korea Tel : (001) 82-31-219-5232 Fax : (001) 82-31-219-5238E-mail : nsyclim@gmail.com Keywords Churg-Strauss syndrome, Intracerebral hemorrhages, Subarachnoid hemorrhageThis is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Journal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.255  Case Report INTRODUCTION Churg-Strauss syndrome (CSS) is a systemic dis- order characterized by asthma, transient pulmonary  infiltrates, hypereosinophilia, and systemic vasculitis.",Non-OADS,/arxiv_data1/oa_pdf/6b/41/jcen-14-255.PMC3491225.pdf
"262 ErratumErratumErratum Erratum to “Prevalence and Epidemiological Features of  Moyamoya Disease in Korea ” (JCEN vol.14, no.2, 2012) Sang Hyuk Im,1 Chul Bum Cho,2 Won Il Joo,3 Chung Kee Chough,3 Hae Kwan Park,3 Kyung Jin Lee,3  Hyoung Kyun Rha3 1Department of Neurosurgery, College of Medicine, Catholic University, Seoul, Korea 2Department of Neurosurgery, Hallym University College of Medicine, Seoul, Korea 3Department of Neurosurgery, Catholic Neuroscience Center, Yeouido St. Mary’s Hospital, College of Medicine,  Catholic University, Seoul, KoreaJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.262  Erratum Prevalence and Epidemiological Features of Moyamoya Disease in Korea J Cerebrovasc Endovasc Neurosurg 2012 Jun;14(2) :75-78.",Non-OADS,/arxiv_data1/oa_pdf/1b/14/jcen-14-262.PMC3491226.pdf
"(http://dx.doi.org/10.7461/jcen.2012.14.2.75)  In the above article, name of the first author, “San g Hyuk Im”, was printed mistakenly as “Sang Hyuk  Yim” by negligence of the authors.",Non-OADS,/arxiv_data1/oa_pdf/1b/14/jcen-14-262.PMC3491226.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;83:259-266 http://dx.doi.org/10.4174/jkss.2012.83.5.259 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received May 24, 2012, Revised August 27, 2012, Accepted September 7, 2012 Correspondence to: Jung Han Yoon Department of Surgery, Chonnam National University Medi cal School, 160 Baekseo-ro, Dong-gu, Gwangju 501-746, Korea Tel: ＋82-61-379-7657, Fax: ＋82-61-379-7661, E-mail: jhyoon@jnu.ac.kr This study results were presented at the annual meeting of the Korean Association of Thyroid and Endocrine Surgeons in April 20 12. cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/3e/8b/jkss-83-259.PMC3491227.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;83:267-273 http://dx.doi.org/10.4174/jkss.2012.83.5.267 ORIGINAL ARTICLE JKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received June 25, 2012, Revised August 10, 2012, Accepted September 2, 2012 Correspondence to: Kee-Hyun Nam Department of Surgery, Yonsei University College of Me dicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Korea Tel: ＋82-2-2228-2100, Fax: ＋82-2-313-8289, E-mail: khnam@yuhs.ac cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/fa/92/jkss-83-267.PMC3491228.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;83:274-280 http://dx.doi.org/10.4174/jkss.2012.83.5.274 ORIGINAL ARTICLE JKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received May 7, 2012, Revised July 30, 2012, Accepted August 5, 2012 Correspondence to: Min Chan Kim Department of Surgery, Dong-A University College of Medicine, 26 Daesingongwon-ro, Seo-gu, Busan 602-715, Korea Tel: ＋82-51-240-2643, Fax: ＋82-51-247-9316, E-mail: mckim@donga.ac.kr  cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/96/1c/jkss-83-274.PMC3491229.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;83:281-287 http://dx.doi.org/10.4174/jkss.2012.83.5.281 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received April 13, 2012, Revised August 6, 2012, Accepted September 2, 2012 Correspondence to: Jin Soo Kim Department of Surgery, Chungnam National University Hospital, 282 Munhwa-ro, Jung-gu, Daejeon 301-721, Korea Tel: ＋82-42-280-7175, Fax: ＋82-42-257-8024, E-mail: jskim2000@cnuh.co.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/68/1b/jkss-83-281.PMC3491230.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;83:288-297 http://dx.doi.org/10.4174/jkss.2012.83.5.288 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received May 16, 2012, Revised August 6, 2012, Accepted August 23, 2012 Correspondence to: Gyu-Seog Choi Colorectal Cancer Center, Kyungpook National University Medical Center, Kyungpook National University School of Medicine, 807 Hogukno, Buk-gu, Daegu 702-210, Korea Tel: ＋82-53-200-2166, Fax: ＋82-53-200-2027, E-mail: kyuschoi@mail.knu.ac.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/7c/2a/jkss-83-288.PMC3491231.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;83:298-306 http://dx.doi.org/10.4174/jkss.2012.83.5.298 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received April 26, 2012, Revised September 15, 2012, Accepted October 4, 2012 Correspondence to: Kyung Sik Kim Department of Surgery, Yonsei University College of Me dicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Korea Tel: ＋82-2-2228-2125, Fax: ＋82-2-313-8289, E-mail: kskim88@yuhs.ac cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/03/db/jkss-83-298.PMC3491232.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;83:307-315 http://dx.doi.org/10.4174/jkss.2012.83.5.307 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received May 29, 2012, Revised August 10, 2012, Accepted August 23, 2012 Correspondence to: Young-Wook Kim Division of Vascular Surgery, Department of Surgery, Samsung Medical Center, Sungkyu nkwan University School of Medicine, 81  Irwon-ro, Gangnam-gu, Seoul 135-710, Korea Tel: ＋82-2-3410-3461, Fax: ＋82-2-3410-0040, E-mail: ywkim@skku.edu cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/00/49/jkss-83-307.PMC3491233.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;83:316-320 http://dx.doi.org/10.4174/jkss.2012.83.5.316 CASE REPORTJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received April 20, 2012, Revised July 9, 2012, Accepted July 30, 2012 Correspondence to: Jin Seok Heo  Department of Surgery, Sa msung Medical Center, Sungkyunkwan Un iversity School of Medicine, 81  Irwon-ro, Gangnam-gu, Seoul 135-7 10,  Korea Tel: ＋82-2-3410-0262, Fax: ＋82-2-3410-6980, E-mail: jinseok.heo@samsung.com cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/67/f3/jkss-83-316.PMC3491234.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;83:321-324 http://dx.doi.org/10.4174/jkss.2012.83.5.321 CASE REPORT JKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received March 5, 2012, Revised June 29, 2012, Accepted July 30, 2012 Correspondence to: Shin Young Park Department of Pathology, Konyang University Hospital, 158 Gwanjeodong-ro, Seo-gu, Daejeon 302-718, Korea Tel: ＋82-42-600-9302, Fax: ＋82-42-600-9280, E-mail: parksy@konyang.ac.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/10/16/jkss-83-321.PMC3491235.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;83:325-329 http://dx.doi.org/10.4174/jkss.2012.83.5.325 CASE REPORTJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received May 14, 2012, Revised July 23, 2012, Accepted August 10, 2012 Correspondence to: Dong Hee Ryu Department of Surgery, Chungbuk National University College of Medicine and Medical Research Institute, 410 Sungbong-ro,  Heungdeok-gu, Cheong ju 361-763, Korea Tel: ＋82-43-269-6034, Fax: ＋82-43-266-6037, E-mail: dhryu@chungbuk.ac.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/dd/1f/jkss-83-325.PMC3491236.pdf
"Copyright © 2012, the Korean Surgical SocietyJ Korean Surg Soc 2012;83:330-334 http://dx.doi.org/10.4174/jkss.2012.83.5.330 CASE REPORT JKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received May 7, 2012, Revised June 27, 2012, Accepted July 3, 2012 Correspondence to: Chol-Kyoon Cho Division of Hepatico-Biliary-Pancreatic Surgery, Department of Surgery, Chonnam National University Medical School, 42 Jebong-r o,  Dong-gu, Gwangju 501-757, KoreaTel: ＋82-61-379-7646, Fax: ＋82-61-379-7661, E-mail: ckcho@jnu.ac.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/88/72/jkss-83-330.PMC3491237.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/a7/d2/IJO-60-349.PMC3491256.pdf
Available from: http://www.nigeriamasterweb.com/Nigeria06censusng.,Non-OADS,/arxiv_data1/oa_pdf/3c/5a/IJO-60-351.PMC3491257.pdf
Available from : http://www.ogunstate.gov.ng.,Non-OADS,/arxiv_data1/oa_pdf/3c/5a/IJO-60-351.PMC3491257.pdf
Available from: http://www.preemiehelp.com.,Non-OADS,/arxiv_data1/oa_pdf/3c/5a/IJO-60-351.PMC3491257.pdf
Available from: http://www.narayananethralaya.org/ pdf_files/iim_ahmedabad_case_study_n_kidro.,Non-OADS,/arxiv_data1/oa_pdf/3c/5a/IJO-60-351.PMC3491257.pdf
Available from: http://www.CIA World Fact Book/ Latin America.,Non-OADS,/arxiv_data1/oa_pdf/3c/5a/IJO-60-351.PMC3491257.pdf
Available from: http://www.CIA World Fact Book / Latin America.,Non-OADS,/arxiv_data1/oa_pdf/3c/5a/IJO-60-351.PMC3491257.pdf
Available from: http://www.visualiza / Latin America.,Non-OADS,/arxiv_data1/oa_pdf/3c/5a/IJO-60-351.PMC3491257.pdf
Available from: http://www.Fundación Visión / Latin America.,Non-OADS,/arxiv_data1/oa_pdf/3c/5a/IJO-60-351.PMC3491257.pdf
Available from: http://www.Instituto de la Visión / Latin America.,Non-OADS,/arxiv_data1/oa_pdf/3c/5a/IJO-60-351.PMC3491257.pdf
`Available from: http://www.sbp.org.pk/departments/stats/PakEconomy_HandBook/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/54/46/IJO-60-358.PMC3491258.pdf
Author Help: Online Submission of the Manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/54/46/IJO-60-358.PMC3491258.pdf
Available from: http://www.vision2020.org/ mediaFiles/downloads/2905749/Vision2020_report_pdf.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5c/21/IJO-60-365.PMC3491259.pdf
Available from: http://www.icoph.,Non-OADS,/arxiv_data1/oa_pdf/5c/21/IJO-60-365.PMC3491259.pdf
Available from: http://www.paao.org/images/ Downloads/spanish/pdf/ProgramaDeSaludComunitaria2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5c/21/IJO-60-365.PMC3491259.pdf
Available from: http://www.who.int/ blindness/ACTION_PLAN_WHA62-1-English.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5c/21/IJO-60-365.PMC3491259.pdf
Available from: https://www.iceh.,Non-OADS,/arxiv_data1/oa_pdf/5c/21/IJO-60-365.PMC3491259.pdf
Available from: http://www.iceh.org.uk/display/ WEB/Home.,Non-OADS,/arxiv_data1/oa_pdf/5c/21/IJO-60-365.PMC3491259.pdf
Available from: http://www.phmovement.org/sites/www.phmovement.org/files/phm-pch-english.pdf.,Non-OADS,/arxiv_data1/oa_pdf/65/25/IJO-60-368.PMC3491260.pdf
Available from: http://www.who.int/social_determinants/thecommission/finalreport/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/65/25/IJO-60-368.PMC3491260.pdf
Available from: http://hdr.undp.org/en/statistics/hdi/.,OADS,/arxiv_data1/oa_pdf/65/25/IJO-60-368.PMC3491260.pdf
Available from: http://www.vision2020.org/documents/publications/SotWS%20Report_wth_Stop_Press.pdf.,Non-OADS,/arxiv_data1/oa_pdf/65/25/IJO-60-368.PMC3491260.pdf
Available from: http://www.who.int/blindness/estimates2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/20/26/IJO-60-376.PMC3491261.pdf
Available from: http://www.who.int/blindness/ACTION_PLAN_WHA62-1-English.pdf.,Non-OADS,/arxiv_data1/oa_pdf/20/26/IJO-60-376.PMC3491261.pdf
Available from: http://www.who.int/blindness/ACTION_PLAN_ WHA62-1-English.pdf.,Non-OADS,/arxiv_data1/oa_pdf/20/26/IJO-60-376.PMC3491261.pdf
Available from : http://npcb.nic.in/ writereaddata/mainlinkFile/File246.pdf.,Non-OADS,/arxiv_data1/oa_pdf/20/26/IJO-60-376.PMC3491261.pdf
Available from: http://www.who.int/classifications/icd/2006updates.pdf.,OADS,/arxiv_data1/oa_pdf/55/6b/IJO-60-380.PMC3491262.pdf
Available from: http://www.who.int/blindness/Vision2020_report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/55/6b/IJO-60-380.PMC3491262.pdf
Available from: http://www.icee.org/publications/ research/pdfs/hr/A%20Comprehensive%20Refractive%20Error%20Training.pdf.,Non-OADS,/arxiv_data1/oa_pdf/55/6b/IJO-60-380.PMC3491262.pdf
Available from: http://www.ecoo.info/mm/ DiplERegulations.pdf.,Non-OADS,/arxiv_data1/oa_pdf/55/6b/IJO-60-380.PMC3491262.pdf
Available from: http://www.schoolsandhealth.org/Documents/Declaration%20of%20the%20Second%20Oxford%20Conference%20on%20Child%20Vision.pdf.,Non-OADS,/arxiv_data1/oa_pdf/55/6b/IJO-60-380.PMC3491262.pdf
Available from: http://trachoma.org/sites/default/files/guidesandmanuals/2020INSight_EnglishLR.pdf.,Non-OADS,/arxiv_data1/oa_pdf/55/6b/IJO-60-380.PMC3491262.pdf
Available from: http://www.vision2020india.org/dr_manual.pdf.,Non-OADS,/arxiv_data1/oa_pdf/55/6b/IJO-60-380.PMC3491262.pdf
Available from: http://www.who.int/blindness/publications/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/55/6b/IJO-60-380.PMC3491262.pdf
Available from: http://www.amdalliance.org/ user_files/documents/Global%20cost%20of%20VI_FINAL%20 report.pdf.,OADS,/arxiv_data1/oa_pdf/55/6b/IJO-60-380.PMC3491262.pdf
Available from: http://www.vision2020.org/mediaFiles/downloads/1691061/HealthSystemsandEyeHealthBP.,Non-OADS,/arxiv_data1/oa_pdf/55/6b/IJO-60-380.PMC3491262.pdf
Available  from: http://www.who.int/workforcealliance/Kampala%20 Declaration%20and%20Agenda%20web%20file.%20FINAL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/55/6b/IJO-60-380.PMC3491262.pdf
Available from: http://www.vision2020.org/documentHandler.cfm?dld=3532&pflag=docm93j ijm4n3532.,Non-OADS,/arxiv_data1/oa_pdf/55/6b/IJO-60-380.PMC3491262.pdf
Available  from: http://www.vision2020.org/documentHandler.cfm?dld=353 3&pflag=docm93jijm4n3533.,Non-OADS,/arxiv_data1/oa_pdf/55/6b/IJO-60-380.PMC3491262.pdf
Available from: http://www.vision2020.org/mediaFiles/ downloads/1691061/NECManualLowResFINAL3 pdf.,Non-OADS,/arxiv_data1/oa_pdf/55/6b/IJO-60-380.PMC3491262.pdf
Available from : http://apps.who.,Non-OADS,/arxiv_data1/oa_pdf/9d/57/IJO-60-387.PMC3491263.pdf
Available from:  http://www.vision2020.org/ main.cfm?type=RECOMMITTEE&objectid=3572.,Non-OADS,/arxiv_data1/oa_pdf/9d/57/IJO-60-387.PMC3491263.pdf
Available from: http://www.live.who.int/healthinfo/  paper36.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9d/57/IJO-60-387.PMC3491263.pdf
Available  from: http://www.icee.org/pdf/10-may/20100416_Delhi%20Declaration_FINAL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/63/d4/IJO-60-401.PMC3491265.pdf
Available from: http://www.sightsavers.org/in_depth/policy_and_research/ health/13150_Eyecare%20in%20India%20-%20A%20Situaltion%20Analysis.pdf.,Non-OADS,/arxiv_data1/oa_pdf/63/d4/IJO-60-401.PMC3491265.pdf
"The remarkable achievements of the ‘ Africa Program for  Figure 2:  Expected number of cases of severe acute malnutrition by  region across the Sahel in 2012https://www.unicef.ie/Downloads/Sahel_Appeal2.pdf downloaded April 30, 2012",Non-OADS,/arxiv_data1/oa_pdf/ac/b0/IJO-60-411.PMC3491267.pdf
Available from : http://www.afro.who.int/index.php?option=com_ docman&task=doc_download&gid=427&Itemid=2111.,OADS,/arxiv_data1/oa_pdf/ac/b0/IJO-60-411.PMC3491267.pdf
Available from : http://siteresources.worldbank.org/ INTGLOMONREP2007/Resources/3413191-1179404785559/Chp2- GMR07_webPDF-corrected-may-14-2007-5.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ac/b0/IJO-60-411.PMC3491267.pdf
Available  from: http://www.oecd.org/dataoecd/50/52/49177689.pdf.,OADS,/arxiv_data1/oa_pdf/ac/b0/IJO-60-411.PMC3491267.pdf
Available from : http://www.handicap-international.fr/ bibliographie-handicap/4PolitiqueHandicap/hand_pauvrete/mdg/ REPORT_EU_Conference_MDGs_Inclusion_of_PwD.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ac/b0/IJO-60-411.PMC3491267.pdf
Available from: http://www.apapr.ro/images/stories/materiale/ COMUNICATE/2010/2010%2031%20attach.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ac/b0/IJO-60-411.PMC3491267.pdf
Available from:  http://www.who.int/nutrition/topics/vad/en.,Non-OADS,/arxiv_data1/oa_pdf/ac/b0/IJO-60-411.PMC3491267.pdf
Available from: http://www.ceeindia.,Non-OADS,/arxiv_data1/oa_pdf/ac/b0/IJO-60-411.PMC3491267.pdf
Available at: http://www.ghd-net.org/negotiations/health-related- mdgs/research/undp-unlocking-progress-mdg-acceleration- road-2015-0.,Non-OADS,/arxiv_data1/oa_pdf/ac/b0/IJO-60-411.PMC3491267.pdf
Available at http://www.unicef.org/ publications/index_58840.html.,Non-OADS,/arxiv_data1/oa_pdf/ac/b0/IJO-60-411.PMC3491267.pdf
Available from: http://www.who.int/features/2006/trachoma/ en/index.html.,OADS,/arxiv_data1/oa_pdf/ac/b0/IJO-60-411.PMC3491267.pdf
Available from: http://www.un.org/millenniumgoals/environ.,Non-OADS,/arxiv_data1/oa_pdf/ac/b0/IJO-60-411.PMC3491267.pdf
Available from: http://www.screening.nhs.uk/kpi.,Non-OADS,/arxiv_data1/oa_pdf/86/c8/IJO-60-428.PMC3491270.pdf
Available from: http://www.who.int/ mediacentre/news/releases/2006/pr55/en/print.html.,Non-OADS,/arxiv_data1/oa_pdf/75/3e/IJO-60-432.PMC3491271.pdf
Available  from: http://www.icee.org/news/news_display.asp?ID=44.,Non-OADS,/arxiv_data1/oa_pdf/75/3e/IJO-60-432.PMC3491271.pdf
Available from: http://www.icee.org/publications/annual_reports/Annual_Review2011_web.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/3e/IJO-60-432.PMC3491271.pdf
Available from: http://hdr.undp.org/en/statistics/hdi/.,OADS,/arxiv_data1/oa_pdf/4a/c3/IJO-60-438.PMC3491272.pdf
Available from: http://www.igidr.ac.in/pdf/publication/WP-2010-001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/38/IJO-60-451.PMC3491274.pdf
Affordable equipment and low vision devices are available from the Low Vision  Resource Centre (LVRC) at the Hong Kong Society for the Blind  (http://www.hksb.org.hk/en/).,Non-OADS,/arxiv_data1/oa_pdf/3d/75/IJO-60-456.PMC3491275.pdf
Available from: http://www.who.int/hpr/NPH/docs/declaration_almaata.pdf.,OADS,/arxiv_data1/oa_pdf/3d/75/IJO-60-456.PMC3491275.pdf
Available from: http://www.who.int/about/regions/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/3d/75/IJO-60-456.PMC3491275.pdf
Available from: https://educators.icoph.org/Tsearch.php?Title=&Description=&Guideline=2&Source=&Importance=0 &Contributor=&DateSelect=&date2=&Category[]=1&Extensions =0&Language=0&Interactivity=0&Search=Search.,Non-OADS,/arxiv_data1/oa_pdf/3d/75/IJO-60-456.PMC3491275.pdf
"American Diabetes Association www.diabetes.org Diabetic retinopathy Yes  American Health Assistance Foundationwww.ahaf.org Age-related macular degeneration, glaucomaYes ARVO Foundation for Eye Researchhttp://arvo.org/eweb/DynamicPage.aspx?site=foundation&WebCode=awardsVarious Yes  Foundation Fighting Blindness www.blindness.org Retinitis pigmentosa, macular degeneration, Usher syndrome, retinal degenerative diseasesYes Glaucoma Foundation www.glaucomafoundation.org Glaucoma Yes Glaucoma Research Foundationwww.glaucoma.org Glaucoma Yes Helen Keller Foundation www.helenkellerfoundation.org Vision impairing conditions Yes  Juvenile Diabetes Foundation www.jdrf.org Diabetic retinopathy Yes Macular Degeneration Foundationwww.eyesight.org Macular degeneration Yes Prevent Blindness America www.preventblindness.org Eye diseases that threaten vision loss and blindnessNo Vision of Children Foundation www.visionofchildren.org Hereditary childhood blindness and other vision disordersYes",Non-OADS,/arxiv_data1/oa_pdf/a3/59/IJO-60-460.PMC3491276.pdf
Available from: http://www.vision-research.eu/index.php?id=684.,Non-OADS,/arxiv_data1/oa_pdf/a3/59/IJO-60-460.PMC3491276.pdf
Available from: http://www.vision2020.org/main.cfm?type=STRATPLAN.,Non-OADS,/arxiv_data1/oa_pdf/a3/59/IJO-60-460.PMC3491276.pdf
–Available from: http://www.icoph.org/resources/2/Research- Agenda-for-Global-Blindness-Prevention.html.,Non-OADS,/arxiv_data1/oa_pdf/a3/59/IJO-60-460.PMC3491276.pdf
Available from: http://report.nih.gov/rcdc/categories/.,OADS,/arxiv_data1/oa_pdf/a3/59/IJO-60-460.PMC3491276.pdf
Available from: http://www.usinflationcalculator.com/inflation/annual-averages-for-rate-of-inflation/.,Non-OADS,/arxiv_data1/oa_pdf/a3/59/IJO-60-460.PMC3491276.pdf
Available from: http://www.report.nih.gov.,OADS,/arxiv_data1/oa_pdf/a3/59/IJO-60-460.PMC3491276.pdf
Available from: http://www.mrc.ac.uk/Fundingopportunities/Applicanthandbook/Successrates/Applicationsuccessrates/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/a3/59/IJO-60-460.PMC3491276.pdf
Available from: http://www.nhmrc.gov.au/grants/research-funding-statistics-and-data/summary-funding-data/nhmrc-project-grants-success-rate-b.,Non-OADS,/arxiv_data1/oa_pdf/a3/59/IJO-60-460.PMC3491276.pdf
Available from: http://www.eyesight.org/Grant_Application/grant_application.html.,Non-OADS,/arxiv_data1/oa_pdf/a3/59/IJO-60-460.PMC3491276.pdf
Available from: http://www.pfizer.com/research/investigator/investigator_initiated_research.jsp.,OADS,/arxiv_data1/oa_pdf/a3/59/IJO-60-460.PMC3491276.pdf
Available from: http://www.alcon.com/en/research-development/ari/.,Non-OADS,/arxiv_data1/oa_pdf/a3/59/IJO-60-460.PMC3491276.pdf
Available from: http://www.lionsclubs.org/EN/member-center/planning-projects/sight-hearing/sight/lehp/index.php?utm_source=constantcontact&utm_medium=email&utm_campaign=Nov2012Newswire.,Non-OADS,/arxiv_data1/oa_pdf/a3/59/IJO-60-460.PMC3491276.pdf
http://phi.uhce.ox.ac.uk/instruments.php [Last accessed on 2012 Aug 6] 48.,Non-OADS,/arxiv_data1/oa_pdf/ae/0a/IJO-60-464.PMC3491277.pdf
London: Kings Fund; 2011. http://www.kingsfund.org.uk/topics/patientcentred_care/.,Non-OADS,/arxiv_data1/oa_pdf/ae/0a/IJO-60-464.PMC3491277.pdf
The full research report outlines the assumptions and data  sources used and can be located at the following link: http://www.hollows.org.au/our-work/the-price-of-sight.,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs282/e/.,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://www.who.int/blindness/ACTIO_PLA_ WHA62-1-English.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://www.who.int/healthsystems/ strategy/everybodys_business.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from:  http://www.vision2020.org/documents/publications/Vision2020_ report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://www.cartercenter.org/ documents/1047.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://data.worldbank.,OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://www.amdalliance.org/user_files/documents/Global%20cost%20of%20VI_FINAL%20report.pdf.,OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://www.vision2020uk.org.uk/ukvisionstrategy/page.asp?sectio=74.,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://www.vision2020.,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://www.oecd.,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://www.payscale.,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://www.fahcsia.gov.au/our-responsibilities/disability-and-carers/publications-articles/policy-research/rural-and-remote-disability-employment-assistance-study.,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available  from: http://www.federalreserve.gov/releases/g5a/current/.,OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://www.x-rates.com/cgi-bi/hlookup.cgi.,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=6442459888.,OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://data.worldbank.org/about/country-classifications/country-and-lending-groups.,OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://esa.u.org/ unpp.,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from:  http://www.who.int/rpc/summit/e/Task_Force_o_Health_Systems_ Research.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://www.trachomacoalitio.org/about-us/get- 2020.,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://www.cera.org.au/ uploads/CERA_clearinsight.pdf.,OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://www.at0086.com/CDMU/admission- information.aspx.,Non-OADS,/arxiv_data1/oa_pdf/1e/e1/IJO-60-475.PMC3491279.pdf
Available from: http://www.nrhm-mis.nic.in.,Non-OADS,/arxiv_data1/oa_pdf/b8/99/IJO-60-492.PMC3491282.pdf
Available from: http://www.tribal.nic.in.,Non-OADS,/arxiv_data1/oa_pdf/b8/99/IJO-60-492.PMC3491282.pdf
Available from: http://www.censusindia.gov.in.,OADS,/arxiv_data1/oa_pdf/b8/99/IJO-60-492.PMC3491282.pdf
(http://www.who.int/immunization_monitoring/routine/EPI_coverage_survey.pdf)  16.,Non-OADS,/arxiv_data1/oa_pdf/b8/99/IJO-60-492.PMC3491282.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/cc/8a/IJHG-18-150.PMC3491285.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/22/83/IJHG-18-155.PMC3491286.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3y sr3me for the free  applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/22/83/IJHG-18-155.PMC3491286.pdf
Available from http://www.measuredhs.com/pubs/pdf/SR128/SR128.pdf.,Non-OADS,/arxiv_data1/oa_pdf/39/ed/IJHG-18-177.PMC3491290.pdf
Author Help: Online Submission of the Manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/45/a1/IJHG-18-217.PMC3491296.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/58/39/IJHG-18-222.PMC3491297.pdf
2006; Available from: http://www.emedicine.com/med/ topic317.htm 3.,Non-OADS,/arxiv_data1/oa_pdf/da/55/IJHG-18-229.PMC3491299.pdf
2004; Available  from: http://www.wma.net/e/policy/b3.htm 5. International Conference of Harmonisation (ICH).,Non-OADS,/arxiv_data1/oa_pdf/da/55/IJHG-18-229.PMC3491299.pdf
1996; Available from:  http://www.ich.org/LOB/media/MEDIA482.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/da/55/IJHG-18-229.PMC3491299.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/8a/62/DRJ-9-361.PMC3491320.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/78/06/DRJ-9-381.PMC3491322.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/15/52/DRJ-9-393.PMC3491324.pdf
Start a QR-code reading software (see list of free  applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/22/ee/DRJ-9-441.PMC3491332.pdf
See http:// tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/22/ee/DRJ-9-441.PMC3491332.pdf
Available  from: http://www.en.wikipedia.org/wiki/Phosphoric_ acid#composition_and_ph_of_a_Phosphoric_acid_aqueous_ solution.,Non-OADS,/arxiv_data1/oa_pdf/43/82/DRJ-9-447.PMC3491333.pdf
Available  from: http://www.azon.com/article.aspx?,Non-OADS,/arxiv_data1/oa_pdf/43/82/DRJ-9-447.PMC3491333.pdf
Available  from: http://www.azon.com/article.aspx?article ID:1336#_ summary_of_corrosion.,Non-OADS,/arxiv_data1/oa_pdf/43/82/DRJ-9-447.PMC3491333.pdf
Available  from: http://www.en.wikipedia.org/wiki/ultrasonic-cleaning.,Non-OADS,/arxiv_data1/oa_pdf/43/82/DRJ-9-447.PMC3491333.pdf
Available from: http://www.pulpdent.com/ products/view/16/category [Last Cited on 2010 Mar 01].,Non-OADS,/arxiv_data1/oa_pdf/5d/32/DRJ-9-460.PMC3491335.pdf
Available from:  http://www.kerrhawe.com/learning/publications/2009catalog/english/Chapter03English.pdf [Last cited on 2010 Mar 11].,Non-OADS,/arxiv_data1/oa_pdf/5d/32/DRJ-9-460.PMC3491335.pdf
"2012, 8      http://www.biolsci.org  1206  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2012; 8(8):1206-1216. doi: 10.7150/ ijbs.5147   Research Paper   Tube -Like Structures with Co -Expression of D2 -40 and CD34 : Newly Formed  Vasculatures ?",Non-OADS,/arxiv_data1/oa_pdf/b0/c6/ijbsv08p1206.PMC3491428.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org /  licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b0/c6/ijbsv08p1206.PMC3491428.pdf
"2012, 8      http://www.biolsci.org  1207  Introduction   Colorectal cancer (CRC) is one of the most  common human malignancies worldwide, and it is  estimated that about 1,200,000 people are diagnosed  with, and over 600,000 people die from, CRC annually  [1].",Non-OADS,/arxiv_data1/oa_pdf/b0/c6/ijbsv08p1206.PMC3491428.pdf
"2012, 8    http://www.biolsci.org  1208  in the adult organs, and that tumor -infiltrating i m- mune cells are major factors to stimu late angiogenesis  and lymphangiogenesis, we have speculated that the  formation of new vasculatures is mediated by the  convergence of stem cells budding and lymphocyte  infiltration.",Non-OADS,/arxiv_data1/oa_pdf/b0/c6/ijbsv08p1206.PMC3491428.pdf
